url
stringlengths 41
420
| text
stringlengths 276
123k
| in_y0
bool 1
class | in_y1
bool 2
classes | category
stringclasses 2
values | publisher
stringclasses 1
value | crawl_date
stringclasses 172
values |
|---|---|---|---|---|---|---|
https://www.kbtx.com/2022/03/31/aggie-fans-ready-history-mens-basketball-teams-plays-nit-championship/
|
Aggie Fans ready for history as Men’s Basketball Teams plays for NIT Championship
BRYAN, Texas (KBTX) - Tip off for the NIT Championship Game starts at 6 p.m., and Aggie fans are gearing up for the basketball game. Texas A&M is playing Xavier at Madison Square Garden in hopes of taking home the championship title.
Back in the Brazos Valley, fans are hoping to see the Aggie’s finish the season strong. Throughout the day local businesses were preparing for big turnouts as the Aggie Men’s Basketball season comes to a close.
Businesses like BigShots have been getting lots of phone calls as fans make plans to watch the game Thursday night.
“We expect a lot of Aggies to come out, new, Former, upcoming Aggies. We’re going to be showing the game on all our TV’s in the bays out here in the yard so we anticipate a lot of people here,” said Rocio Stephens, BigShots Events Sales Manager.
The late season game will be a big boost for businesses from BigShots to bars.
“With this beautiful weather right now and you know opportunity to watch Aggie Basketball on the patio right now is pretty big so we’re excited to have a lot of people out this afternoon at Carneys’ and looking forward to it,” said Barry Ivins, Carney’s Pub & Grill Owner,
Aggies older and younger are excited to see their team get this national attention. Students like Dawson Pruitt feel vindicated after the Aggies missed a spot in March Madness.
“I think it’s just cool that hopefully we go and win the championship and kind of prove people wrong,” said Pruitt.
This is the Aggies’ eighth appearance in the NIT. The game can be watched on ESPN.
KBTX’s Tyler Shaw and Caleb Britt are in New York covering the game.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/aggie-parent-toured-madison-square-garden-with-son-years-ago-now-hes-court/
|
Aggie parent toured Madison Square Garden with son years ago, now he’s on the court
NEW YORK CITY, New York (KBTX) - Aggie parent Leah Spain was full of emotion after Tuesday’s National Invitation Tournament semifinal game in Madison Square Garden. She said she was elated to see the team make it so far as she has attended multiple basketball games throughout the season.
“I went to Houston, Vanderbilt, Georgia, obviously being out of Georgia, Auburn, then I went down to Tampa for the SEC Tournament as well too,” Spain said.
Spain is no stranger to the big apple and brought her son, Jelani Spain, to Madison Square Garden for a tour when he was younger. They even got to see the player locker rooms. Now, she gets to watch her son, who’s a basketball manager, and godson, no. 22 Davin Watkins, on the court at the NIT championship Thursday.
“I’ve got a picture of him already in there and stuff but for them to actually be in there with their stuff, it is amazing,” Spain said. “Everybody is so excited, pumped up and focused.
The Aggie parent said the championship game will be bittersweet after the team and many fans were disappointed that the Aggies didn’t make the NCAA Tournament, also known as the “Big Dance.”
“They’ve played their hearts out, they’ve played to let the people know that you made a mistake by not letting us in that dance but we’re here, and we made it to the New York final four,” Spain said.
As the Aggies gear up for the championship game against Xavier, Spain said she has no worries about the outcome.
“I’m excited, I’m very very excited, I feel like we got this in the bag,” Spain said.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/aggie-track-field-hosts-no-1-texas-dual-meet/
|
Aggie Track & Field Hosts No. 1 Texas in Dual Meet
BRYAN-COLLEGE STATION, Texas – The Texas A&M men’s and women’s track & field teams host No. 1 Texas in a Dual Meet on Saturday, April 2 beginning at 1 p.m. at E.B. Cushing Stadium.
Texas A&M enters the weekend ranked No. 3 in the men’s USTFCCCA national rankings and No. 4 in the women’s poll, while the Longhorns are No. 1 on both the men’s and women’s sides. The dual meet will be scored 5, 3, 2, 1, with five points awarded to the top finisher. Only two individual entries per institution shall score, while the relays will be scored five points for first place and three for second place.
Saturday’s competition is slated to begin with field events at 1 p.m., while the gun goes off for track events at 4:30 p.m. General admission to the meet starts at $7 for adults and $4 for youth. Tickets can be purchased at 12thman.com/tracktickets or at the E.B. Cushing stadium ticket office.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/aggies-begin-3-game-series-against-alabama-friday/
|
Aggies to begin 3 game series against Alabama Friday
TUSCALOOSA, Alabama – The Texas A&M Aggies continue road action with a three-game series against the Alabama Crimson Tide at Sewell-Thomas Stadium. The opener is slated for Friday at 6:02 pm with games also booked for 4:02 pm on Saturday and 1:02 pm on Sunday.
ABOUT THE AGGIES
The Maroon & White have been solid in true road games this year, posting a series win at then-No. 8 LSU, as well as midweek wins at Rice and then-No. 8 Texas the last two Tuesdays, for a 4-1 mark in enemy territory.
The Aggie bats have picked up steam the last eight games, hitting at a .317 clip with a .408 on-base percentage and .538 slugging percentage. The squad has clubbed 21 doubles, two triples and 14 home runs in the span.
Texas A&M boasts one of the nation’s most experienced hitters in Dylan Rock. The UTSA transfer ranks 17th among active NCAA Division I players with 739 at-bats. He ranks fifth among active players in runs (167), seventh in doubles (51), 10th in hits (239), 12th in total bases (368), 23rd in games played (198) and 24th in RBI (134). Rock has an 11-game hit streak, compiling a .477 batting average (21-for-44) over the span with six home runs, four doubles, 14 runs and 19 RBI. On the season, Rock is hitting .358 (29-for-81) with six home runs, six doubles, 21 RBI and 20 runs. He leads the team with eight stolen bases on the season.
Kole Kaler leads the SEC and ranks fifth in the nation with his 27 walks. HIs clip of 1.12 walks per game also leads the SEC and ranks eighth in the nation. Kaler has also been hit by one pitch and he’s batting .270 (24-for-89) with a team-high 22 walks, plus three doubles, 11 RBI and six stolen bases. He sports a .441 on-base percentage. In the last eight games, Kaler has a .545 on-base percentage. During the stretch, he has hit .387 (12-for-31) with two doubles, 10 runs and six RBI and has been walked 11 times. Kaler’s batting average has improved from .207 to 270 over the span.
Jack Moss leads the attack early in the season, batting .393 with a .468 on-base percentage, both team highs. He has reached base in the last 20 games and in 23 of the 24 games this season. On the season, he has a team-high 11 multi-hit games. In addition to batting average and on-base percentage, he leads the team in hits (35). Moss had a 5-for-5 game, hitting for the Aggies’ first cycle since 2018 in A&M’s 12-9 win at Texas. He singled in the first and fourth innings, smashed a two-run home run in the third and roped a double in the sixth. Moss legged out a triple in the eighth to seal the cycle. He also accounted for one of the team’s two grand slams on the season, launching the four-ribbie dinger against Rice.
The Aggies are one of nine teams NCAA Division I teams (301) who have not suffered back-to-back losses in 2022. The list includes Arkansas, Connecticut, Maryland, Oregon State, South Florida, Tennessee Texas A&M, Texas State and Virginia. The Maroon & White are 9-0 in games after a loss in 2022.
SCOUTING THE OPPONENTS
Alabama enters the series with a 15-11 mark, including a 2-4 league ledger. Last weekend, Alabama suffered two walk-off losses to Mississippi State in Starkville, before claiming the series finale. The Tide are batting .291 with a .365 on-base percentage and .464 slugging percentage. A trio of Alabama players are hitting .300 or higher, led by Tommy Seidl who sports a .363 average (33-for-91) with 18 runs, nine doubles, one home run, 16 RBI and seven stolen bases. Zane Denton is hitting .301 (31-for-103) with 20 runs, eight doubles, seven home runs and 22 RBI. Jim Jarvis is batting .300 (30-for-100) with two doubles, three triples, two home runs, nine RBI and five stolen bases.
SERIES NOTES
The Maroon & White have taken the field against Alabama in 27 games previously with the Aggies holding the all-time series lead 17-0.. The programs first met in 1995 with a 6-2 win by Texas A&M. The teams took an eight-year hiatus before meeting in 2003, followed by another 10 years dormant stage until the Aggies joined the SEC in 2013. Texas A&M owns a 14-10 edge in the series since they became league brethren.
In 2021, Alabama swept the Aggies on Olsen Field at Blue Bell Park, winning the games by a combined tally of 18-10.
FOLLOW THE AGGIES
Saturday’s game is featured on SEC Network. All three games can be seen on SEC Network+. On Friday and Sunday, fans can tune in locally on 1150 AM/93.7 FM. Saturday’s game airs on NewsTalk 1620 AM/94.5 FM. All three games can be heard inside the 12th Man Mobile App.
Visit 12thman.com for more information on Texas A&M baseball. Fans can keep up to date with the A&M baseball team on Facebook, Instagram, and on Twitter by following @AggieBaseball.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/bond-white-named-head-coach-southern-illinois/
|
Bond-White named head coach at Southern Illinois
Published: Mar. 31, 2022 at 6:13 PM CDT|Updated: 46 minutes ago
COLLEGE STATION, Texas (KBTX) - Longtime Texas A&M women’s assistant basketball coach Kelly Bond-White has been hired to replace Cindy Stein as the new head coach at Southern Illinois.
Kelly has worked under Gary Blair for the last 22 years, dating back to a three-year run at Arkansas from 2000-2003.
She followed Blair to A&M and helped the Aggie women win an NCAA title in 2011, and was part of 444 wins in 19 years in College Station.
Bond-White has ties to Illinois. She was born in Chicago and played high school ball at Whitney Young under the late Arthur Penny before going to Illinois and helping the program reach consecutive Sweet Sixteens in 1997 and 1998.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/crash-slowing-traffic-thursday-evening-sh-6-college-station/
|
Crash slowing traffic Thursday evening on SH 6 in College Station
Published: Mar. 31, 2022 at 6:44 PM CDT|Updated: 14 minutes ago
COLLEGE STATION, Texas (KBTX) - A motor vehicle crash Thursday evening is slowing traffic on Highway 6 southbound in College Station.
The traffic is backed up from Harvey Mitchell Parkway to University Drive.
No other details were immediately available.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/milam-county-man-sentenced-30-years-child-sex-crime/
|
Milam County man sentenced to 30 years for child sex crime
Published: Mar. 31, 2022 at 5:42 PM CDT|Updated: 1 hour ago
CAMERON, Texas (KBTX) - A Thorndale man has been sentenced to 30 years after pleading guilty to a first-degree felony for child sex crimes.
Patrick Michael Anness, 52, was charged with sexual performance by a child under 14. He must serve half of his sentence before becoming eligible for parole, according the Milam County District Attorney’s Office.
The court heard testimony from Special Agent Richard Rieger during the sentencing hearing and was the primary agent who investigated the case.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/police-13-year-old-runaway-girl-dies-hospital-after-found-unresponsive-motel/
|
Police: 13-year-old runaway girl dies at hospital after found unresponsive at motel
D’IBERVILLE, Miss. (WALA/Gray News) - A 13-year-old girl has died in a Mississippi-area hospital after being reported as a runaway from Alabama earlier this month.
WALA reports the Mobile Police Department first reported Keyanna Sylvester as a runaway on March 21. She was then found unresponsive in a motel room in D’Iberville, Mississippi, on March 24, according to D’Iberville Police Capt. Jason King.
Sylvester was taken to the hospital but later died, according to police.
The 13-year-old spent time in Ocean Springs and Moss Point, Mississippi, according to reports.
King said it was too early in the investigation to decide whether foul play was involved in the girl’s death.
“We’re making sure we’re careful about not saying whether it’s criminal or not criminal,” he said.
King also said police are waiting for a report by the medical examiner.
“This hurts me real bad because Keyanna was my baby,” said neighbor Alexie Thames. “You all need to help find whoever did this to my baby. "
Anyone with further information on this case was urged to contact the D’Iberville Police Department at 228-396-4252.
Copyright 2022 WALA via Gray Media Group, Inc. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/professional-bull-rider-talks-upcoming-pbr-boot-barn-classic-aggieland/
|
Professional Bull Rider talks upcoming PBR Boot Barn Classic in Aggieland
The event will be at Reed Arena on April 9 and 10
BRYAN, Texas (KBTX) - For the second time in as many years, the Professional Bull Rider’s (PBR) Pendleton Whisky Velocity Tour is coming back to College Station. It will return to Reed Arena on April 8 and 9 with the PBR Boot Barn Classic in Aggieland. Thor Hoefer II, one of the world’s top professional bull riders, joined First News at Four to discuss his bull riding career and the upcoming competition.
“It’s really an honor to be a part of the PBR, you know you’re part of the greatest bull riders that the world can assemble,” said Hoefer. “There’s going to be riders from Australia, Mexico, Brazil, Canada, and the US all competing together in College Station and I’m just really blessed to be a part of it.”
Hoefer started at a young age, first riding sheep, then graduating to calves. He really got into riding bulls professionally at age 20.
“I would say one of my greatest blessings with it would be the camaraderie between the bull riders. There’s not many sports that, your competitors, are also some of your best friends, and you really strive for everybody to do good, you just want to do better, and that makes for some really good competition,” he said.
Get tickets for the PBR Boot Barn Classic here.
Watch the full interview in the player above.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/three-aggies-earn-ncea-all-america-honors/
|
Three Aggies Earn NCEA All-America Honors
FORT WORTH, Texas – Texas A&M equestrian standouts MacKenzie Chapman, Emmy-Lu Marsh and Hanna Olaussen earned national Collegiate Equestrian Association Ariat All-America honors, the NCEA Selection Committee announced Thursday.
Chapman earned second team honors in Horsemanship, while Marsh was named to the second team in Reining. Olaussen was awarded honorable mention recognition in Horsemanship.
The graduate student led the Aggies in Horsemanship with a 10-2-2 record, including two Most Outstanding Performer honors. Chapman started the season at 7-0 and ended the year 3-1-1 in her last five appearances. She earned her first MOP recognition after defeating Georgia’s Leah Anderson with Cowboy, 76.5-72.5, at home. The Bellevue, Michigan, native, earned her second MOP at the SEC Championships in the final against Auburn’s Taylor Searles on Garth with a score of 229.5-220.
Marsh compiled an 8-4-2 record in Reining, including a seven meet undefeated stretch from November 18 to March 12 going 5-0-2. The junior earned three MOP accolades, including a school record ride of 78 in the season opener. A Tallulah, Louisiana, native, Marsh earned her second MOP after defeating Georgia’s Jax Bound, 73-72.5, on Slash in Bishop, Georgia, and her third MOP came in the SEC Championship final when she outscored Auburn’s Terri June Granger, 216-214, also on Slash.
In her rookie season, Olaussen recorded an 8-4-2 record in Horsemanship. Most notably, the San Antonio, native, registered a 7-1 record stretching from October 29 to March 5, which included one MOP at Georgia after edging Grace Himes, 79-78, on Clyde.
Texas A&M opens NCEA Championship as the No. 3 seed against No. 6 Baylor on Thursday, April 14 at the World Equestrian Center in Ocala, Florida.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/treat-day-blinn-college-celebrates-139th-birthday/
|
Treat of the Day: Blinn College celebrates 139th birthday
Published: Mar. 31, 2022 at 5:51 PM CDT|Updated: 1 hour ago
BRYAN, Texas (KBTX) - Blinn College is celebrating its 139th birthday.
The college looks a lot different now than it did in 1883. But one thing that hasn’t changed in the school’s commitment to helping their students achieve their educational goals.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/03/31/ukrainians-remain-defiant-world-awaits-russias-next-move/
|
Ukrainians remain defiant as the world awaits Russia’s next move
WASHINGTON, D.C. (KBTX) - Moscow has pledged to scale back its attacks in Ukraine, but that statement is being met with skepticism. KBTX Chief Political Analyst Greta Van Susteren joined First News at Four to speak about the war and her recent visit to Ukraine.
Van Susteren admitted no one really knows what Russia is up to.
She said, “clearly the troops are moving away from Kyiv, but is that because they are retreating or because they are repositioning or changing their strategy?”
Among those who believe they are repositioning is the NATO Secretary General.
While people aren’t necessarily optimistic, there is good news in this according to Van Susteren.
“It does indicate, though, that the Russian forces have been unsuccessful to seize Kyiv. They thought they were going to seize Kyiv in about three days. Well, that was beginning February 24th and Ukraine has put up a robust defense of that city,” said Van Susteren.
On her trip to Poland and Ukraine, Van Susteren says she was struck by the strength of the Ukrainian people.
“You see the incredible amount of pride in these Ukrainians and they’re very determined, which is one of the problems the Russians are having is they are up against people who are very much inspired and very much they’re ready to lay down their life for Ukraine,” she explained.
Watch the full interview in the player above.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/oscars-producer-says-police-offered-arrest-will-smith/
|
Oscars producer says police offered to arrest Will Smith
LOS ANGELES (AP) — Oscars producer Will Packer said Los Angeles police were ready to arrest Will Smith after Smith slapped Chris Rock on the Academy Awards stage.
“They were saying, you know, this is battery, was a word they used in that moment,” Packer said in a clip released by ABC News Thursday night of an interview he gave to “Good Morning America.” “They said we will go get him. We are prepared. We’re prepared to get him right now. You can press charges, we can arrest him. They were laying out the options.”
But Packer said Rock was “very dismissive” of the idea.
“He was like, ‘No, no, no, I’m fine,” Packer said. “And even to the point where I said, ‘Rock, let them finish.’ The LAPD officers finished laying out what his options were and they said, ‘Would you like us to take any action?’ And he said no.”
The LAPD said in a statement after Sunday night’s ceremony that they were aware of the incident, and that Rock had declined to file a police report. The department declined comment Thursday on Packer’s interview, a longer version of which will air on Friday morning.
The Academy of Motion Pictures Arts and Sciences met Wednesday to initiate disciplinary proceedings against Smith for violations against the group’s standards of conduct. Smith could be suspended, expelled or otherwise sanctioned.
The academy said in a statement that “Mr. Smith’s actions at the 94th Oscars were a deeply shocking, traumatic event to witness in-person and on television.”
Without giving specifics, the academy said Smith was asked to leave the ceremony at the Dolby Theatre, but refused to do so.
Smith strode from his front row seat on to the stage and slapped Rock after a joke Rock made about Smith’s wife, Jada Pinkett Smith, when he was on stage to present the Oscar for best documentary.
On Monday, Smith issued an apology to Rock, the academy and to viewers, saying “I was out of line and I was wrong.”
The academy said Smith has the opportunity to defend himself in a written response before the board meets again on April 18.
Rock publicly addressed the incident for the first time, but only briefly, at the beginning of a standup show Wednesday night in Boston, where he was greeted by a thunderous standing ovation. He said “I’m still kind of processing what happened.”
___
Follow AP Entertainment Writer Andrew Dalton on Twitter: https://twitter.com/andyjamesdalton
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/usda-forecasting-higher-food-grocery-costs-2022/
|
USDA forecasting higher food, grocery costs in 2022
(Gray News) - It looks like elevated food prices are going to continue this year, according to the U.S. Department of Agriculture.
The USDA released its Food Price Outlook for 2022 and predicted the cost of groceries would continue to increase to as much as 4%.
According to the Consumer Price Index, grocery and supermarket food prices were already 8.6% higher in February than last year and up nearly 1.5% from January to February in 2022.
As reported by the Associated Press, prices for U.S. consumers have continued to jump recently, leaving families facing the highest inflation rate since 1990.
“We’re getting into this situation where we have spiraling inflation,” said Jay Hatfield, CEO of Infrastructure Capital Advisors. “Inflation in one area drives inflation in another.”
Currently, the CPI reports all food categories are increasing in price other than fresh vegetables. Last year, the beef and veal categories had the most significant price increase of 9.3%, and the fresh vegetable category had the smallest at 1.1%. However, no food categories decreased in price in 2021.
Poultry prices are also expected to increase up to 7%, with egg prices predicted to increase up to 3.5% in 2022.
Overall, grocery store and supermarket food purchases are expected to increase up to 4%, with restaurant purchases or food away from home forecasted to increase up to 6.5%, according to the USDA.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/5-fetuses-found-inside-dc-home-anti-abortion-activist/
|
5 fetuses found inside DC home of anti-abortion activist
WASHINGTON (AP) — Police found five fetuses in the home of a self-proclaimed “anti-abortion activist” who was indicted this week on federal charges alleging that she was part of a group of people who blocked access to a Washington, D.C. reproductive health center.
The Metropolitan Police Department says officers were responding to a tip about “potential bio-hazard material” at a home in Southeast Washington on Wednesday when they located the five fetuses inside.
A local television station, WUSA9, captured video of police searching the home and reported that the home belonged to Lauren Handy. The 28-year-old was one of nine people charged in an indictment that was made public on Wednesday that accused the group of traveling to Washington, blocking access to the reproductive health center and streaming it on Facebook.
The station, which first reported the discovery, said Handy told a reporter that “people will freak out when they hear” what detectives found inside her house. Handy did not respond to a message sent to her Facebook profile seeking comment.
Police said the five fetuses were collected by Washington’s medical examiner and the investigation is ongoing.
In the indictment, prosecutors said Handy had called the clinic pretending to be a prospective patient and scheduling an appointment. Once there, on Oct. 22, 2020, eight of the suspects pushed their way inside and began blocking the doors, according to the indictment. Five of them chained themselves together on chairs to block the treatment area as others blocked the employee entrance to stop other patients from coming inside, the indictment alleges. Another suspect blocked people from coming into the waiting room, prosecutors charge.
Handy and the eight others were charged with conspiracy against rights and violating the Freedom of Access to Clinic Entrances Act. The federal law, more commonly known as the FACE Act, prohibits physically obstructing or using the threat of force to intimidate or interfere with a person seeking reproductive health services.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/aggies-denied-nit-championship-following-73-72-loss-xavier/
|
Aggies denied NIT Championship following 73-72 loss to Xavier
NEW YORK CITY, New York (KBTX) - The Texas A&M (27-13) men’s basketball team closed out the 2021-2022 season with a one point loss to Xavier (23-13) as the Musketers claimed the 2022 NIT Championship Thursday night at Madison Square Garden.
Xavier overcame a 40-32 halftime deficit to beat the Aggies 73-72. It was the Musketeers’ first NIT title since 1958.
Texas A&M was up 72-71 thanks to a pair of free throws by Quenton Jackson with 26.8 seconds left, but Xavier’s Jack Nunge answered with a hook shot with :03 left in the game. Texas A&M had the last shot and could have won it but Tyrece Radford’s jumper from 24 feet was off the mark as the Aggies see their up and down season finish with a one point loss.
Jackson led the Aggies in scoring with 23 points, while Radford added 15 points and Hassan Diarrra tossed in 12.
The Musketeers were led in scoring by Colby Jones’ 21 points, Dwon Odem added 18, and Nunge had 15 including the game winner.
National Invitation Tournament – Championship Madison Square Garden (New York, New York)
Thursday, March 31, 2022 | 6 p.m. CT tipoff
ABOUT THE GAME
· The Texas A&M men’s basketball dropped a back-and-forth 73-72 decision to Xavier in the Championship game of the National Invitational Tournament on Thursday at Madison Square Garden.
· In a game that featured 17 lead changes, the Aggies had a potential game-winning jump shot from Tyrece Radford rattle out as time expired.
· A pair of Aggies were named to the NIT All-Tournament Team: Quenton Jackson and Tyrece Radford.
RECORDS AND SERIES NOTES
· The Aggies ended the season with a 27-13 record, which marked a 19-victory improvement from 2020-21 (8-10). It is the largest season-to-season win total improvement in program history, bettering the 14-win improvement from 2003-04 to 2004-05 in Billy Gillispie’s first season at Texas A&M. Gillispie’s initial coaching staff included current Aggie head coach Buzz Williams.
· The 27 wins were one shy of the school record of 28 wins in a season, which was accomplished by the 2015-16 Aggies that were SEC Co-Champions and advanced to the NCAA Sweet 16.
· The Aggies joined an elite handful of teams that have reached the 40-game plateau in game played in a season tonight. The NCAA record for games played in a season is 41 games, accomplished by UConn’s 2011 national championship team and Michigan’s national runner-up team in 2018. Texas A&M is the 18th team in NCAA history to reach the 40-game plateau. The Aggies’ previous high number of games in a season was 37 by the 2015-16 Aggies.
· The Aggies fell to 11-8 all-time in the NIT and now trail Xavier 2-0 in the all-time series between the two schools.
TEAM NOTES
· The nation’s leader in steals, the Aggies had five takeaways against Xavier to raise their season total to 398, which obliterated the old record of 288 steals.
· Texas A&M utilized a starting lineup of Quenton Jackson, Wade Taylor IV, Henry Coleman III, Tyrece Radford and Manny Obaseki for the 13th time (11-2).
INDIVIDUAL NOTES
· With a game-high 23 points in the final, senior Quenton Jackson raised his season point total to 591 points, which moved him to No. 8 on Texas A&M’s all-time single season scoring list.
· Jackson closed out the season with double figure points in 21 of the Aggies’ last 22 games and in 32 of the Aggies’ 40 games in 2021-22. It marked the 19th game this season where Jackson led the team in points.
· Sophomore Henry Coleman III had a team-high nine rebounds, including three offensive boards, marking the 19th time that he led the Aggies in rebounds in a game.
· The Aggies had a 17-to-8 advantage in bench points, which included a 12-point game from Queens, New York, native Hassan Diarra.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/blue-ribbon-ceremony-held-commemorate-child-abuse-prevention-month/
|
Blue Ribbon ceremony held to commemorate Child Abuse Prevention Month
COLLEGE STATION, Texas (KBTX) -April is recognized as Child Abuse Prevention Month.
Scotty’s House, a non-profit Child Advocacy Center serving seven counties in the Brazos Valley, and the College Station Police Department took a moment Thursday afternoon to sound the alarm and raise awareness about child abuse.
According to Tex Protects, a children’s advocacy group in Texas, more than four children die from abuse or neglect on average every week, 184 children are confirmed victims daily, and more than seven children are maltreated every hour.
In Brazos County, officials identified 630 confirmed child victims of abuse and neglect in 2021, slightly lower than 663 confirmed cases in 2020. It s an unfortunate situation Tammy Bales, director of operations for Scotty’s House, says we all can help fix.
”It is a problem that belongs to all of us, and it’s a problem that can be solved by every one of us,” said Bales. “It takes each of us not only to be aware and to accept that there is a problem but to be educated and to learn about it and how you can learn about signs of child abuse.”
Friday is also wear blue day in Texas. It’s an opportunity to show support for the essential work needed in the community to ensure a better, safer future for all children.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/doctor-convicted-prescribing-over-1m-opioid-pills-las-vegas-cocktail-drugs/
|
Doctor convicted for prescribing over $1M in opioid pills, ‘Las Vegas cocktail’ of drugs
(Gray News) - A physician in Texas was recently convicted for wrongly prescribing more than $1 million worth of opioid hydrocodone pills.
According to the U.S. Department of Justice, 52-year-old James Pierre, a Houston doctor, unlawfully prescribed controlled substances from June 2015 through July 2016 to individuals posing as patients at a West Parker Medical Clinic, a pill-mill clinic located in Houston.
Trial evidence showed Pierre and his physician assistant issued hundreds of unlawful prescriptions for hydrocodone and carisoprodol, a combination of controlled substances known as the “Las Vegas Cocktail,” to hundreds of individuals posing as patients each week.
According to the Justice Department, “runners” brought numerous people to pose as patients at the clinic and paid about $220 to $500 per visit in exchange for the prescriptions.
Throughout the scheme, West Parker made about $1.75 million from prescriptions, and over $300,000 went to Pierre, according to investigators.
The Department of Justice reports Pierre was convicted of one count of conspiracy to unlawfully distribute and dispense controlled substances and seven counts of unlawfully distributing and dispensing controlled substances.
The 52-year-old is currently scheduled to be sentenced on June 27 and faces up to 20 years in prison for each count.
Officials said that one co-conspirator has pleaded guilty to conspiracy to distribute controlled substances unlawfully.
DEA Houston investigated the case, according to the Department of Justice.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/tariffs-seafood-imported-russia-fuel-prices-having-impact-foodservice/
|
Tariffs on seafood imported from Russia, fuel prices having a impact on foodservice
BRYAN, Texas (KBTX) -The latest attempt to punish Russia for the invasion of Ukraine includes sanctions and bans on imported seafood, alcohol, and diamonds from Russia.
According to census data, from Jan. 1, 2020, to Jan. 31, 2022, Russia exported more than 28 million pounds (12.7 million kilograms) of cod to the U.S. Russia is also a significant crab and Alaska pollock supplier, widely used in fast-food sandwiches and processed products like fish sticks.
Here locally, the sanctions, combined with fluctuating fuel prices, could raise prices on seafood items that are not imported from Russia.
Wade Beckman owns multiple restaurants, including Shipwreck Grill in Bryan. He purchases all his seafood locally. Although Beckman doesn’t purchase food directly from Russia, he’s concerned about the trickle-down effect on the entire supply chain.
“You know that as the supplies deplete, there are more people after the same supplies that we are, and I’m sure that s had some effect along with many other things,” said Beckman.
Beckman says prices from his supplier have drastically increased, but it’s part of the cost of doing business and getting what the customers want.
“Some of our seafood prices are up as much as 60% on shrimp, gulf oysters, and our snow crab,” said Beckman.
Supply chain issues and the rising cost of fuel continue to be an issue for businesses.
Korey Thomas owns The Remnant of Nawlins in Bryan. He says in order to keep from having to pay higher shipping prices; he travels to Louisianna to pick up his orders straight from the supplier.
“Especially like my seafood, like my crawfish and my shrimp, I’ve had to drive like way to Louisiana to get some,” said Thomas.
Thomas says It’s all in an effort to keep from raising prices.
“I have to pay more in gas, but it’s cheaper for me to buy the product there and then bring it back,” Said Thomas. " So when we weighed our options, we saw that I might pay a little bit more in gas opposed to paying higher for the product.”
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/thousands-baby-teether-rattles-recalled-due-choking-hazard/
|
Thousands of baby teether rattles recalled due to choking hazard
(Gray News) - A recall has been issued for nearly 9,000 motion-activated baby rattles sold in the U.S. and Canada.
PlayMonster has recalled the Kid O Hudson glow rattles due to their legs possibly breaking off and posing a choking hazard to young children, according to the Consumer Product Safety Commission.
The agency describes the product as a motion-activated rattle shaped like a puppy that makes a soft rattling sound when shaken. The plastic puppy is white with spots that can glow in red or green. The puppy’s legs are textured soft plastic for teething children.
Currently, there have been three reports of the rattle legs breaking off, according to the recall. No injuries have been reported.
Consumers are advised to immediately take the recalled walkers away from young children and contact PlayMonster by calling 1-800-469-7506 to discuss refund options.
The rattles were sold at specialty stores nationwide and online at Target.com, Amazon.com, Walmart.com and other sites from February 2018 through February 2022.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/bcs-impact-ukraine-aid-refugee-crisis-proves-successful-difficult-according-those-ground/
|
BCS impact on Ukraine aid and refugee crisis proves successful but difficult, according to those on ground
BRYAN, Texas (KBTX) - Fighting in Ukraine has been going on for over a month, but many people have found ways to contribute to efforts even from Bryan and College Station.
Jerry Fox, COO of First Financial Bank, and Kent Dale, a Cattle Rancher, have worked with an organization called Project for Humanitarian Aid. Over the years, they have traveled to Ukraine supporting struggling youth and orphanages in the country many times. Fox recently returned from Ukraine and said it was different than previous trips.
“It was a very heartbreaking trip in a lot of ways. I’ve made probably a dozen trips over there before and they have never been for a purpose like this,” he said.
Fox used this trip to take money to those helping on the ground in Ukraine and determine the biggest needs.
Fox and Dale spoke with Dima Grischuk on Thursday over video call. Dima is a volunteer on the ground in Ukraine who works to help transport aid and refugees all over the country as it is under attack.
“We drove through Kharkiv, a lot of damages, a lot of damages. I [took] a couple of pictures which just broke my heart. This is not military bases. This is not the military places or government places. This is just a place where people used to live,” Dima said.
Kent has seen the areas he and his wife visited many times now turned to rubble.
“It breaks your heart, not just for the architecture, but also for the people that have lived there, raised families there and have the same hopes and dreams as we do,” he said.
Dima and his team of over 30 drivers called the Volunteer Brothers travel up to ten hours a day, sometimes into the most dangerous areas.
As he works to help in Ukraine, Dima’s wife and children found refuge in Croatia. She is working to help get supplies to Dima, like medicine and bullet proof vests, but there is no easy way to do it. Dima said he can not believe this is his life now.
“I just came to the understanding, to realize this piece [of life] is a reality. But my life before becomes more and more like a dream,” Dima said.
In order to continue transports and the work they do, Dima said they rely heavily on donations. Program for Humanitarian Aid has a fund set up at the A&M Church of Christ.
“Anyone that wants to help with our effort, A&M Church of Christ, our home church, we have a fund that is set up that is designated for Ukraine aid and 100% of that is going to Ukraine to help Dima and his team of drivers,” Kent said.
This fund is making a large difference for Dima and his team.
“I really appreciate A&M Church, by the way, for you managing our funds right now. And you are a great partner of our relief program here and so I really appreciate what you’re doing for us,” he said.
If a donation isn’t possible, Dima just asked that the world continue paying attention to the situation in Ukraine and to stay informed.
Fox said his fear is that even if the fighting were to stop, the damage has been done and could take decades to rebuild.
Copyright 2022 KBTX. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/closing-arguments-next-michigan-gov-whitmer-kidnap-plot/
|
Closing arguments next in Michigan Gov. Whitmer kidnap plot
(AP) - Jurors will hear closing arguments Friday in the trial of four men accused of a brazen conspiracy to kidnap Michigan Gov. Gretchen Whitmer, a case built with informants, undercover agents, secret recordings and two people who pleaded guilty and cooperated.
Only one defendant, Daniel Harris, chose to testify in his own defense. But his denial of any crime Thursday was met by an aggressive cross-examination in which prosecutors used his own words to show his contempt for Whitmer and even suggestions about how to kill her.
Adam Fox, Barry Croft Jr. and Brandon Caserta declined to testify, and defense attorneys called only a few witnesses. The four deny any scheme to get Whitmer at her vacation home in fall 2020, though they were livid with government as well as restrictions imposed during the COVID-19 pandemic.
The men were arrested in October 2020 amid talk of raising $4,000 for an explosive that could blow up a bridge and stymie police after a kidnapping, according to trial evidence. Fox twice traveled to northern Michigan to scout the area.
Defense attorneys, however, insist they were under the spell of informants and agents who got them to say and do violent, provocative things.
Harris repeatedly answered “absolutely not” when asked by his lawyer if he was part of a plot. His testimony was perilous because he exposed himself to numerous challenges by prosecutors who had been offering evidence against the group for days.
Harris and Assistant U.S. Attorney Jonathan Roth sometimes talked over each other. At one point, Harris snapped, “Next question.”
“Everyone can take it down a notch,” U.S. District Judge Robert Jonker said later.
Roth confronted Harris with his own chat messages about posing as a pizza deliveryman and killing Whitmer at her door. He reminded Harris, a former Marine, that he worked with explosives while training with the group, especially in Luther, Michigan, in September 2020, about a month before their arrest.
Roth played a conversation of Croft talking about militias overthrowing governments in various states and “breaking a few eggs” if necessary.
“When this man talks to you at a diner about killing people, you don’t stand up and walk out, do you sir?” Roth asked. “You don’t say, ‘This group is not for me,’ do you sir?”
“No,” Harris answered.
A “shoot house” that was intended to resemble Whitmer’s second home was a key part of the Luther training weekend, according to the government. Harris admitted that he brought materials but said he didn’t build it with her house in mind.
He didn’t participate in an evening ride to Elk Rapids, Michigan, to scout Whitmer’s home and a bridge during that same weekend. Harris said he had purchased $200 of cheap beer and cigarettes so he could return to the camp and “get wasted” with others.
Two more men, Ty Garbin and Kaleb Franks, pleaded guilty and cooperated with investigators. Garbin last week said the group acted willingly and hoped to strike before the election, cause national chaos and prevent Joe Biden from winning the presidency.
Whitmer, a Democrat, rarely talks publicly about the kidnapping plot, though she referred to “surprises” during her term that seemed like “something out of fiction” when she filed for reelection on March 17.
She has blamed former President Donald Trump for fomenting anger over coronavirus restrictions and refusing to condemn right-wing extremists like those charged in the case. Whitmer has said Trump was complicit in the Jan. 6 Capitol riot.
___
Find AP’s full coverage of the Whitmer kidnap plot trial at: https://apnews.com/hub/whitmer-kidnap-plot-trial
___
White reported from Detroit.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/russians-leave-chernobyl-ukraine-braces-renewed-attacks/
|
Russians leave Chernobyl; Ukraine braces for renewed attacks
KYIV, Ukraine (AP) — Russian troops left the heavily contaminated Chernobyl nuclear site early Friday after returning control to the Ukrainians, authorities said, as eastern parts of the country braced for renewed attacks and Russians blocked another aid mission to the besieged port city of Mariupol.
Ukraine’s state power company, Energoatom, said the pullout at Chernobyl came after soldiers received “significant doses” of radiation from digging trenches in the forest in the exclusion zone around the closed plant. But there was no independent confirmation of that.
The exchange of control happened amid growing indications the Kremlin is using talk of de-escalation in Ukraine as cover to regroup, resupply its forces and redeploy them for a stepped-up offensive in the eastern part of the country.
GRAPHIC WARNING: Videos in this story may contain disturbing content.
Ukrainian President Volodymyr Zelenskyy warned that Russian withdrawals from the north and center of the country were just a military tactic to build up forces for new powerful attacks in the southeast. A new round of talks between the countries was scheduled Friday, five weeks into a conflict that has left thousands dead and driven 4 million Ukrainians from the country.
“We know their intentions,” Zelenskyy said in his nightly video address to the nation. “We know that they are moving away from those areas where we hit them in order to focus on other, very important ones where it may be difficult for us.”
“There will be battles ahead,” he added.
Meanwhile in Mariupol, Russian forces blocked a convoy of 45 buses attempting to evacuate people after the Russian military agreed to a limited cease-fire in the area. Only 631 people were able to get out of the city in private cars, according to the Ukrainian government.
Russian forces also seized 14 tons of food and medical supplies in a dozen buses that were trying to make it to Mariupol, Deputy Prime Minister Iryna Vereshchuk said.
The city has been the scene of some of the worst suffering of the war. Tens of thousands have managed to get out in the past few weeks by way of humanitarian corridors, reducing the population from a prewar 430,000 to an estimated 100,000 by last week, but other relief efforts have been thwarted by continued Russian attacks.
The International Atomic Energy Agency said it had been informed by Ukraine that the Russian forces at the site of the world’s worst nuclear disaster had transferred control of it in writing to the Ukrainians. The last Russian troops left early Friday, the Ukrainian government agency responsible for the exclusion zone said.
Energoatom gave no details on the condition of the soldiers it said were exposed to radiation and did not say how many were affected. There was no immediate comment from the Kremlin, and the IAEA said it had not been able to confirm the reports of Russian troops receiving high doses. It said it was seeking more information.
Russian forces seized the Chernobyl site in the opening stages of the Feb. 24 invasion, raising fears that they would cause damage or disruption that could spread radiation. The workforce at the site oversees the safe storage of spent fuel rods and the concrete-entombed ruins of the reactor that exploded in 1986.
Edwin Lyman, a nuclear expert with the U.S.-based Union of Concerned Scientists, said it “seems unlikely” a large number of troops would develop severe radiation illness, but it was impossible to know for sure without more details.
He said contaminated material was probably buried or covered with new topsoil during the cleanup of Chernobyl, and some soldiers may have been exposed to a “hot spot” of radiation while digging. Others may have assumed they were at risk too, he said.
Early this week, the Russians said they would significantly scale back military operations in areas around Kyiv and the northern city of Chernihiv to increase trust between the two sides and help negotiations along.
But in the Kyiv suburbs, regional governor Oleksandr Palviuk said on social media Thursday that Russian forces shelled Irpin and Makariv and that there were battles around Hostomel. Ukrainian forces counterattacked and some Russian withdrawals around the suburb of Brovary to the east, Pavliuk said.
At a Ukrainian military checkpoint outside Kyiv, soldiers and officers said they don’t believe Russian forces have given up on the capital.
“What does it mean, significantly scaling down combat actions in the Kyiv and Chernihiv areas?” asked Brig. Gen. Valeriy Embakov. “Does it mean there will be 100 missiles instead of 200 missiles launched on Kyiv or something else?”
Chernihiv came under attack as well. At least one person was killed and four were wounded in the Russian shelling of a humanitarian convoy of buses sent to Chernihiv to evacuate residents cut off from food, water and other supplies, said Ukrainian Human Rights Commissioner Lyudmyla Denisova.
Elsewhere, Ukraine reported Russian artillery barrages in and around the northeastern city of Kharkiv.
Ukraine’s emergency services also said the death toll had risen to 20 in a Russian missile strike Tuesday on a government administration building in the southern city of Mykolaiv.
NATO Secretary-General Jens Stoltenberg said intelligence indicates Russia is not scaling back its military operations in Ukraine but is instead trying to regroup, resupply its forces and reinforce its offensive in the Donbas.
“Russia has repeatedly lied about its intentions,” Stoltenberg said. At the same time, he said, pressure is being kept up on Kyiv and other cities, and “we can expect additional offensive actions bringing even more suffering.”
The Donbas is the predominantly Russian-speaking industrial region where Moscow-backed separatists have been battling Ukrainian forces since 2014. In the past few days, the Kremlin, in a seeming shift in its war aims, said that its “main goal” now is gaining control of the Donbas, which consists of the Donetsk and Luhansk regions, including Mariupol.
The top rebel leader in Donetsk, Denis Pushilin, issued an order to set up a rival city government for Mariupol, according to Russian state news agencies, in a sign of Russian intent to hold and administer the city.
With talks set to resume between Ukraine and Russia via video, there seemed little faith that the two sides would resolve the conflict any time soon.
Russian President Vladimir Putin said that conditions weren’t yet “ripe” for a cease-fire and that he wasn’t ready for a meeting with Zelenskyy until negotiators do more work, Italian Premier Mario Draghi said after a telephone conversation with the Russian leader.
As Western officials search for clues about what Russia’s next move might be, a top British intelligence official said demoralized Russian soldiers in Ukraine are refusing to carry out orders and sabotaging their equipment and had accidentally shot down their own aircraft.
U.S. intelligence officials have concluded that Putin is being misinformed by his advisers about how badly the war is going because they are afraid to tell him the truth.
Kremlin spokesman Dmitry Peskov said that the U.S. is wrong and that “neither the State Department nor the Pentagon possesses the real information about what is happening in the Kremlin.”
___
Karmanau reported from Lviv, Ukraine. Associated Press journalists around the world contributed to this report.
___
Follow the AP’s coverage of the war at https://apnews.com/hub/russia-ukraine
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/house-passes-35-a-month-insulin-cap-dems-seek-wider-bill/
|
House passes $35-a-month insulin cap as Dems seek wider bill
WASHINGTON (AP) — The House has passed a bill capping the monthly cost of insulin at $35 for insured patients, part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation.
Experts say the legislation, which passed 232-193 Thursday, would provide significant relief for privately insured patients with skimpier plans and for Medicare enrollees facing rising out-of-pocket costs for their insulin. Some could save hundreds of dollars annually, and all insured patients would get the benefit of predictable monthly costs for insulin. The bill would not help the uninsured.
But the Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms. For the legislation to pass Congress, 10 Republican senators would have to vote in favor. Democrats acknowledge they don’t have an answer for how that’s going to happen.
“If 10 Republicans stand between the American people being able to get access to affordable insulin, that’s a good question for 10 Republicans to answer,” said Rep. Dan Kildee, D-Mich., a cosponsor of the House bill. “Republicans get diabetes, too. Republicans die from diabetes.”
Public opinion polls have consistently shown support across party lines for congressional action to limit drug costs.
But Rep. Cathy McMorris Rodgers, R-Wash., complained the legislation is only “a small piece of a larger package around government price controls for prescription drugs.” Critics say the bill would raise premiums and fails to target pharmaceutical middlemen seen as contributing to high list prices for insulin.
Sen. Chuck Grassley, R-Iowa, said Democrats could have a deal on prescription drugs if they drop their bid to authorize Medicare to negotiate prices. “Do Democrats really want to help seniors, or would they rather have the campaign issue?” Grassley said.
The insulin bill, which would take effect in 2023, represents just one provision of a much broader prescription drug package in President Joe Biden’s social and climate legislation.
In addition to a similar $35 cap on insulin, the Biden bill would authorize Medicare to negotiate prices for a range of drugs, including insulin. It would penalize drugmakers who raise prices faster than inflation and overhaul the Medicare prescription drug benefit to limit out-of-pocket costs for enrollees.
Biden’s agenda passed the House only to stall in the Senate because Democrats could not reach consensus. Party leaders haven’t abandoned hope of getting the legislation moving again, and preserving its drug pricing curbs largely intact.
The idea of a $35 monthly cost cap for insulin actually has a bipartisan pedigree. The Trump administration had created a voluntary option for Medicare enrollees to get insulin for $35, and the Biden administration continued it.
In the Senate, Republican Susan Collins of Maine and Democrat Jeanne Shaheen of New Hampshire are working on a bipartisan insulin bill. Georgia Democratic Sen. Raphael Warnock has introduced legislation similar to the House bill, with the support of Sen. Majority Leader Chuck Schumer of New York.
Stung by criticism that Biden’s economic policies spur inflation, Democrats are redoubling efforts to show how they’d help people cope with costs. On Thursday, the Commerce Department reported a key inflation gauge jumped 6.4% in February compared with a year ago, the largest year-over-year rise since January 1982.
But experts say the House bill would not help uninsured people, who face the highest out-of-pocket costs for insulin. Also, people with diabetes often take other medications as well as insulin. That’s done to treat the diabetes itself, along with other serious health conditions often associated with the disease. The House legislation would not help with those costs, either. Collins says she’s looking for a way to help uninsured people through her bill.
About 37 million Americans have diabetes, and an estimated 6 million to 7 million use insulin to keep their blood sugars under control. It’s an old drug, refined and improved over the years, that has seen relentless price increases.
Steep list prices don’t reflect the rates insurance plans negotiate with manufacturers. But those list prices are used to calculate cost-sharing amounts that patients owe. Patients who can’t afford their insulin reduce or skip doses, a strategy born of desperation, which can lead to serious complications and even death.
Economist Sherry Glied of New York University said the market for insulin is a “total disaster” for many patients, particularly those with skimpy insurance plans or no insurance.
“This will make private insurance for people with diabetes a much more attractive proposition,” said Glied.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/14m-jury-award-protesters-could-resonate-around-us/
|
$14M jury award for protesters could resonate around US
DENVER (AP) — A federal jury’s $14 million award to Denver protesters hit with pepper balls and a bag filled with lead during 2020 demonstrations over the police killing of George Floyd in Minneapolis could resonate nationwide as courts weigh more than two dozen similar lawsuits.
The jury found police used excessive force against protesters, violating their constitutional rights, and ordered the city of Denver to pay 12 who sued.
Nationwide, there are at least 29 pending lawsuits challenging law enforcement use of force during the 2020 protests, according to a search of the University of Michigan’s Civil Rights Litigation Clearinghouse.
The verdict in Denver could give cities an incentive to settle similar cases rather than risk going to trial and losing, said Michael J. Steinberg, a professor at the University of Michigan Law School and director of the Civil Rights Litigation Initiative. It could also prompt more protesters to sue over their treatment at the hands of police.
“There’s no doubt that the large jury verdict in Denver will influence the outcome of pending police misconduct cases brought by Black Lives Matter protesters across the country,” said Steinberg, whose law students have been working on a similar lawsuit brought by protesters in Detroit.
Lawyers for the claimants argued that police used indiscriminate force against the nonviolent protesters, including some who were filming the demonstrations, because officers did not like their message critical of law enforcement.
“To the protest of police violence they responded with brutality,” one of their attorneys, Timothy Macdonald, told jurors.
People who took part in the protests have already made similar allegations in lawsuits filed across the country.
In Washington, DC, activists and civil liberties groups sued over the forcible removal of protesters before then-President Donald Trump walked to a church near the White House for a photo op. The claims against federal officials were dismissed last year but a judge allowed the case against local police to continue.
Several lawsuits alleging protesters were wrongfully arrested or that police used excessive force have been filed against New York City and its police department, including one brought by New York Attorney General Letitia James that claims police used excessive force and wrongfully arrested protesters. In Rochester, New York, people who protested the death of Daniel Prude, a Black man who lost consciousness after being pinned to the street by officers during a mental health call in 2020, claim police used extreme force against them in a lawsuit that also alleges city officials have allowed a culture of police brutality against racial minorities to fester.
One of their attorneys, Donald Thompson, said he plans to raise the Denver award in settlement talks with the city and note that unlike most of the Denver protesters, some of his clients suffered lasting injuries including the loss of an eye and scarring from being hit in the face with a tear gas canister. Thompson also thinks the Denver verdict shows that the public, in the age of cellphone and body camera videos, is not as willing to give police the benefit of the doubt anymore.
“Now people see how this policing really works. You can’t be naïve,” he said.
A spokesperson for Rochester did not return a call and an email seeking comment. When the case was filed, the city said it had already revised the way police responds to protests.
Over the last two months, the city of Austin, Texas has agreed to pay a total of $13 million to four people who were hit in the head with bean bag rounds fired by police.
Even before the Denver ruling last week, the police department made some changes in response to criticism that arose from the protests, including eliminating the use of 40mm foam rounds for crowd control and changing the way officers are permitted to use pepper balls.
Denver’s Department of Public Safety, which includes the police department, said in a statement that the city was not prepared for the level of sustained violence and destruction. During the trial, lawyers and witnesses said over 80 officers were injured as some in the crowds hurled rocks, water bottles and canned food at them.
The department said it continues to evaluate its policies to “better protect peaceful protestors while addressing those who are only there to engage in violence.”
Still, the large award is not expected to lead to an overhaul of how officers respond to what experts say are inherently chaotic situations that are difficult to prepare for.
Ed Obayashi, a use-of-force consultant to law enforcement agencies and a deputy sheriff and legal adviser in Plumas County, California, said society may have to bear the cost of such settlements because innocent people can be injured during protests as outnumbered police try to react on the fly, including to people intent on violence.
“It really goes south in an instant because there are individuals out there who want to cause chaos,” he said.
Obayashi said there is not much police training for protests, which have been relatively rare. He said it would be prohibitively expensive to have officers practice deploying equipment such as tear gas canisters. Because projectiles used in crowds and considered “less lethal” by police, such as rubber bullets and pepper balls, have less velocity and less power to hurt people, it is harder to ensure they hit their intended target, he said.
Lawyers representing people who have also alleged police misconduct and violation of their constitutional right to protest can now use the Denver damage award as part of their own settlement negotiations, said Mark Silverstein, legal director of the American Civil Liberties Union, which represented some of the winning Denver protesters.
The decision came nearly two years after thousands of people angry about Floyd’s death took the streets nationwide, a relatively quick result for the legal system and soon enough for others who allege misconduct by police to file a claim. In Colorado and many other states, there is a two-year statute of limitations for such lawsuits Silverstein said, leaving only a few months for others to sue.
The city attorney’s office said it has not decided whether to appeal the verdict, but appeals in such big cases are common, said Gloria Browne-Marshall, a professor at John Jay College of Criminal Justice. Outside lawyers will also scrutinize the case to try to determine if there are unique circumstances that may have led to a “lightning in a bottle” verdict that is less likely to be repeated.
However, she thinks the verdict sends a significant message that regular people respect the right of protest and demand change from the government, which she believes police and prosecutors have been undermining.
“It should send a message to both, but whether or not they listen is a different issue,” Browne-Marshall said.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/another-solid-month-us-hiring-expected-despite-obstacles/
|
Another solid month of US hiring expected despite obstacles
(AP) - Defying a pandemic and supply chain disruptions, the U.S. economy has cranked out more than 400,000 jobs every month for nearly a year — a blazing winning streak in wildly uncertain times.
And despite surging inflation, the hiring wave likely continued last month in the face of yet another jolt: Russia’s war in Ukraine, which has unsettled the economic outlook and catapulted gasoline prices to painful levels.
Economists surveyed by the data firm FactSet expect the Labor Department’s jobs report for March to show that employers added 478,000 jobs and that the unemployment rate dipped from 3.8% to 3.7%. That would mark the lowest unemployment rate since just before the pandemic struck two years ago, when joblessness reached a 50-year low of 3.5%.
The government will issue the March jobs report at 8:30 a.m. Eastern time Friday.
“With the war in Ukraine, economic uncertainty rising and surging energy prices, we may see a modest slowdown in hiring in March,’’ said Daniel Zhao, senior economist at the jobs website Glassdoor. “However, employer demand remains strong, which should sustain a healthy level of hiring.’’
The booming U.S. job market reflects a robust rebound from the brief but devastating coronavirus recession, which wiped out 22 million jobs in March and April 2020 as businesses shut down or cut hours and Americans stayed home to avoid infection.
But the recovery has been swift. Fueled by generous federal aid, savings amassed during the pandemic and ultra-low borrowing rates engineered by the Federal Reserve, U.S. consumers have spent so fast that many factories, warehouses, shipping companies and ports have failed to keep pace with their customer demand. Supply chains have snarled, forcing up prices.
As the pandemic has eased, consumers have been broadening their spending beyond goods to services, such as health care, travel and entertainment, which they had long avoided during the worst of the pandemic. The result: Inflation is running at 40-year highs, causing hardships for many lower-income households that face sharp increases for such necessities as food, gasoline and rent.
It’s unclear whether the economy can maintain its momentum of the past year. The government relief checks are gone. The Fed raised its benchmark short-term interest rate two weeks ago and will likely keep raising it well into next year. Those rate hikes will result in more expensive loans for many consumers and businesses.
Inflation has also eroded consumers’ spending power: Hourly pay, adjusted for higher consumer prices, fell 2.6% in February from a year earlier — the 11th straight month in which inflation has outpaced year-over-year wage growth. According to AAA, average gasoline prices, at $4.23 a gallon, are up a dizzying 47% from a year ago.
Squeezed by inflation, some consumers are paring their spending. The Commerce Department reported Thursday that consumer spending rose just 0.2%% in February — and fell 0.4% when adjusted for inflation — down from a 2.7% increase in January.
Still, the job market has kept hurtling ahead. Employers posted a near-record 11.3 million positions in February. Nearly 4.4 million Americans quit their jobs, a sign of confidence that they could find something better.
“We’re still seeing a very tight labor market,’’ said Karen Fichuk, CEO of the staffing company Randstad North America, who noted that the United States now has a record 1.7 job openings for every unemployed person.
Even so, so many jobs were lost in 2020 that the economy still remains more than 2 million shy of the number it had just before the pandemic struck. Over the past year, employers have added an average of 556,000 jobs a month. At that pace — no guarantee to continue — the nation would recover all the jobs lost to the pandemic by June. (That still wouldn’t include all the additional hiring that would have been done over the past two years under normal circumstances.)
Brighter job prospects are beginning to draw back into the labor force people who had remained on the sidelines because of health concerns, difficulty finding or affording daycare, generous unemployment benefits that have now expired or other reasons.
Over the past year, 3.6 million people have joined the U.S. labor force, meaning they now either have a job or are looking for one. But their ranks are still nearly 600,000 short of where they stood in February 2020, just before the pandemic slammed into the economy.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/pope-begs-forgiveness-indigenous-canada-school-abuses/
|
Pope begs forgiveness of Indigenous for Canada school abuses
VATICAN CITY (AP) — Pope Francis apologized and begged forgiveness Friday for the “deplorable” abuses suffered by Indigenous Peoples in Canada’s residential schools, saying he was ashamed and indignant at all they had endured at the hands of Catholic educators.
Francis made the apology and vowed to visit Canada during an audience with dozens of members of the Metis, Inuit and First Nations communities who came to Rome seeking a papal apology and a commitment for the Catholic Church to repair the damage.
More than 150,000 native children in Canada were forced to attend state-funded Christian schools from the 19th century until the 1970s in an effort to isolate them from the influence of their homes and culture. The aim was to Christianize and assimilate them into mainstream society, which previous Canadian governments considered superior.
“For the deplorable conduct of those members of the Catholic Church, I ask forgiveness of the Lord,” Francis said. “And I want to tell you from my heart, that I am greatly pained. And I unite myself with the Canadian bishops in apologizing.”
The trip to Rome by the Indigenous was years in the making but gained momentum last year after the discovery of hundreds of unmarked graves outside some of the residential schools. The three groups of Indigenous met separately with Francis over several hours this week, culminating with Friday’s audience.
Francis spoke in Italian, and it wasn’t immediately clear if the audience understood what he had said, though they stood and applauded after he finished.
And the audience continued on with joyous performances of Indigenous prayers, drum, dance and fiddlers that Francis watched, applauded and at one point gave a thumbs up to. The Indigenous then presented him with gifts, including snow shoes.
The head of the Metis, Cassidy Caron, presented Francis with a bound book of their people’s stories: Much of what the Indigenous sought to accomplish during their meetings this week was to tell Francis the individual stories of loss and abuse that they suffered.
The Canadian government has admitted that physical and sexual abuse was rampant at the schools, with students beaten for speaking their native languages. That legacy of that abuse and isolation from family has been cited by Indigenous leaders as a root cause of the epidemic rates of alcohol and drug addiction on Canadian reservations.
Nearly three-quarters of the 130 residential schools were run by Catholic missionary congregations.
Last May, the Tk’emlups te Secwepemc Nation announced the discovery of 215 gravesites near Kamloops, British Columbia, that were found using ground-penetrating radar. It was Canada’s largest Indigenous residential school and the discovery of the graves was the first of numerous, similar grim sites across the country.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/texas-caseworkers-after-abbotts-order-investigations-into-transgender-kids-parents-given-priority/
|
Texas caseworkers: After Abbott’s order, investigations into transgender kids’ parents given priority
AUSTIN, Texas (AP) — When Texas Gov. Greg Abbott put in motion abuse investigations into the parents of some transgender kids, child welfare supervisor Randa Mulanax said what happened next strayed from normal protocols.
There was unusual secrecy, with texts and emails discouraged. Allegations about trans kids received elevated status. In Texas, fewer than three in 10 child welfare investigations end with findings that harm likely occurred — classified as “reason to believe” — but the changes looked to Mulanax like these cases would be predetermined from the start.
“It was my understanding that they wanted to be found ‘reason to believe,’” Mulanax told The Associated Press in her first interview since leaving the Texas Department of Family and Protective Services, where she worked for six years until quitting last month. “That’s why we were having to figure out a way to staff it up and see how we go about it, since it doesn’t match our policy right now.”
As early as Friday, the Texas Supreme Court could decide whether the state can resume at least nine investigations into the parents of transgender children. They are the first to fall on the radar of child welfare authorities since Texas’ Republican governor in February directed the state to begin handling reports of gender-confirming care for kids as child abuse — the first such order issued in the U.S.
The court fight in Texas comes as Republicans across the country are leaning into policies aimed at transgender Americans, most prominently through bans on transgender athletes on girls sports teams. But Texas is the only state where a GOP governor has greenlighted abuse cases against the parents of transgender children, which several current and departing Texas child welfare workers say was rushed into action and has sunk already low morale at their troubled state agency even deeper.
It is unclear how many Texas child welfare investigators — who are tasked with carrying out Abbott’s directive — have quit in protest. Mulanax is one of at least two state Child Protective Services workers who are leaving and added their names this week to a court brief that urged Texas’ justices to keep the investigations sidelined. Five other investigators who remain at the agency also signed on.
Abbott’s instructions to Texas child welfare officials takes aim at treatments for children that include puberty blockers and hormone therapy.
Patrick Crimmins, spokesman for the Texas Department of Family and Protective Services, declined comment Thursday, citing the ongoing lawsuit.
“We’re being so closely monitored on those type of cases that you wouldn’t be able to just say, ‘Oh, nothing to see,’” said Shelby McCowen, a child welfare investigator who called the directive the ‘last straw’ and is quitting after less than a year at the agency.
Texas completed more than 157,000 child welfare investigations in the last fiscal year, according to state data. McCowen said the cases involving parents of transgender families were drawing the same attention as child death investigations, and like Mulanax, said instructions were given not to discuss the cases through state emails or phones — only on personal devices, or face-to-face.
The cases were to be referred to as “special assignments” rather than using a case name or number, according to McCowen. She said upper managers told investigators a survey would be sent out internally to address questions about the directive, but none ever arrived.
“I don’t know how many times they go into the cases, but we’re told that if we get one of these cases, the documentation has to be almost instant because it’s being monitored,” she said.
Abbott’s directive goes against the nation’s largest medical groups, including the American Medical Association, which have opposed Republican-backed restrictions filed in statehouses nationwide. On Thursday, President Joe Biden marked Transgender Day of Visibility by denouncing such legislation, saying “the onslaught of anti-transgender state laws attacking you and your families is simply wrong.”
In pressing that the investigations in Texas be allowed to continue, Republican Texas Attorney General Ken Paxton’s office wrote that “if DFPS cannot investigate possible child abuse, children may be harmed — perhaps irreversibly — in the interim.”
Mulanax said if the investigations were to resume, she considers it unlikely that any children would be removed from their homes around Texas’ biggest cities, which are controlled by Democrats and where some county officials have already said they would reject such cases.
But in the event of a finding of harm, Mulanax said, putting in place what are usually other safety plans don’t make sense to her either. She said those options typically include required parental supervision or services such as therapy, which Mulanax said some of the families might already be doing.
“It was just a complete betrayal of the department,” she said.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/gm-recalls-nearly-682000-suvs-windshield-wipers-can-fail/
|
GM recalls nearly 682,000 SUVs; windshield wipers can fail
Published: Apr. 1, 2022 at 7:04 AM CDT|Updated: 18 minutes ago
DETROIT (AP) — General Motors is recalling nearly 682,000 small SUVs because the windshield wipers can fail.
The recall covers the Chevrolet Equinox and GMC Terrain from the 2014 and 2015 model years.
Ball joints in the wiper module can rust, causing one or both wipers to fail, increasing the risk of a crash.
Dealers will inspect the module and repair or replace it. Owners will be notified by letter starting May 2.
Copyright 2022 The Associated Press. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/2022/04/01/parents-ashes-personal-belongings-sold-auction-after-movers-fail-deliver-mans-things/
|
Parents’ ashes, personal belongings sold at auction after movers fail to deliver man’s things
WILMINGTON, N.C. (WECT/Gray News) – A man who had been living in Oregon for 25 years decided to move across the country to be closer to family during the pandemic.
Dan Zimmerman landed a physician’s assistant position in Wilmington, packed up everything he owned and started looking for a company to help him with his move in October.
Dismayed by the initial estimates he received, Zimmerman started selling everything he could, deciding only to keep sentimental and high-value items with which he couldn’t part.
By that point, he only had a week before he was supposed to be in Wilmington to start his new job.
He ended up choosing what he thought was Mayflower Transit, one of the most trusted names in the business. Eventually, he learned that was not the case, and he had actually hired another company with a copycat name – Mayflower Relocation Services.
“They scheduled it, I paid them $1,300 with instructions that I’d pay them three payments: $1,300 at the signing of the contract, $1,300 when they come up and pick up my stuff, and another $1,300 when they finally delivered my belongings,” Zimmerman told WECT.
Zimmerman arranged for the company to store his belongings at a storage facility in North Carolina while he tried to find a house.
By December, Zimmerman had purchased a home and called the moving company to schedule delivery, but that’s when he says the excuses started.
First, he was told the mover was having trouble with his truck. Then, the mover had come down with COVID-19 and would be out for two weeks.
Zimmerman said the company stopped talking to him altogether and wouldn’t answer his calls.
Eventually, he received a text saying his things were in a storage unit in Charlotte, but they wouldn’t disclose the address.
Upon further research, he learned Mayflower Relocation Services was not a full-service moving company, but a broker that has an “F” rating with the Better Business Bureau.
They have more than a dozen complaints against them on file, including some from consumers like Zimmerman who said they never received their belongings.
After countless phone calls, Zimmerman learned his move was contracted out to Efficient Moving and Storage, who informed him his things had been in a storage unit in Idaho but were sold in an auction.
“I called and sure enough, somebody had told them that I would be calling them looking for my belongings. And she said, ‘I’m so sorry, but your belongings have been auctioned.’ And sent me pictures. And it just ended my life. I mean, literally, it was unreal,” Zimmerman said of realizing everything he owned had been sold to a stranger without his knowledge.
Not only did his belongings include expensive sporting equipment, antique clocks his father made and a guitar worth over $30,000, but also his deceased parents’ ashes, jewelry and all his family photo albums.
With the help of a warrant obtained by the Eugene, Oregon, Police Department, authorities were able to make contact with the people who’d purchased Zimmerman’s belongings on StorageTreasures.com in mid-February for just under $5,000.
Central Self Storage in Idaho put the contents of the unit up for sale when the person who’d rented it failed to pay the storage bill.
The buyers had already thrown away many of Zimmerman’s pictures and personal effects by the time authorities contacted them.
They offered to mail Zimmerman the remaining photo albums they found, but they had not found his parents’ ashes.
The new owners declined to return any other valuables, saying they were trying to recover the money spent purchasing the contents of the storage unit.
Zimmerman said he remains devastated over the loss and disappointed that there is not a better system in place to police unscrupulous movers.
“I thought I was safe. I already had all my belongings packed. … All they had to do is come pick it up and then deliver it. I never ever, ever perceived that I would lose my entire family history, gone, everything,” Zimmerman said.
In addition to the complaints on file against Mayflower Relocation Services with the Better Business Bureau, the Federal Motor Carrier Safety Administration lists dozens of complaints filed against the company.
Copyright 2022 WECT via Gray Media Group, Inc. All rights reserved.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/94th-academy-awards-generated-more-than-17m-online-mentions-highest-level-seen-5-years/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Sunday's 94th Academy Awards was filled with surprises–catalysts of online conversations that reverberated far after the closing of the ceremony. Beyonce's performance, popular looks from the Red Carpet, the big winners of the night, and the altercation between Will Smith and Chris Rock are all among the subjects of new research conducted by Maven Road to understand what conversations during the gala revealed about the night's winners and unexpected moments.
"We at Maven Road analyzed more than 17.3 million worldwide conversations surrounding The Oscars, the most discussions around the event during the last five years, to analyze what drove that online buzz," said Paul Herrera, COO & Co-founder at Maven Road.
Predictions favored Dune for Best Picture and Spielberg for Best Director
Of all the award categories, Best Picture generated the most attention on social media (708.5K total online conversations). "Dune" was the favorite among online predictions (90.3K mentions before the ceremony), followed by "The Power of the dog" (81.9K mentions). Yet "Coda" triumphed. Many fans expressed their displeasure about "Dune" not winning the category, and praised the film for winning six academy awards.
In the Best Director category, also of great interest among online conversations, Steven Spielberg narrowly surpassed Jane Campion as the favorite (62.4K online mentions vs. 61.7K); yet the "The Power of the Dog," director was awarded the prize, with Campion being among only three women who have taken the statuette in Oscars history. Her win drove the most social buzz among all conversations related to the category (32.8%).
The altercation between Will Smith and Chris Rock drove discussions
The most unexpected moment during the ceremony made the Oscars a trending topic, generating 5.3M total discussions and driving nearly a third of overall Oscar-related conversations (30.8%). It occurred when actor Will Smith struck comedian Chris Rock following a joke about his wife, Jada Pinkett Smith. Some Twitter users remarked that they had not watched the Oscars, commenting that ratings have declined over the past few years; however, the Smith-Rock incident once again placed the event at the center of attention, and controversy.
More than 570K Unique Authors commented about the event. Much of the opinionated commentary about the incident was negative due to fans and celebrities criticizing Will Smith's violent behavior. However, the limited positive conversations stood by Smith's reaction and shared supporting tweets about alopecia and Jada Smith.
Zendaya and Timothée Chalamet sported the most praised looks
Red carpet style was the subject of conversations among 304.7K Unique Users. Most discussions around celebrity fashion at the event occurred around 6:00 pm (55.9K). Media outlets and users shared posts with updates on celebrities' arrivals and the most eye-catching looks. Outlets also discussed the designers behind the celebrities' attire.
Zendaya and Timothée Chalamet were among the celebrities to generate the most buzz for their red carpet style (32.3K and 24.7K mentions, respectively), as fans praised their looks.
The Oscars 2022 proved very memorable, with unexpected moments being the driving force behind conversations that far surpassed those of previous years. The incident involving Will Smith was one of the most mentioned topics and revived the online conversation about the event. The analysis of social conversations about this and other events provides important insight into their relevance and impact.
To read the complete research, please visit: What drove online buzz surrounding the 94th Academy Awards and its memorable moments?
About Maven Road
Maven Road is a global business intelligence firm focused on creating lean, actionable consumer and audience intelligence. Our knowledge and expertise allow our customers to reach new pockets of consumer data that would otherwise remain untapped. Our Big Data, Machine Learning Models, and Advanced Analytics help global brands stay ahead of the market. To learn more, visit mavenroad.com.
View original content to download multimedia:
SOURCE Maven Road
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/aercap-signs-lease-agreements-ten-new-airbus-a320neo-aircraft-two-new-airbus-a330neo-aircraft-with-ita-airways/
|
DUBLIN, April 1, 2022 /PRNewswire/ -- AerCap Holdings N.V. ("AerCap" or the "Company") (NYSE: AER) today announced it has signed lease agreements for ten new Airbus A320neo aircraft and two new Airbus A330neo aircraft with ITA Airways. The aircraft are scheduled to deliver beginning in 2023 through 2024. The integration of these new aircraft is in line with the fleet plan of the Italian flag carrier.
Peter Anderson, Chief Commercial Officer of AerCap, said, "We are very pleased to expand our relationship with ITA Airways through the lease of these twelve advanced-technology Airbus A320neo and A330neo aircraft. These aircraft will enable ITA Airways to expand its network, whilst advancing its commitment to maintain an environmentally friendly, fuel-efficient fleet. We thank the team at ITA Airways for the confidence they have placed in AerCap, and we look forward to building the partnership for many years to come."
Francesco Presicce, Chief Technology Officer of ITA Airways, said: "The integration of these new aircraft is perfectly in line with the Company's fleet plan. This agreement represents a further step in our strategy of building a new environmental-friendly fleet with leadingedge technologies which will optimize efficiency, quality of service and significantly reduce the environmental impact. ITA Airways places the best customer service at the centre of its strategy with a strong focus on sustainability. The collaboration with AerCap allows us to improve cost efficiencies across our fleet. I wish to thank the AerCap team for their cooperation.
AerCap is the global leader in aviation leasing with one of the most attractive order books in the industry. AerCap serves approximately 300 customers around the world with comprehensive fleet solutions. AerCap is listed on the New York Stock Exchange (AER) and is based in Dublin with offices in Shannon, Miami, Singapore, Amsterdam, Shanghai, Abu Dhabi, Seattle, Toulouse and other locations around the world.
This press release contains certain statements, estimates and forecasts with respect to future performance and events. These statements, estimates and forecasts are "forward-looking statements". In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as "may," "might," "should," "expect," "plan," "intend," "will", "aim", "estimate," "anticipate," "believe," "predict," "potential" or "continue" or the negatives thereof or variations thereon or similar terminology. All statements other than statements of historical fact included in this press release are forward-looking statements and are based on various underlying assumptions and expectations and are subject to known and unknown risks, uncertainties and assumptions, and may include projections of our future financial performance based on our growth strategies and anticipated trends in our business. These statements are only predictions based on our current expectations and projections about future events. There are important factors, including the impacts of, and associated responses to: the Covid-19 pandemic, our ability to successfully integrate GECAS' operations and employees and realize anticipated synergies and cost savings; and the potential impact of the consummation of the GECAS transaction on relationships, including with employees, suppliers, customers and competitors, that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied in the forward-looking statements. As a result, we cannot assure you that the forward-looking statements included in this press release will prove to be accurate or correct. In light of these risks, uncertainties and assumptions, the future performance or events described in the forward-looking statements in this press release might not occur. Accordingly, you should not rely upon forward-looking statements as a prediction of actual results and we do not assume any responsibility for the accuracy or completeness of any of these forward-looking statements. Except as required by applicable law, we do not undertake any obligation to, and will not, update any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information regarding AerCap and to be added to our email distribution list, please visit www.aercap.com and follow us on Twitter www.twitter.com/aercapnv.
AerCap Holdings N.V.
65 St. Stephen's Green, Dublin 2, Ireland www.aercap.com
View original content to download multimedia:
SOURCE AerCap Holdings N.V.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/aex-vietnam-endorser-competition-begins/
|
AEX Vietnam Endorser Competition Begins - 100,000 USDT Giveaways!
HO CHI MINH CITY, Vietnam, April 1, 2022 /PRNewswire/ -- With the launch of the Vietnam Operation Center, AEX Global started the Vietnamese Blockchain Eco-development Plan with 100,000,000 USD. Recently, AEX announced that they will launch the 'Vietnam Endorser Competition' activity on April 7, 2022. The top 3 endorsers will get over 2,000,000,000 VND rewards (valued at 100,000 USD), among which the champion will get 1,500,000,000 VND (valued at 66,666 USD), the prize for second place is 380,000,000 VND (valued at 16,666 USD), and the third place gets 150,000,000 VND (valued at 6,666 USD). The top 10 will get the rewards and customized NFT! AEX Global declares its global business expansion with a high endorsement bonus and endorsers voted by users is also in line with the current DAO principle in the blockchain ecosystem, which will further establish AEX Vietnam ecosystem. Endorser application link: https://forms.gle/ssyRqwTAi8kN9xXu8
Different from other crypto exchanges, AEX Global doesn't cooperate with sports stars for brand exposure, nine years of experience have led AEX to opt for a more ecologically oriented DAO style instead. By community voting to select the native KOL(s), Vietnam blockchain investors can deeply involve themselves in ecological construction and also share crypto finance development bonuses. Currently, AEX has launched dozens of ecological activities, providing global blockchain investors with diversified portfolios.
"AEX Global Vietnam Operation Center has launched a series of ecological activities for Vietnamese users, for example Vietnam Endorser Competition, Up To 1,000 USDT Registration Rewards, 100% Novice Finance APR, Trading Sharing Of 200,000 USDT, and KAI Token Giveaways In Listing Desk and so on. From the very first moment a user enters AEX.com, he/she can enjoy richer investment ideas and obtain higher returns as the platform provides them with comprehensive and complete finance events. AEX crypto service platform gathers business models such as Finance, Loan, Mining, and DeFi as it is striving to provide a stable, safe, and professional digital finance management service for users around the world", said by Brand spokesperson of AEX, Shergina Asya.
The closer you look, the further you see. AEX Global Service Platform is continually developing, and our goal is to provide 1 billion people with safe, complete, simple, and diversified crypto finance management service in the next 9 years.
Vietnam Endorser Competition is in full swing, up to 100,000 USDT Giveaway, rewards sending the top 10 competitors and the Champion gets 66,666 USDT!
Click to become an Endorser: https://forms.gle/ssyRqwTAi8kN9xXu8
AEX: https://www.aex.com/page/h5/m_regist.html#/newByInvite?from=q0c909
View original content:
SOURCE AEX exchange
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/afrm-shareholder-alert-jakubowitz-law-reminds-affirm-holdings-inc-shareholders-lead-plaintiff-deadline-april-29-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Affirm Holdings, Inc. (NASDAQ: AFRM).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/affirm-holdings-inc-loss-submission-form/?id=25394&from=4
This lawsuit is on behalf of all investors who purchased or otherwise acquired Affirm Holdings, Inc. securities on February 10, 2022 after the Company sent a Tweet concerning its Second Quarter 2022 financial results at approximately 1:15 p.m. EST.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until April 29, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to the filed complaint, on February 10, 2022 at approximately 1:15 p.m., Affirm issued a Tweet from its official account in which the Company disclosed certain metrics from its second quarter 2022 financial results. The Tweet, which was published prior to the Company's planned release of its financial results, portrayed a highly successful quarter, which included an increase in revenue of 77%. This caused Affirm's share price to spike nearly 10% in intra-day trading. The Tweet was materially misleading, in that it omitted to disclose the full details of Affirm's second quarter financial results. Affirm deleted the Tweet and released its full second quarter financial results ahead of schedule. The full financial results were lackluster – with the Company posting a loss of $0.57 per share, compared with analyst expectations of $0.37 per share.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/alcresta-therapeutics-announces-series-commercial-milestone-achievements-relizorb/
|
NEWTON, Mass., April 1, 2022 /PRNewswire/ -- Alcresta Therapeutics, Inc., a leading commercial-stage company focused on developing and commercializing novel enzyme-based products, today announced a series of commercial milestone achievements. Alcresta announced its first profitable year in 2021, the completion of royalty payments to the Cystic Fibrosis Foundation (CFF) and a doubling of its sales force to expand the promotion of RELiZORB, a first-of-its-kind digestive enzyme cartridge used in enteral feeding designed to mimic the function of pancreatic lipase. RELiZORB is the only enzyme product cleared by the FDA for use in enteral feeding.
Payer access to RELiZORB has improved significantly over the last two years, resulting in 70% growth year-over-year in net sales with 24% adjusted EBITDA. In December 2013, CFF granted to Alcresta a research award to support the research program that resulted in RELiZORB. As part of the grant agreement, Alcresta agreed to pay certain royalties and milestone payments over time. The rapid net sales growth allowed the company to complete its royalty obligation to CFF, which was an early supporter of the company's platform. Alcresta's final royalty payment to CFF was made in March 2022.
"Both broad payer access and profitability have allowed us to further invest to reach deeper into the population of CF patients who are enterally fed," said Daniel Orlando, Chief Executive Officer at Alcresta Therapeutics.
Supporting this rapid growth is a recently expanded account manager team up from seven sales territories in one region to 16 territories in two regions. RELiZORB is currently used by approximately 23% of treatable patients within the cystic fibrosis total addressable market. Over the past 24 months, RELiZORB has been added as a covered benefit for most commercial payers and state Medicaids. This expanded access follows the recent favorable CMS/Medicare local coverage determination (LCD ID No. 38955) covering RELiZORB for patients who meet the coverage criteria for enteral nutrition and have a diagnosis of exocrine pancreatic insufficiency. The improved access allows the expanded sales team to accelerate execution of Alcresta's commercial strategy to position RELiZORB as the standard of care for enterally fed patients with CF.
For more information on RELiZORB, please visit www.relizorb.com
About Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. is dedicated to developing and commercializing novel, enzyme-based products designed to address challenges faced by patients living with gastrointestinal disorders and rare diseases. Alcresta currently markets RELiZORB for enterally fed patients with pancreatic insufficiency, which occurs in cystic fibrosis, pancreatic cancer, and pancreatitis, and is developing platform applications for patients with short bowel syndrome (SBS) and prematurely born infants treated in the NICU. Alcresta Therapeutics, Inc. is backed by top-tier investors: Athyrium Capital Management, Bessemer Venture Partners, HealthQuest Capital, Frazier Healthcare Partners, and Third Rock Ventures. More information can be found at www.alcresta.com.
Internal Media Contact:
Corey Starke
Alcresta Therapeutics, Inc.
media@alcresta.com
617-431-3600
View original content:
SOURCE Alcresta Therapeutics, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/alten-technology-usa-syncroness-merge-strengthen-us-engineering-service-offerings/
|
Merger brings decades of engineering and IT consulting experience together under one roof
TROY, Mich., April 1, 2022 /PRNewswire/ -- ALTEN Technology USA Inc. and Syncroness Inc. have merged under the name ALTEN Technology USA Inc. This merger combines decades of project-based engineering and IT consulting experience so clients can benefit from a wider array of service offerings on a larger scale across the U.S. and around the world.
Both ALTEN Technology USA and Syncroness have provided engineering consulting, product development and IT consulting services to clients for more than 20 years. Going forward, ALTEN Technology USA will support the aerospace, defense, automotive, industrial, rail, medtech, energy and environment, life science and robotics and unmanned systems industries.
According to Brian Wyatt, COO of ALTEN Technology USA, "Combining Syncroness' 20-plus years of specialized product development experience with ALTEN's scale and global footprint will enable us to provide our clients with even more value while cultivating deeper relationships, which is what our business is all about."
Mike Walraven, CEO of Syncroness, agrees: "This merger will allow us to better serve our clients by working on bigger and more complex projects while retaining our commitment to providing our clients with high-quality work and world-class talent."
ALTEN Technology USA will remain a wholly owned subsidiary of the ALTEN Group, a French multinational engineering and IT consulting company founded in 1988. The ALTEN Group operates in 30 countries across Europe, North America, Asia, Africa and the Middle East and has more than 40,000 employees worldwide. Syncroness was acquired by the ALTEN Group in 2017 but operated independently until this merger.
For more information about ALTEN Technology USA, please visit www.altenusa.com.
About ALTEN Technology USA: ALTEN Technology USA is an engineering consulting company that provides innovative solutions for engineering, IT and product development projects across the product life cycle. For decades, ALTEN Technology USA has been helping clients develop products that are changing the world, whether by shaping the future of space exploration, saving lives with medical devices that set new standards of care or creating the fully autonomous electric taxi of tomorrow. The company provides support across industries including aerospace, defense, medtech and life sciences, unmanned systems and robotics, automotive OEM and Tier 1 suppliers, commercial vehicles, electric vehicles, energy and environment, rail and more.
View original content to download multimedia:
SOURCE ALTEN Technology USA
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/april-is-national-safe-digging-month/
|
Southwest Gas reminds the public to stay safe and call 811 before digging
PHOENIX, April 1, 2022 /PRNewswire/ -- Nearly two in five homeowners throughout the country will put themselves – and their communities – at risk by not calling 811 before beginning digging projects*. April is historically the beginning of the dig season in many of our service areas and is recognized nationally as Safe Digging Month.
It's important for professional excavators and do-it-yourself homeowners to know that one easy, free phone call to 811 quickly begins the process of getting underground utility lines marked for free. Call 811 is for residential and commercial digging jobs of all sizes, from planting trees and mailbox installation to large construction projects. Completing this process before starting any digging project is critical to preventing accidents. The annual societal cost of damages to underground infrastructure nationally exceeds $30 billion.
While damages to Southwest Gas infrastructure dipped slightly in 2021, 32% of pipeline damages in our service territories were caused by a failure to call 811 at least two working days in advance, which matches the national figure.
Anyone who thinks they may have damaged an underground pipeline, even if they're not a natural gas customer, should leave the area immediately and call 911 and Southwest Gas at 877-860-6020. A natural gas leak can be detected by a distinct sulfur-like odor, similar to rotten eggs, even if it's faint or momentary. Unusual hissing or roaring coming from the ground or an above-ground pipeline, bubbling water and discolored plants or grass surrounding a pipeline can also be signs of a leak.
For more information about the Call 811 process and natural gas safety, visit swgas.com/safety.
Southwest Gas Corporation proudly serves more than two million customers in Arizona, California and Nevada, safely and reliably. For more information about Southwest Gas, please visit www.swgas.com.
*Courtesy Common Ground Alliance 2021 Omnibus Study
View original content:
SOURCE Southwest Gas Corporation
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/barbara-bush-foundation-receives-16-million-grant-dollar-general-literacy-foundation/
|
Award will support implementation of the first-ever multisector National Action Plan for Adult Literacy
WASHINGTON, April 1, 2022 /PRNewswire/ -- The Barbara Bush Foundation for Family Literacy is pleased to announce that it has received a grant of $1.6 million from the Dollar General Literacy Foundation to support implementation of the National Action Plan for Adult Literacy.
Conceived and convened by the Barbara Bush Foundation, the first-ever National Action Plan for Adult Literacy was developed in collaboration with more than 100 expert stakeholders including representatives from corporations and foundations; community organizations and associations; federal, state and local governments; academic experts; and edtech leaders. The plan was officially launched at the Foundation's National Summit on Adult Literacy in October 2021, which featured Dr. Jill Biden, First Lady of the United States, as keynote speaker.
This multisector, multiyear initiative aims to transform adult and family literacy for millions of Americans by driving inclusive, collective action to address systemic challenges over the next five years. The plan has three broad, mutually reinforcing goals:
- Access: Make literacy support services accessible to everyone who wants them.
- Quality: Ensure that literacy programs are effective and efficient in helping adults improve their reading, writing, digital and numeracy skills.
- Participation: Encourage more adults to engage in support programs that improve their literacy, digital and numeracy skills.
Today, 130 million Americans – 54% of adults between the ages of 16 and 74 years old – lack proficiency in literacy, essentially reading below the equivalent of a sixth-grade level. A 2020 Gallup study commissioned by the Barbara Bush Foundation found that the U.S. could be losing up to $2.2 trillion annually in GDP due to low adult literacy rates.
"Literacy is about so much more than words on a page. It's an issue of equity that is directly linked to the social and economic wellbeing of not only individuals and their families, but businesses, communities and our entire nation," said British A. Robinson, president and CEO of the Barbara Bush Foundation. "We couldn't ask for a better partner than the Dollar General Literacy Foundation, one of the nation's most steadfast voices for literacy, as we work to move the needle on this issue once and for all."
"The National Action Plan has the ability to transition our shared vision of a country in which adults can easily access high-quality, effective literacy support in their hometown communities to collective action," said Denine Torr, vice president corporate social responsibility and philanthropy for Dollar General and executive director of the Dollar General Literacy Foundation. "Working together, we can begin to address the opportunity gaps that exist and serve more students. We are very proud to partner with the Barbara Bush Foundation on this effort," said Torr, who also serves as a member of the Barbara Bush Foundation's board of directors.
The Dollar General Literacy Foundation recently announced a commitment of approximately $5 million in grants to five national organizations working to address the critical literacy needs identified in its newly released State of American Literacy Report. The two-year commitment to the Barbara Bush Foundation for Family Literacy will support implementation of the National Action Plan for Adult Literacy, with a focus on boosting literacy organizations, advancing professional development for teachers and identifying opportunity gaps.
About the Barbara Bush Foundation for Family Literacy: The Barbara Bush Foundation for Family Literacy has been the nation's leading advocate for family literacy for more than three decades. Established by former First Lady Barbara Bush in 1989, the Foundation is a public charity dedicated to creating a stronger, more equitable America in which everyone can read, write and comprehend in order to navigate the world with dignity. To learn more, visit www.BarbaraBush.org.
View original content to download multimedia:
SOURCE Barbara Bush Foundation for Family Literacy
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/bd-announces-completion-embecta-corp-spinoff/
|
FRANKLIN LAKES, N.J., April 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has completed its spinoff of Embecta Corp. (embecta) (NASDAQ: EMBC), which holds BD's former Diabetes Care business and is now one of the largest pure-play diabetes management companies in the world.
"The completion of this spinoff is a significant achievement for both BD and embecta," said Tom Polen, chairman, CEO and president of BD. "While BD is proud of its heritage in the diabetes care category, we are just as excited to see our legacy advanced by embecta as a newly independent, publicly-traded corporation. Moving forward, each of our organizations will be able to focus on investment and innovation in our respective core businesses, support our customers and the patients they serve, drive strategic growth and enhance long-term shareholder value."
The spinoff of embecta demonstrates BD's ongoing commitment to the company's BD 2025 strategy, which includes its three strategic pillars of Grow, Simplify and Empower. The strategic rationale for the spinoff was to create two, independent companies with attractive long-term value for BD shareholders and enhanced strategic, operational and financial characteristics. Each company will focus on its core business and product portfolios, with BD maintaining its category leadership positions across its BD Medical, BD Life Sciences and BD Interventional segments.
embecta will focus on building on its solid foundation as the leading producer of diabetes injection devices, investing in both organic and inorganic growth opportunities and improving the lives of people living with diabetes.
Shareholders will receive one share of embecta common stock for every five common shares of BD that they held as of the close of business on March 22, 2022, the record date for the spin-off, with cash in lieu of any fractional shares of embecta common stock.
BD retains no ownership interest in embecta, which will begin trading today on the NASDAQ under the symbol EMBC on a "regular way" basis.
Perella Weinberg Partners LP, Morgan Stanley & Co. LLC, Wachtell, Lipton, Rosen & Katz, Skadden, Arps, Slate, Meagher & Flom LLP, Baker McKenzie, and PricewaterhouseCoopers are acting as advisors to BD in connection with the transaction.
Please visit investors.bd.com for additional information regarding the spinoff, including links to filings with the SEC.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Forward-Looking Statements This press release contains certain forward-looking statements (as defined under Federal securities laws) regarding BD and the spinoff of embecta, including the anticipated benefits of the spinoff. All such statements are based upon current expectations of BD and involve a number of risks and uncertainties. With respect to forward-looking statements contained herein, a number of factors could cause actual outcomes to vary materially. These factors include, but are not limited to, risks associated with the impact or terms of the spinoff, as well as other factors discussed in BD's filings and embecta's filings with the SEC. We do not intend to update any forward-looking statements to reflect events or circumstances after the date hereof except as required by applicable laws or regulations.
View original content to download multimedia:
SOURCE BD (Becton, Dickinson and Company)
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/better-homes-gardens-real-estate-masiello-group-announces-new-director-its-award-winning-relocation-services/
|
BEDFORD, N.H., April 1, 2022 /PRNewswire/ -- Better Homes and Gardens Real Estate The Masiello Group has a new Director of Relocation Services to lead its highly-recognized relocation team.
Diane Stuart was named Director of Relocation Services & Business Development this month, bringing nearly 25 years of experience as a licensed real estate agent and extensive expertise in relocation services. The Masiello Group's relocation department works with the highest ranking brokerages in the country to relocate corporate employees as they move in and out of New England.
"Diane is a proven agent and leader in the relocation field," said Chris Masiello, Chairman and CEO of Better Homes and Gardens Real Estate The Masiello Group. "We couldn't be more pleased she's taken this role to lead this important part of the Masiello business portfolio."
Stuart has been an agent with the Masiello Group for the past 22 years and a resident of New Hampshire for more than 30 years, giving her on-the-ground expertise and understanding of which communities will best fit families as when they move into New England. She has served as Closing Coordinator, Business Support Specialist, and Relocation Coordinator/Affinity Manager for The Masiello Group, building affinity relationships with organizations like AARP and Navy Federal Credit Union (NFCU).
"First and foremost, I hope to maintain the high level of service this award-winning department has consistently delivered," said Stuart. "The real estate market has grown hyper-competitive in recent years. By leveraging our deep experience in the New England real estate market and stand-out service, we can continue to meet the needs of our corporate relocation clients."
The Masiello Group has been widely recognized as a leader in relocation services, named a Top 25 Broker by Realogy Leads Group in 2022 for its excellent performance and customer satisfaction. This prestigious annual award honors the top 25 companies across the Realogy Advantage Network of more than 500 brokerages nationwide. Award criteria are based on rigorous scoring and success in a variety of performance metrics surrounding customer satisfaction.
Since 2012, The Masiello Group has received 19 awards for its relocation services from organizations such as the Cartus Broker Network, RealTrends 500, AIRES Broker Network, and USAA.
About The Masiello Group
With 36 offices throughout Northern New England, Better Homes and Gardens Real Estate The Masiello Group is the largest real estate firm north of Boston and is the only company in the region to offer a complete spectrum of home services, including mortgage, title, home warranty, homeowner insurance, and relocation services. The Masiello Group was recently named a Top 25 Broker by Realogy Leads Group in recognition of its excellent performance and customer satisfaction. In January 2022, Swanepoel Power 200 recognized Chairman and CEO Christopher J. Masiello as one of the most influential leaders in the residential real estate industry. Visit www.masiello.com.
View original content to download multimedia:
SOURCE Better Homes and Garden Real Estate The Masiello Group
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/biostage-reports-fourth-quarter-fiscal-year-2021-financial-results/
|
HOLLISTON, Mass., April 1, 2022 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in treating esophageal cancer (conducted at the Mayo Clinic and published last August) and FDA approval to commence a clinical trial of the Biostage Esophageal Implant for severe esophageal disease including cancer, today announced its financial results for the three months and year ended December 31, 2021.
The Company will be hosting a conference call on Friday, April 1, 2022 at 9;00 A.M. Eastern Time. You can access the live conference call by dialing the following phone numbers toll free 877-407-8293 or international +1 201-689-8349.
For the three months ended December 31, 2021, the Company reported a net loss of $5.9 million, or $0.55 per share, as compared to a net loss of $1.0 million, or $0.12 per share, for the three months ended December 31, 2020. The $4.9 million quarter-over-quarter increase in net loss was due primarily to a charge of approximately $3.3 million relating to the contingency matter for our ongoing litigation for a wrongful death complaint and related matters more fully described in Note 9 to our consolidated financial statements and an increase in legal costs of approximately $1.3 million for fees for filing claims against our insurance carrier to seek continuance of insurance coverage for the same litigation. In addition, research and development costs increased $0.2 million and the Company recognized lower grant income for qualified expenditures from the SBIR grant of $0.1 million as the grant expired effective September 30, 2021.
Net loss increased approximately $3.1 million to approximately $8.0 million, or $0.79 per share, for the year ended December 31, 2021 as compared to approximately $4.9 million, or $0.55 per share, for the year ended December 31, 2020.
The $3.1 million year-over-year increase in net loss was due primarily to a charge of approximately $3.3 million relating to the contingency matter for our ongoing litigation for a wrongful death complaint and related matters more fully described in Note 9 to our consolidated financial statements and an increase in legal costs of approximately $1.3 million for fees for filing claims against our insurance carrier to seek continuance of insurance coverage for the same litigation. These increases are offset, in part, by approximately $0.8 million of lower employee and share-based expenses due to the separations of our former chief executive and chief financial officers during 2020.
In addition, research and development costs decreased by $0.5 million Notes Payable were forgiven resulting in a $0.4 million gain and grant income decreased by $0.2 million which account for the change in net loss year-over-year.
As of December 31, 2021, the Company had operating cash on-hand of $1.2 million, a decrease of $0.2 million from the prior year. During the year ended December 31, 2021, the Company used net cash in operations of $2.6 million, which was offset, in total, by $2.8 million of proceeds from private placement transactions that resulted in the issuance of 1,372,464 shares of our common stock and warrants to existing investors.
We expect that our operating cash on-hand as of December 31, 2021 of $1.2 million will enable us to fund our operating expenses and capital expenditure requirements into early third quarter of 2022.
Biostage is a clinical-stage biotech company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects. We have performed the world's first regeneration of an esophagus in a human cancer patient. This surgery was performed at Mayo Clinic and was published in August 2021.
Biostage has 7 issued U.S. patents, 2 orphan-drug designations (which provide 7 years of market exclusivity in addition to any patents), and the possibility of 2 Priority Review Vouchers from the FDA.
Biostage's current goals include raising capital, uplisting from the OTC bulletin board to NASDAQ and beginning its clinical trial for repair of the esophagus in adults.
For more information, please visit www.biostage.com and connect with the Company on Twitter and LinkedIn.
Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements in this press release include, but are not limited to, statements relating to the capabilities and performance of our products and product candidates; our capital raising plans and expectations, including uplifting to NASDAQ; development expectations and regulatory approval of any of the Company's products, including those utilizing its Biostage Esophageal Implant technology, by the U.S. Food and Drug Administration, the European Medicines Agency or otherwise, which expectations or approvals may not be achieved or obtained on a timely basis or at all; and success with respect to any collaborations, clinical trials and other development and commercialization efforts of the Company's products, which such success may not be achieved or obtained on a timely basis or at all. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this press release, including, among other things, the Company's inability to obtain needed funds in the immediate future; the Company's ability to obtain and maintain regulatory approval for its products; plus other factors described under the heading "Item 1A. Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2021 or described in the Company's other public filings. The Company's results may also be affected by factors of which the Company is not currently aware. The forward-looking statements in this press release speak only as of the date of this press release. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such statements to reflect any change in its expectations with regard thereto or any changes in the events, conditions or circumstances on which any such statement is based.
Investor Relations Contact
Shunfu Hu
Vice President of Business Development
and Operations
774-233-7300
shu@biostage.com
View original content to download multimedia:
SOURCE Biostage, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/blue-fin-group-an-integrichain-company-promotes-reena-k-patel-partner/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Blue Fin Group, a full-service management consulting firm to the pharmaceutical industry, today announced the promotion of Reena K. Patel to Partner. Reena joined Blue Fin Group in 2011 as Principal Consultant, and has advised pharmaceutical manufacturers extensively across the entire commercialization spectrum, primarily focusing on product commercialization launches and strategy development, market access, gross-to-net optimization, government pricing and public policy, and channel and patient services. In her new role, Reena will have direct client oversight and responsibility and will lead several corporate responsibilities.
"Reena is a go-to expert in government pricing, contracting, compliance and reimbursement both with our clients and within our firm," said William Roth, Blue Fin Group's General Manager and Managing Partner. "She has been instrumental helping interpret and analyze the impact of healthcare policy areas for our largest clients, and has finely honed her consulting and leadership skills. Most importantly, Reena has valued and effectively communicated our mission and core purpose to help our clients bring their science to market to ensure patients have affordable access to life saving products in a timely manner. Now with our recent acquisition by IntegriChain, her expertise is even more critical as our broader organization supports roughly 400 manufacturers across contracting, government pricing, gross-to-net and an array of products and services that optimize the patient journey."
Reena grew up in Dallas (Plano), Texas and currently resides in New York City. She holds a Bachelor of Science in Pharmaceutical and Healthcare Business from the Mayes College of Healthcare Business and Policy, University of Sciences in Philadelphia (USP).
Learn more about Reena K. Patel at https://youtu.be/DyBpRe3Lflc.
About Blue Fin Group, an IntegriChain Company
Blue Fin Group develops strategies to optimize patient access, commercialization, and gross-to-net to support life sciences manufacturers throughout the product life cycle. Blue Fin Group is a full-service management consulting firm delivering research, strategy, and implementation to help manufacturers align all the elements of marketing, market access, field sales, pharmacy and distribution, and patient services as a seamless commercial strategy that helps optimize patient outcomes. Blue Fin Group has served more than 300 manufacturers–primarily those commercializing their first asset or large global firms with products that span cell and gene therapies, orphan/rare, specialty, primary care, vaccines, biosimilars, and generics.
For additional information, visit https://consultbfg.com/ or follow on Twitter bluefingroup and LinkedIn.
For Media Inquiries: Contact Cynthia Keveney at ckeveney@consultbfg.com
View original content:
SOURCE Blue Fin Group, an IntegriChain Company
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/borgwarner-completes-acquisition-santrolls-light-vehicle-emotor-business/
|
- Expected to strengthen electric propulsion systems leadership
- Complementary, market leading vertical integration capabilities
AUBURN HILLS, Mich., April 1, 2022 /PRNewswire/ -- BorgWarner Inc. (NYSE: BWA) today announced that it has completed its acquisition of Santroll Automotive Components, a carve-out of Santroll's eMotor business. The acquisition is expected to strengthen BorgWarner's vertical integration, scale, and portfolio breadth in light vehicle e-motors while allowing for increased speed to market.
"We are pleased to complete our acquisition of Santroll and welcome Santroll's talented employees in China to BorgWarner," said Frédéric Lissalde, President and CEO, BorgWarner.
Based in Tianjin, China, Santroll designs and manufactures hairpin and concentrated-winding technology eMotors for use in light vehicles. Santroll supplies its patented technology to the Chinese OEM market. With nearly 400 full-time employees, Santroll brings manufacturing equipment design capabilities and proven automation expertise that have allowed it to secure business relationships with many leading customers in China.
About BorgWarner
For more than 130 years, BorgWarner has been a transformative global product leader bringing successful mobility innovation to market. Today, we're accelerating the world's transition to eMobility — to help build a cleaner, healthier, safer future for all.
Forward-Looking Statements: This press release may contain forward-looking statements as contemplated by the 1995 Private Securities Litigation Reform Act that are based on management's current outlook, expectations, estimates and projections. Words such as "anticipates," "believes," "continues," "could," "designed," "effect," "estimates," "evaluates," "expects," "forecasts," "goal," "guidance," "initiative," "intends," "may," "outlook," "plans," "potential," "predicts," "project," "pursue," "seek," "should," "target," "when," "will," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. Further, all statements, other than statements of historical fact contained or incorporated by reference in this press release that we expect or anticipate will or may occur in the future regarding our financial position, business strategy and measures to implement that strategy, including changes to operations, competitive strengths, goals, expansion and growth of our business and operations, plans, references to future success and other such matters, are forward-looking statements. Accounting estimates, such as those described under the heading "Critical Accounting Policies and Estimates" in Item 7 of our most recently-filed Annual Report on Form 10-K ("Form 10-K"), are inherently forward-looking. All forward-looking statements are based on assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances. Forward-looking statements are not guarantees of performance, and the Company's actual results may differ materially from those expressed, projected or implied in or by the forward-looking statements.
You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking statements are subject to risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed, projected or implied in or by the forward-looking statements. These risks and uncertainties, among others, include: supply disruptions impacting us or our customers, such as the current shortage of semiconductor chips that has impacted original equipment manufacturer ("OEM") customers and their suppliers, including us; commodities availability and pricing; competitive challenges from existing and new competitors including OEM customers; the challenges associated with rapidly-changing technologies, particularly as relates to electric vehicles, and our ability to innovate in response; uncertainties regarding the extent and duration of impacts of matters associated with the COVID-19 pandemic, including additional production disruptions; the difficulty in forecasting demand for electric vehicles and our electric vehicles revenue growth; the ability to identify targets and consummate acquisitions on acceptable terms; failure to realize the expected benefits of acquisitions on a timely basis including our recent acquisition of AKASOL AG and our 2020 acquisition of Delphi Technologies PLC; the ability to identify appropriate combustion portfolio businesses for disposition and consummate planned dispositions on acceptable terms; the failure to promptly and effectively integrate acquired businesses; the potential for unknown or inestimable liabilities relating to the acquired businesses; our dependence on automotive and truck production, both of which are highly cyclical and subject to disruptions; our reliance on major OEM customers; fluctuations in interest rates and foreign currency exchange rates; our dependence on information systems; the uncertainty of the global economic environment; the outcome of existing or any future legal proceedings, including litigation with respect to various claims; future changes in laws and regulations, including, by way of example, taxes and tariffs, in the countries in which we operate; impacts from any potential future acquisition or disposition transactions; and the other risks noted in reports that we file with the Securities and Exchange Commission, including Item 1A, "Risk Factors" in our most recently-filed Form 10-K and/or Quarterly Report on Form 10-Q. We do not undertake any obligation to update or announce publicly any updates to or revisions to any of the forward-looking statements in this press release to reflect any change in our expectations or any change in events, conditions, circumstances, or assumptions underlying the statements.
View original content to download multimedia:
SOURCE BorgWarner
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/bright-scholar-announces-receipt-nyse-non-compliance-letter-regarding-ads-trading-price/
|
FOSHAN, China, April 1, 2022 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global premier education service company, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated March 25, 2022, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure period for the Company to regain compliance expires on September 26, 2022.
Pursuant to applicable NYSE continued listing standards, a company would be considered "below criteria" by the NYSE if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period. Once notified, the company must bring its ADS trading price and average ADS trading price back above $1.00 within the applicable cure period following receipt of the notification. The company can regain compliance at any time during the cure period if on the last trading day of any calendar month during the cure period the company has an ADS closing price of at least $1.00 and an average ADS closing price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. In the event that at the expiration of the cure period, both a $1.00 ADS closing price on the last trading day of the cure period and a $1.00 average ADS closing price over the 30 trading-day period ending on the last trading day of the cure period are not attained, the NYSE will commence suspension and delisting procedures.
To address this issue, the Company intends to monitor the market conditions of its listed securities and is still considering its options.
About Bright Scholar Education Holdings Limited
Bright Scholar is a global premier education service company, which primarily provides quality international education to global students and equip them with the critical academic foundation and skillsets necessary to succeed in the pursuit of higher education. Bright Scholar also complements its international offerings with Chinese government-mandated curriculum for students who wish to maintain the option of pursuing higher education in China.
Safe Harbor Statement
This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Such statements are based upon management's current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's control, which may cause the Company's actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
IR Contact:
GCM Strategic Communications
Email: BEDU.IR@gcm.international
Media Contact:
Email: media@brightscholar.com
Phone: +86-757-6683-2507
View original content:
SOURCE Bright Scholar Education Holdings Ltd.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/caba-shareholder-alert-jakubowitz-law-reminds-cabaletta-shareholders-lead-plaintiff-deadline-april-29-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/cabaletta-bio-inc-loss-submission-form/?id=25393&from=4
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Cabaletta common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about October 24, 2019; and/or (b) Cabaletta securities between October 24, 2019 and December 13, 2021, both dates inclusive.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until April 29, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Cabaletta Bio, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (i) top-line data of the Phase 1 Clinical Trial indicated that Cabaletta's lead product candidate, DSG3-CAART, had, among other things, worsened certain participants' disease activity scores and necessitated additional systemic medication to improve disease activity after DSG3-CAART infusion; (ii) accordingly, DSG3-CAART was not as effective as the Company had represented to investors; (iii) therefore, the Company had overstated DSG3-CAART's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/cae-announces-appointment-patrick-m-shanahan-caes-board-directors/
|
MONTREAL, April 1, 2022 /PRNewswire/ - (NYSE: CAE; TSX: CAE) - CAE announced today the appointment of Patrick M. Shanahan as a new member of CAE's Board of Directors.
"We are very pleased to welcome Patrick M. Shanahan to CAE's Board of Directors. Mr. Shanahan's more than 30 years of experience in the defense sector will help CAE achieve greater alignment with the needs and priorities of National Defense Departments, from the U.S. and Canada, to NATO and allies worldwide. He brings deep knowledge of Defense policy, strategy, technology, supply chain and operations that will strengthen our Board." said the Honourable John Manley, Chair of CAE's Board of Directors.
Mr. Shanahan served as Acting U.S. Secretary of Defense in 2019 and as Deputy Secretary of Defense from 2017 to 2019. He also helped lead the development of several key U.S. Department of Defense policies and strategies in 2018 and 2019.
Shanahan also provided critical leadership in the creation of the Space Force and execution of the first-ever full-scope U.S. Department of Defense financial statement audit. He was a champion of digital and technological advancement for the department, spearheading modernization in cybersecurity, artificial intelligence, cloud computing and command, control and communication. Shanahan also established the Joint Artificial Intelligence Center in 2018 and published The Department of Defense's Artificial Intelligence Strategy.
Shanahan previously served as Senior Vice President, Supply Chain & Operations at The Boeing Company. He joined Boeing in 1986, becoming involved in Computer Services and the Boeing 777 program. Over the course of his career, he held management roles with respect to the Boeing Defense Systems, as well as 737, 747, 767, 777, and 787 commercial airline programs. He served at Boeing until 2017.
Patrick M. Shanahan is a National Academy of Engineering Member, a Royal Aeronautical Society Fellow, a Society of Manufacturing Engineers Fellow and an American Institute of Aeronautics and Astronautics Associate Fellow. He also served as a regent at the University of Washington for over five years.
Mr. Shanahan holds a Bachelor of Science degree in mechanical engineering from the University of Washington and two advanced degrees from the Massachusetts Institute of Technology.
For more on CAE's Board of Directors, click here.
CAE is a high technology company, at the leading edge of digital immersion, providing solutions to make the world a safer place. Backed by a record of 75 years of industry firsts, we continue to reimagine the customer experience and revolutionize training and operational support solutions in civil aviation, defence and security, and healthcare. We are the partner of choice to customers worldwide who operate in complex, high-stakes and largely regulated environments, where successful outcomes are critical. As testament to our customers' ongoing needs for our solutions, over 60 percent of CAE's revenue is recurring in nature. We have the broadest global presence in our industry, with approximately 13,000 employees, 180 sites, and training locations in over 35 countries. www.cae.com
Follow us on Twitter: CAE_Inc
Facebook: www.facebook.com/cae.inc
LinkedIn: www.linkedin.com/company/cae
Hashtags: #CAE; #CAEpilot
View original content to download multimedia:
SOURCE CAE INC.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/caesars-entertainment-inc-report-2022-first-quarter-results-may-3-2022/
|
LAS VEGAS and RENO, Nev., April 1, 2022 /PRNewswire/ -- Caesars Entertainment, Inc. (NASDAQ: CZR) will release its financial results for the first quarter 2022 after the market closes on Tuesday, May 3, 2022. The company will also host a conference call on May 3, 2022 at 5:00 p.m. Eastern Time, 2:00 p.m. Pacific Time, to discuss its results and other matters related to the company.
Participants should dial (833) 665-0647, or (914) 987-7309 for international callers, and enter Conference ID 8183518 approximately 10 minutes before the call start time. The call will be accessible on the Investor Relations section of Caesars Entertainment's website at https://investor.caesars.com.
A recording of the live call will be available on the Investor Relations section of the Company's website for 90 days after the event.
Caesars Entertainment, Inc. (NASDAQ: CZR) is the largest casino-entertainment company in the US and one of the world's most diversified casino-entertainment providers. Since its beginning in Reno, NV, in 1937, Caesars Entertainment, Inc. has grown through development of new resorts, expansions and acquisitions. Caesars Entertainment, Inc.'s resorts operate primarily under the Caesars®, Harrah's®, Horseshoe®, and Eldorado® brand names. Caesars Entertainment, Inc. offers diversified gaming, entertainment and hospitality amenities, one-of-a-kind destinations, and a full suite of mobile and online gaming and sports betting experiences. All tied to its industry-leading Caesars Rewards loyalty program, the company focuses on building value with its guests through a unique combination of impeccable service, operational excellence and technology leadership. Caesars is committed to its employees, suppliers, communities and the environment through its PEOPLE PLANET PLAY framework. Know When To Stop Before You Start®. Gambling Problem? Call 1-800-522-4700. For more information, please visit. www.caesars.com/corporate.
View original content to download multimedia:
SOURCE Caesars Entertainment, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/cardinal-health-webcast-discussion-third-quarter-results-fiscal-year-2022-may-5/
|
DUBLIN, Ohio, April 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
To access the webcast and corresponding slide presentation, go to the Investor Relations page at ir.cardinalhealth.com. No access code is required. Presentation slides and a webcast replay will be available until May 4, 2023.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for health care facilities. With 50 years in business, operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
View original content to download multimedia:
SOURCE Cardinal Health
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/casi-pharmaceuticals-statement-status-under-holding-foreign-companies-accountable-act/
|
ROCKVILLE, Md. and BEIJING, April 1, 2022 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced today that on March 30, 2022, the Securities and Exchange Commission (SEC) provisionally identified CASI Pharmaceuticals Inc (CASI) on the list, pursuant to the Holding Foreign Companies Accountable Act (HFCAA), that uses an auditor not subject to Public Company Accounting Oversight Board (PCAOB) inspection.
This identification was anticipated, by the Company, as a routine application of the HFCAA, as we recently filed an annual report, via Form 10K, with the SEC on March 28, 2022. We are evaluating strategic options, which include but are not limited to adding business processes and control to meet the requirements of the HFCAA.
About CASI Pharmaceuticals
CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing, and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the Greater China market, leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd., located in Beijing, China. The Company has built a commercial team of more than 100 hematology and oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.
Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, revenue growth, strategies, expectations and goals. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and we assume no duty to update forward-looking statements. New factors emerge from time to time, and it is not possible for us to predict which factors will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Actual results could differ materially from those currently anticipated due to a number of factors.
View original content to download multimedia:
SOURCE CASI Pharmaceuticals, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/centene-hold-2022-annual-meeting-following-2022-first-quarter-financial-results-conference-call/
|
– Live Audio Webcast of Annual Meeting Available –
ST. LOUIS, April 1, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that following the release of its 2022 first quarter financial results on Tuesday, April 26, 2022, the Company will hold its 2022 Annual Meeting of Stockholders at 11:00 a.m. (Eastern Time)/10:00 a.m. (Central Time) in the auditorium at Centene's headquarters, 7700 Forsyth Boulevard, St. Louis, Missouri. At the meeting, Centene is expected to make remarks regarding the Company's performance and future prospects. A live audio webcast of the meeting can be accessed via the Company's website at www.centene.com under the Investors section.
About Centene Corporation
Centene Corporation, a Fortune 25 company, is a leading healthcare enterprise that is committed to helping people live healthier lives. The Company takes a local approach – with local brands and local teams – to provide fully integrated, high-quality, and cost-effective services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Centene offers affordable and high-quality products to nearly 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace, the TRICARE program, and individuals in correctional facilities. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene focuses on long-term growth and the development of its people, systems and capabilities so that it can better serve its members, providers, local communities, and government partners.
Centene uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Centene is routinely posted and is accessible on Centene's investor relations website, http://investors.centene.com.
View original content:
SOURCE Centene Corporation
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/clearlake-capital-backed-wheel-pros-acquires-teraflex/
|
Strategic Acquisition Expands Wheel Pros' Suspension and Performance Shock Product Offerings
GREENWOOD VILLAGE, Colo. and WEST JORDAN, Utah, April 1, 2022 /PRNewswire/ -- Wheel Pros, a designer, manufacturer and distributor of proprietary branded aftermarket vehicle enhancements for light trucks, SUVs, passenger cars and ATVs/UTVs backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and in partnership with management, today announced it has acquired TeraFlex (or "the Company"), a designer, manufacturer and distributor of aftermarket suspensions, shocks, and other components for automotive and off-roading enthusiasts. TeraFlex's Founder and CEO Mark Falkner, President Benjamin Falkner, and VP of Organizational Development Ian Falkner will remain with the combined company. Financial terms of the transaction were not disclosed.
"TeraFlex has built an impressive suite of brands and products in the suspension and shock categories that complement our offerings in lift kits extremely well," said Randy White, Co-Founder and CEO, and Brian Henderson, Chief Strategy Officer, at Wheel Pros. "We are excited to partner with Mark, Ben, Ian and the broader TeraFlex team to scale our combined business and continue to expand our suite of aftermarket vehicle enhancements for automotive and off-roading enthusiasts."
Headquartered in West Jordan, Utah, TeraFlex is a designer, manufacturer and distributor of aftermarket suspensions, shocks, dampers, steering, axles, and other components for the Jeep Wrangler. TeraFlex has established brands, such as Falcon, and in-house product development capabilities that deliver high performance, quality products. TeraFlex operates three domestic U.S. facilities and sells 3,470 distinct product SKUs across 24 core product families. The Company distributes its products to 1,250+ dealers and 500+ total customers across 47 U.S. states and 35 countries globally.
"We're excited to join the Wheel Pros organization and leverage their design expertise, scale and operational footprint to accelerate growth," said Mr. Falkner. "We believe we can expand on Wheel Pros' existing footprint in the suspension category, and together, provide automotive enthusiasts with access to a larger suite of aftermarket vehicle enhancements. We look forward to embarking on this next chapter of combined growth."
"The talented TeraFlex team has created a high growth platform with a robust suite of brands in the aftermarket suspension and shock categories," said José E. Feliciano, Co-Founder and Managing Partner, and Colin Leonard, Partner, at Clearlake. "We look forward to expanding the product breadth and distribution footprint of the combined Wheel Pros platform through increased investment and by utilizing our O.P.S.® framework to better serve automotive and off-roading enthusiasts."
"Wheel Pros has historically demonstrated its ability to enter new adjacent product categories both organically and through acquisition, and then drive accelerated growth in these new categories," added Dilshat Erkin, Senior Vice President at Clearlake. "We are eager to welcome TeraFlex to the Wheel Pros organization and to execute on its proven playbook in the attractive enthusiast suspension and shock segments."
ABOUT WHEEL PROS
Founded in 1995, Wheel Pros serves the automotive enthusiast industry with a wide selection of vehicle enhancements from its portfolio of lifestyle brands, including Fuel-Off-Road, American Racing, KMC, Rotiform and Black Rhino. Utilizing its expanding global network of distribution centers spanning North America, Australia and Europe, Wheel Pros serves over 13,500 retailers and has a growing ecommerce presence to provide enthusiast consumers with access to the products they desire. More information is available at www.wheelpros.com.
ABOUT TERAFLEX
TeraFlex is a designer, manufacturer and distributor of aftermarket suspensions, shocks, dampers, steering, axles, and other components for the Jeep Wrangler. Founded in 1996, TeraFlex has developed a strong reputation for manufacturing quality with the support of 230 employees across three domestic U.S. facilities. TeraFlex sells 3,470 distinct product SKUs across 24 core product families to 1,250+ dealers and 500+ total customers in 47 U.S. states and 35 countries globally. More information if available at www.teraflex.com.
ABOUT CLEARLAKE
Clearlake Capital Group, L.P. is an investment firm founded in 2006 operating integrated businesses across private equity, credit and other related strategies. With a sector-focused approach, the firm seeks to partner with management teams by providing patient, long-term capital to businesses that can benefit from Clearlake's operational improvement approach, O.P.S.® The firm's core target sectors are industrials, technology, and consumer. Clearlake currently has approximately $70 billion of assets under management, and its senior investment principals have led or co-led over 300 investments. The firm is headquartered in Santa Monica, CA with affiliates in Dallas, TX, London, UK and Dublin, Ireland. More information is available at www.clearlake.com and on Twitter @Clearlake.
Contact
For Wheel Pros:
Max Krapff
Backbone Media
970.658.5252 ext. 1174
max.krapff@backbone.media
For Clearlake:
Jennifer Hurson
Lambert & Co.
+1 845-507-0571
jhurson@lambert.com
View original content to download multimedia:
SOURCE Wheel Pros; Clearlake Capital Group
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/cold-stone-creamery-welcomes-spring-with-new-peeps-flavored-ice-cream/
|
Bright and Cheerful Colors of the Season Shine in Limited Time Flavor
SCOTTSDALE, Ariz., April 1, 2022 /PRNewswire/ -- Spring has sprung and this year, Cold Stone Creamery is highlighting one of the tastiest treats of the season with our new PEEPS® Flavored Ice Cream. PEEPS® lovers will delight in the instantly-recognizable bright yellow hue and Marshmallow-y flavor featured in both an engaging Creation™ and Shake. The new PEEPS® Flavored Ice Cream will be available beginning April 1 at Cold Stone Creamery® (www.ColdStoneCreamery.com).
Put a little spring in your step with our PEEPS® Sweet Spring Creation™ featuring PEEPS® Flavored Ice Cream mixed with Whipped Topping and Blue Sugar Crystals and topped with a Yellow PEEPS® Marshmallow Chick.
For the shake lovers who prefer to sip on the flavors of spring, our Shaking it up with my PEEPS® Shake is made with PEEPS® Flavored Ice Cream and topped with Whipped Topping, Blue Sugar Crystals and a Yellow PEEPS® Marshmallow Chick!
"Cold Stone Creamery is thrilled to partner with Just Born and PEEPS® to create a new PEEPS® Marshmallow flavor that captures the sunny essence of Spring," said Sara Schmillen, vice president of marketing at Kahala Brands™, parent company of Cold Stone Creamery®. "We love both being a part of making family memories and bringing back memories for the young at heart – and ice cream that tastes just like PEEPS® does just that!"
The PEEPS® Flavored Ice Cream, Creation™ and Shake will be available in Cold Stone Creamery® stores nationwide until May 10.
Promotional Flavor:
- PEEPS® Flavored Ice Cream
Promotional Creation™:
- PEEPS® Sweet Spring™ – PEEPS® Flavored Ice Cream mixed with Whipped Topping and Blue Sugar Crystals and topped with a Yellow PEEPS® Marshmallow Chick.
Promotional Shake:
- Shaking it up with my PEEPS® Shake™ – PEEPS® Flavored Ice Cream topped with Whipped Topping, Blue Sugar Crystals and a Yellow PEEPS® Marshmallow Chick
About Cold Stone Creamery
Cold Stone Creamery® delivers the Ultimate Ice Cream Experience® through a community of franchisees who are passionate about ice cream. The secret recipe for smooth and creamy ice cream is handcrafted fresh daily in each store, and then customized by combining a variety of mix-ins on a frozen granite stone. Headquartered in Scottsdale, Arizona, Cold Stone Creamery is owned by parent company Kahala Brands™, one of the fastest growing franchising companies in the world with a portfolio of nearly 30 fast-casual and quick-service restaurant brands with approximately 3,000 locations in 35 countries. The Cold Stone Creamery brand operates nearly 1,500 locations globally in approximately 30 countries worldwide.
For more information about Cold Stone Creamery, visit www.ColdStoneCreamery.com.
About Just Born Quality Confections:
Just Born Quality Confections is a third-generation family-owned candy manufacturer with its purpose to bring sweetness to people's lives. Just Born is the maker of some of America's most beloved and iconic brands – PEEPS®, MIKE AND IKE®, HOT TAMALES® and GOLDENBERG'S® PEANUT CHEWS®. In 1923, the founder, Sam Born, opened a small candy shop in Brooklyn, New York, where he marketed the freshness of his daily-made candy with a sign that declared, "Just Born." Together with Born's brothers-in-law, Irv and Jack Shaffer, the company thrived and, in 1932, moved its operations to Bethlehem, PA where it has grown to become one of the largest candy companies in the US by giving back to the community, being good environmental stewards and creating a culture where people want to work. For more information, please visit www.justborn.com (and see the breadth of candy and high-quality branded items at www.peepsandcompany.com) Follow us: facebook.com/JustBornInc, twitter.com/JustBornInc.
View original content to download multimedia:
SOURCE Cold Stone Creamery
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/consumers-dental-choice-salutes-worldwide-decision-protect-children-pregnant-women-mercury-dental-fillings/
|
WASHINGTON, April 1, 2022 /PRNewswire/ -- In a stunning turn of world opinion, the nations of the world have united to call for ending dental amalgam use in children and women who are pregnant or breastfeeding.
Dental amalgam is a controversial filling material that is approximately 50% mercury (although deceptively marketed as "silver fillings"). On 26 March, at the 4th Conference of the Parties to the Minamata Convention on Mercury, a treaty of more than 130 nations, the Parties unanimously agreed to an amendment requiring countries to protect vulnerable populations from further use of dental amalgam:
"…Exclude or not allow, by taking measures as appropriate, or recommend against the use of dental amalgam for the dental treatment of deciduous teeth [baby teeth], of patients under 15 years and of pregnant and breastfeeding women…"
Charlie Brown, president of the World Alliance for Mercury-Free Dentistry and executive director of Consumers for Dental Choice, hailed the action: "The world unites to say that mercury is not safe in the mouths of children and their mothers – and its use must stop, this year."
"We salute the nations of Africa, all 54 of them, for initiating and presenting this splendid proposal," Brown said. "Too, we praise the World Health Organization for calling for a worldwide switch to 'minimally-invasive' and mercury-free dental materials."
Brown added that manufacturers and distributors of this toxic product are on notice to stop selling amalgam – because once they sell it, much of it is implanted into children, pregnant women, and breastfeeding mothers.
"Dentists must stop placing amalgam in children and in young women – now." Brown cautioned. "This new amendment represents a worldwide consensus that dental amalgam is not safe for children and other vulnerable populations – it is not safe in their mouths and it is not safe in their environment."
The US Food and Drug Administration, since 2020, and Health Canada, since the 1990s, already recommend the end of amalgam use for children and for pregnant women.
Contact Charlie Brown, 202.246.7642 (cell), 202.544.6333 (ofc.)
View original content:
SOURCE Consumers for Dental Choice
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/distracted-driving-kills-nsc-urges-roadway-users-just-drive/
|
Since its inception 12 years ago, Distracted Driving Awareness Month aims to bring attention to the deadly issue and what can be done to combat it
ITASCA, Ill., April 1, 2022 /PRNewswire/ -- April is Distracted Driving Awareness Month, an observance the National Safety Council brings to national attention by sharing safe driving resources and personal safety stories. NSC urges all people to be attentive behind the wheel and just drive during April and all months.
Preliminary estimates show more than 46,000 people died in preventable crashes on U.S. roads in 2021, a 9% increase over 2020. While causation is not yet detailed, reckless behaviors such as speeding, lack of seat belt use and distracted driving all continue to plague our roads. Mobile devices and in-vehicle systems are often the culprit in distracted driving incidents, while other distractions, such as interacting with passengers, eating, fatigue as well as stress, also contribute to these crashes.
"We can all share a story of witnessing distracted driving," said Mark Chung, executive vice president of roadway practice at NSC. "Whether we are behind the wheel, a passenger, riding a bicycle, or even walking, we see it every day. I urge us all to take responsibility to stop distracted driving. Every road user must put safety first for themselves and others by allowing each other to just drive."
Each year, distracted driving kills more than 3,000 people or approximately eight people each day. That's eight parents, children, friends and co-workers, and we know this number is severely underreported. Yet, many people continue to drive distracted despite the known dangers and threats it brings to U.S. roads. The consequences are deadly; Tom Goeltz, a longtime safety professional, is someone who knows that type of loss heartbreakingly well.
"In 2016, my daughter Megan and her unborn child were killed in a car crash by a distracted driver," said Goeltz, who is a member of the NSC Survivor Advocate Network. "Our family has never been the same, and we have since dedicated our lives to advocating for stricter laws around distracted driving and educating people on the dangers of it. From the bottom of my heart, please take safety seriously and don't drive distracted; if someone had made a safer choice, my daughter and grandchild may still be here today."
Distracted driving takes the lives of people of all ages but particularly some of our youngest road users: teens. Car crashes are the leading cause of preventable death for teens, and NSC offers resources to help save younger, as well as older, lives on our roads:
- Utilize resources from DriveitHOME™, an initiative of the National Safety Council to help teens build experience behind the wheel including The New Driver Deal, a parent-teen driving agreement, and Pointers for Parents, a comprehensive collection of driving lessons designed around the changing experience levels of teen drivers.
- Download our free report: Understanding Driver Distraction. The report offers compelling evidence and concludes that the safest option is to completely eliminate driver use of cell phones and interactive, in-vehicle infotainment systems. The report also includes recommendations for drivers, employers, legislators and manufacturers.
- Join our Distracted Driving Awareness Month Twitter chat at 12 p.m. ET on Wednesday, April 13 to learn about distracted driving, ask questions about roadway safety and engage with other organizations focused on keeping workers safe on the road. Use the hashtag #JustDrive22 to be included in the conversation.
- Take the NSC Just Drive Pledge and commit to drive distraction-free.
- Donate to NSC to help make roads safer for all road users.
- Understand that multitasking is a myth, and there is no safe way to use a cell phone while driving.
- Visit nsc.org/justdrive for ready-to-use resources to share in your workplace and community.
If someone you know was killed or seriously injured in a distracted driving-related crash, please consider joining the NSC network of survivor advocates. Safety is personal, and NSC wants to help share your story to save lives.
About the National Safety Council
The National Safety Council is America's leading nonprofit safety advocate – and has been for over 100 years. As a mission-based organization, we work to eliminate the leading causes of preventable death and injury, focusing our efforts on the workplace, roadway and impairment. We create a culture of safety to not only keep people safer at work, but also beyond the workplace so they can live their fullest lives.
Connect with NSC:
Facebook
Twitter
LinkedIn
YouTube
Instagram
View original content to download multimedia:
SOURCE National Safety Council
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/dorian-lpg-ltd-announces-completion-two-japanese-financing-transactions/
|
STAMFORD, Conn., April 1, 2022 /PRNewswire/ -- LPG Ltd. (NYSE: LPG) (the "Company" or "Dorian LPG"), a leading owner and operator of modern and ECO very large gas carriers ("VLGCs"), today announced that it completed two Japanese financing transactions on March 29 and 31, 2022.
On March 29, 2022, Dorian LPG completed a $64.9 million sale and bareboat charter arrangement for its 2015-built VLGC Chaparral, of which $24.0 million was used to prepay a portion of the 2015 AR Facility (as defined in the Company's most recently filed Form 10-Q), and the balance of which will be used for general corporate purposes. This Japanese financing arrangement has a seven (7) year term plus three (3) option years with no purchase obligation, purchase options beginning on March 29, 2027, and principal and interest totaling $476,500 per month in a mortgage-style debt amortization profile.
On March 31, 2022, Dorian LPG completed a $71.5 million sale and bareboat charter arrangement for its 2016-built VLGC Caravelle resulting in cash proceeds of $50.0 million, of which $24.8 million was used to prepay a portion of the 2015 AR Facility, and the balance of which will be used for general corporate purposes. The financing has a ten (10) year term with purchase options beginning on March 31, 2025, and an average monthly principal and interest payment over the life of the financing of roughly $414,200.
Forward-Looking & Other Cautionary Statements
This press release contains "forward-looking statements." Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "may," "will," "should" and similar expressions are forward-looking statements. These statements are not historical facts but instead represent only the Company's current expectations and observations regarding future results, many of which, by their nature are inherently uncertain and outside of the Company's control. Where the Company expresses an expectation or belief as to future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. However, the Company's forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by those forward-looking statements. The Company's actual results may differ, possibly materially, from those anticipated in these forward-looking statements as a result of certain factors, including changes in the Company's financial resources and operational capabilities and as a result of certain other factors listed from time to time in the Company's filings with the U.S. Securities and Exchange Commission. For more information about risks and uncertainties associated with Dorian LPG's business, please refer to the "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" sections of Dorian LPG's SEC filings, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. The Company does not assume any obligation to update the information contained in this press release.
About Dorian LPG Ltd.
Dorian LPG is a liquefied petroleum gas shipping company and a leading owner and operator of modern VLGCs. Dorian LPG's fleet currently consists of 22 modern VLGCs. Dorian LPG has offices in Stamford, Connecticut, USA; Copenhagen, Denmark; and Athens, Greece.
Visit our website at www.dorianlpg.com
For further information:
Dorian LPG Ltd.
Ted Young
Chief Financial Officer
(203) 674-9900
IR@dorianlpg.com
Source: Dorian LPG Ltd.
View original content:
SOURCE Dorian LPG Ltd.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/dpc-labs-announces-launch-athlete-nft-player-cards-dpc-marketplace/
|
Revolutionary Technology Company Launches Premier NFT Marketplace for All Athletes
MIAMI, April 1, 2022 /PRNewswire/ -- DPC Labs, a Miami-based sports technology company, announced the launch today of their NFT sports marketplace highlighted by their highly anticipated NFT digital player cards hosted on the Solana blockchain network. The DPC Labs NFT marketplace will feature NFT player cards of athletes of all ranks from Youth sports, High School, College and Professional sports.
Youth and Amateur athletes will be able to pay to create their own NFT player card that themselves, friends, and family can own as exclusive memorabilia. DPC enables Youth and Amateur athletes to have the same quality of player cards as their favorite college and professional athletes. College and Professional athletes are partnering with DPC Labs to bring their digital player cards to life through a unique model that aims to generate income on their valuable NIL (Name, Image, and Likeness), open a new engagement between athletes and fans, and most importantly, educate athletes about the expansive potential of the Web3 space.
DPC Labs initial launch of player cards will feature a diverse mix of youth, collegiate and professional athletes that believe in the company and their technology. The notable list of athletes includes: Ahmmon Richards, University of Miami Football, B.J. Johnson, Orlando Magic, Sam Singer, University of California Berkeley Basketball, Jhon Matos, seven-time Boxing National Champion and an array of other impressive athletes. In addition to the player card, athletes involved will be providing card holders utility in the form of extra incentives. Examples of incentives for card holders include but aren't limited to, exclusive access to events, merchandise & memorabilia, meet & greet opportunities, or a virtual FaceTime with the athlete; all intended to foster an exclusive level of engagement awarded to card holders of an athlete.
DPC Labs founding team consists of Daniel Pardo, Founder and CEO, Khambrel Roach, Co-Founder and COO, Jacob Byck, Co-Founder and CFO and Sherer Junior Desinor, Co-Founder and Head of Business Growth.
The DPC player cards are designed by the company's Head of Design, Helmi Kemppaine. Kemppaine is a world-class designer whose expertise brings a great dynamic to the team in the creation of the DPC player cards.
To commemorate the launch, the DPC Labs team will be exhibiting at Miami NFT Week from April 1-3, 2022 at the Mana Wynwood Convention Center in Miami, FL. The three-day event features over 200 speakers, including DPC Labs CEO, Daniel Pardo.
"DPC Labs strives to be a digital player card platform for all athletes of all genders and sports," said Daniel Pardo, Founder and CEO. "The support we've received thus far has been amazing and we can't wait for athletes and sports fans to own DPC player cards."
"Web3 is an expansive network medium creating new avenues for athletes to take ownership of their name, image and likeness and leverage their value in creative ways," said Khambrel Roach, Co-Founder and COO. "By connecting athletes of all ages to their fans through digital player card NFTs, we believe this will further adoption of NFTs a viable business asset and will lead to deeper connections between athletes and their micro communities."
To learn more about DPC Labs, please visit: http://www.dpc-nft.com/.
Connect / Follow DPC Labs
Instagram | Twitter
View original content to download multimedia:
SOURCE DPC Labs
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/e7-solutions-launches-7000-scholarship-support-education-tech/
|
Deadline to Apply is April 15, 2022
TROY, MIich., April 1, 2022 /PRNewswire/ -- E7 Solutions has announced a scholarship of $7,000 to be awarded to a qualified high school senior or higher or undergrad student pursuing a technology-related field of study.
E7 Solutions is represented by its team through core values built on creativity, drive, authenticity, curiosity, and most importantly, working together. It's important that we present ourselves to each other, our clients, and our partners in a way that demonstrates these values.
We are a team that strongly believes in the significance of education and understands the hard work, dedication, and financial burden involved in earning a degree.
To be considered for the award, you must meet these qualifications:
- Be a high school senior with a 3.0 GPA or higher OR an undergrad student with a 3.5 GPA or higher
- In need of financial support
- Pursuing an IT-related degree
The deadline to submit your application is April 15, 2022. The winner of the scholarship will be announced in May 2022. Apply today at https://www.e7solutions.com/scholarship.
About E7 Solutions
As an Atlassian Platinum Solution Partner, E7 Solution's mission is to enhance the velocity of information for our clients, so they can deliver their best and most meaningful work. For three consecutive years, we have been recognized by Atlassian for our performance using best practices and a proven methodology that delivers outstanding results to our clients: 2020 Partner of the Year Cloud Services, 2019 Partner of the Year Cloud, and 2018 Rising Star.
Contact: (248) 606-4612, sarah.kozubiak@e7solutions.com
View original content:
SOURCE E7 Solutions
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/eats-completes-acquisition-mylk-brands-inc/
|
VANCOUVER, BC, April 1, 2022 /PRNewswire/ - Eat & Beyond Global Holdings Inc. ("EATS" or the "Company") (CSE: EATS) (OTCPK: EATBF) (FSE: 988) is pleased to announce the completion today of the arrangement previously announced on January 24, 2022 (the "Arrangement") under the Business Corporations Act (British Columbia) (the "BCBCA"), pursuant to which EATS acquired all of the issued and outstanding common shares of Mylk Brands Inc. ("Mylk"). The Arrangement was overwhelmingly approved by the shareholders of Mylk (the "Mylk Shareholders") in accordance with the requirements of the BCBCA at a special meeting of the Mylk Shareholders held on March 8, 2022 (the "Mylk Meeting"), and was subsequently approved by the Supreme Court of British Columbia on March 11, 2022.
Pursuant to the terms of the Arrangement, each common share in the capital of Mylk (a "Mylk Share") has been exchanged for common shares in the capital of EATS (an "EATS Share"), being the number of EATS Shares equal to the quotient of (i) $11,500,000 divided by the deemed price of $0.52 per Common Share, divided by (ii) the number of Mylk Shares outstanding immediately prior to closing of the Arrangement (the "Exchange Ratio"). In completing the acquisition, EATS has issued 22,115,310 EATS Shares to former Mylk Shareholders. Following completion of the Arrangement, EATS has beneficial ownership and control over 100% of the issued and outstanding Mylk Shares.
A direct registration statements ("DRS Statement") representing the EATS Shares each former holder of Mylk Shares is entitled to received under the Arrangement will be delivered by Olympia Trust Company, the transfer agent of the Company, to the address of such holder as shown on the register of Mylk Shares.
Mylk, a British Columbia corporation, is the sole shareholder of Fresh Start Beverage Company d/b/a Banana Wave. Banana Wave is based in Boca Raton, Florida. Banana Wave's beverages are made from fiber-rich oats and real bananas. They are available in five different flavors: original, unsweetened original, mango, chocolate, and strawberry. All varieties are dairy-free, gluten-free, soy-free, and non-GMO with 65 to 90 calories, and contain Vitamin B2, Vitamin B12. Vitamin C and Vitamin E.
EATS is an investment issuer that makes it easy to invest in the future of food. EATS identifies and makes equity investments in global companies that are developing and commercializing innovative food tech as well as plant-based and alternative food products. Led by a team of food industry experts, EATS is the first issuer of its kind in Canada, providing retail investors with the unique opportunity to participate in the growth of a broad cross-section of opportunities in the alternative food sector, and access companies that are leading the charge toward a smarter, more secure food supply.
Learn more: https://eatbeyondglobal.com/
Find Eat Beyond on Social Media on LinkedIn, Instagram, Twitter and Facebook.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
The Canadian Securities Exchange has not in any way passed upon the merits of the Transaction and has neither approved nor disapproved the contents of this press release.
The securities to be issued in connection with the Transaction have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "1933 Act"), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.
View original content to download multimedia:
SOURCE Eat Beyond Global Holdings Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/edu-shareholder-alert-jakubowitz-law-reminds-new-oriental-shareholders-lead-plaintiff-deadline-april-5-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of New Oriental Education & Technology Group Inc. (NYSE: EDU).
To receive updates on the lawsuit, fill out the form:
The lawsuit seeks to recover losses for shareholders who purchased New Oriental between April 24, 2018 and July 22, 2021.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until April 5, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, New Oriental Education & Technology Group Inc. issued materially false and/or misleading statements and/or failed to disclose that: (a) New Oriental's revenue and operational growth was the result of deceptive marketing tactics and abusive business practices that flouted Chinese regulations and policies and exposed the Company to an extreme risk that more draconian measures would be imposed on the Company; (b) New Oriental had engaged in misleading and fraudulent advertising practices, including the provision of false and misleading discount Information designed to obfuscate the true cost of the Company's programs to its customers; (c) New Oriental had falsified teacher qualifications and experience in order to attract customers and increase student enrollments; (d) New Oriental had defied prior government warnings against linking school enrollments with the provision of private tutoring services; (e) as a result of the foregoing, New Oriental was subject to an extreme undisclosed risk of adverse enforcement actions, regulatory fines and penalties, and the imposition of new rules and regulations adverse to the Company's business and interests; and (f) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and lacked a reasonable, factual basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/eric-shareholder-alert-jakubowitz-law-reminds-telefonaktiebolaget-lm-ericsson-shareholders-lead-plaintiff-deadline-may-2-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/telefonaktiebolaget-lm-ericsson-loss-submission-form/?id=25395&from=4
The lawsuit seeks to recover losses for shareholders who purchased Telefonaktiebolaget LM Ericsson between April 27, 2017 and February 25, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until May 2, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Telefonaktiebolaget LM Ericsson issued materially false and/or misleading statements and/or failed to disclose that: (i) Ericsson overstated the extent to which it had reformed its business practices to eliminate the use of bribes to secure business in foreign countries; (ii) Ericsson had paid bribes to the terrorist group the Islamic State in Iraq and Syria to gain access to certain transport routes in Iraq; (iii) accordingly, the Company's revenues derived from its operations in Iraq were, in at least substantial part, derived from unlawful conduct and thus unsustainable; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/fb-shareholder-alert-jakubowitz-law-reminds-meta-platforms-inc-shareholders-lead-plaintiff-deadline-may-9-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Meta Platforms, Inc. (NASDAQ: FB).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/meta-platforms-inc-loss-submission-form/?id=25398&from=4
The lawsuit seeks to recover losses for shareholders who purchased Meta Platforms, Inc. between March 2, 2021 and February 2, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until May 9, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Meta Platforms, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (1) Apple's iOS privacy changes were having a material impact on Meta's ability to provide the kind of targeted advertising that its customers wanted and, as a result, customer ad spending was dropping precipitously; (2) Meta's mitigation efforts were either not properly implemented or ineffective; (3) measurement of ads was not accurate as mitigation efforts were failing; and (4) Meta did not have a plan in place to properly address the impact of the iOS privacy changes.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/federal-home-loan-bank-chicago-announces-new-grant-programs-aimed-increased-diversity-affordable-housing-development-small-business-growth/
|
CHICAGO, April 1, 2022 /PRNewswire/ -- The Federal Home Loan Bank of Chicago (FHLBank Chicago) today announced three program offerings designed to address critical affordable housing and community economic development needs in Illinois and Wisconsin. Two new programs target affordable housing development and access, while an enhanced capacity building program will bring needed support to small businesses.
"Our 2022 Targeted Community Lending Plan identified opportunities for additional investment in the diverse communities we serve throughout Illinois and Wisconsin," said Katie Naftzger, Vice President, Community Investment Officer, FHLBank Chicago. "To improve outcomes and expand access to opportunities for new housing developers, homebuyers, and small businesses, we are bringing new resources to the table. Our three new programs will create lasting impact for individuals and communities and increase scale in the marketplace, from which all FHLBank Chicago member financial institutions will benefit, as well."
The Community First® Diverse Developer Initiative and the Community First® Housing Counseling Resource Program offer grants and support to bring diverse and underserved developers and homebuyers into the housing market. FHLBank Chicago will also shift its existing Community First® Capacity-Building Grant Program to focus on small businesses in 2022, with the rollout of the new Community First® Accelerate Grants for Small Business. This program will provide flexible grant funds to strengthen small businesses located in Illinois and Wisconsin.
In total, FHLBank Chicago has committed $11.25 million to support these programs for three years (2022-2024). These programs reflect an ongoing commitment to diversity, equity, and inclusion and will deliver lasting impact for individual beneficiaries, members, and their communities. Since 1989, FHLBank Chicago has awarded more than $790 million in grants and funds to help provide housing for low- and moderate-income eligible households and to support small businesses. These new programs will broaden that support.
"We continue to innovate and create new programs to address the needs of our members' communities across Illinois and Wisconsin," said Michael Ericson, President and CEO of FHLBank Chicago. "These new voluntary programs build on the success of our Affordable Housing Program General Fund, Downpayment Plus®, the Community First® Fund, the Community First® Capacity-Building Grant Program and the Community First® Disaster Relief Program. This is just one more way the Federal Home Loan Bank of Chicago fulfills its mission to support our members' community investment activities."
Community First® Diverse Developer Initiative
The Community First® Diverse Developer Initiative (Diverse Developer Initiative) will provide grant funds to support career/talent development initiatives for diverse developers of affordable housing in Illinois and Wisconsin. This program grew out of discussions with FHLBank Chicago's Community Investment Advisory Council, a group of industry leaders in Illinois and Wisconsin that informs FHLBank Chicago's affordable housing and community lending strategy. The Advisory Council's Racial Equity Working Group identified a critical need for resources to advance diversity and equity within the affordable housing development industry.
"It is inspiring to see the Federal Home Loan Bank of Chicago not only leading initiatives to support equity and inclusion, but doing so in a creative and intentional manner that is tied to tangible, objective goals and outcomes," said Kevin Newell, founder and CEO of Royal Capital. "I'm confident that this Diverse Developer Initiative will serve as a playbook for future efforts to increase minority representation in housing development and improve the landscape and trajectory of our communities."
Eligible beneficiary organizations include, but are not limited to: Diverse development firms seeking to expand expertise; Talent development programs dedicated to increasing diversity within the affordable housing industry; Trade/professional associations that support diverse developers; and Established development firms seeking to offer internship opportunities to diverse developers. Grant funds may be used to support diverse developers in one of three tracks: Internships, Training, or Mission-Driven Investments. The competitive application round for the Diverse Developer Initiative will open Monday, April 4, and close on Friday, May 13.
Community First® Housing Counseling Resource Program
The Community First® Housing Counseling Resource Program (Housing Counseling Resource Program) will provide grants to housing counseling agencies in Illinois and Wisconsin to facilitate expanded service to minority and low- and moderate-income homebuyers. Two FHLBank Chicago housing associates, Illinois Housing Development Authority (IHDA) and Wisconsin Housing and Economic Development Authority (WHEDA), will administer the Housing Counseling Resource Program on behalf of FHLBank Chicago.
Eligible beneficiary organizations include HUD-approved housing counseling organizations in Illinois and Wisconsin. The organizations can use grant funds for capacity-building activities that expand organizational reach to minority and low- and moderate-income homebuyers, including but not limited to: Marketing and outreach activities; Program staffing (e.g., hiring an additional housing counselor or a bilingual staff person, allocating a percentage of staff time to working in underserved communities, etc.); and Technology upgrades that facilitate expanded service to these underserved populations.
"IHDA is committed to removing barriers and making housing safe, affordable, and stable for everyone regardless of race, ethnicity, or income," said IHDA Executive Director Kristin Faust. "The Housing Counseling Resource Program will provide vital education and resources to assist households that continually think homeownership is out of reach. IHDA is proud to partner with FHLBank Chicago to make the dream of homeownership a reality in communities throughout the state."
Community First® Accelerate Grants for Small Business
FHLBank Chicago will also roll out the Community First® Accelerate Grants for Small Business (Accelerate Grants) in 2022, as a pivot from its previous Community First® Capacity-Building Grant Program focused on nonprofit community lenders. Accelerate Grants will provide flexible grant funds to strengthen small businesses located in Illinois and Wisconsin. The application round will open on Monday, August 1 and close on Friday, September 9.
About the Federal Home Loan Bank of Chicago
The mission of the Federal Home Loan Bank of Chicago is to partner with our members in Illinois and Wisconsin to provide them competitively priced funding, a reasonable return on their investment in the Bank, and support for community investment activities. FHLBank Chicago is one of 11 Federal Home Loan Banks chartered by the U.S. Congress in 1932 to promote homeownership. Our members include banks, thrifts, credit unions, insurance companies, and community development financial institutions throughout our District. To learn more about FHLBank Chicago, please visit fhlbc.com or follow @FHLBC on Twitter. "Downpayment Plus" and "DPP" are registered trademarks of the Federal Home Loan Bank of Chicago.
View original content to download multimedia:
SOURCE Federal Home Loan Bank of Chicago
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/flood-wholesaler-insurtech-startup-joe-flood-insurance-brokerage-inc-announces-full-launch-coverholder-status/
|
CARVER, Mass., April 1, 2022 /PRNewswire/ -- The founders of Joe Flood Insurance Brokerage, Inc. (JFIB) announce the full launch of their tech-based flood insurance wholesale brokerage. JFIB was founded by Joe "Flood" Rossi, Art McKinney, and Chris St. George to deliver state of the art flood insurance technology, as well as a consultative underwriting approach to agencies of all sizes.
JFIB also announces their status as a coverholder of Chubb European Group, with the unveiling of their own proprietary product on Chubb paper called Upstream. Upstream writes all lines of primary and excess flood business on A++ Chubb paper. "We built JFIB to be agent-centric," Joe noted. "Most of us at JFIB have either been an agent or owned an agency at some point in our careers. With the implementation of Risk Rating 2.0 and all the changes happening in the flood industry, we want to deliver our expertise and experience to agents to make their jobs simpler."
JFIB will be releasing an industry leading quote platform to their partner agents in mid-2022. This technology will provide quotes and rate comparisons from many carriers including the JFIB proprietary product Upstream. The technology will leverage industry data, and simplify the quoting, binding, and sales process. JFIB also provides additional flood insurance related services, such as risk scoring, property risk reports, Letter Of Map Amendment filing, and more. This combined with their multitude of flood insurance offerings, makes JFIB a holistic flood solution for agencies across the country.
Agencies are welcome to sign up to be appointed with JFIB and can do so by visiting joefloodinsurance.com/sign-up. JFIB currently has access to 23 carriers, and is placing business in 22 states, with plans to be in almost every state within the year.
To learn more about Joe Flood Insurance Brokerage, visit joefloodinsurance.com
Press Contact
Joe "Flood" Rossi
President/CEO
781.635.5152
joe@joefloodinsurance.com
View original content to download multimedia:
SOURCE Joe Flood Insurance Brokerage
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/foot-locker-inc-present-jp-morgan-8th-annual-retail-round-up-conference/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Foot Locker, Inc. (NYSE: FL), the New York-based specialty athletic retailer, today announced that Richard Johnson, Chairman and Chief Executive Officer, and Andrew Page, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan 8th Annual Retail Round Up Conference on Thursday, April 7th at 2:00 p.m. ET.
A link to the live audio fireside chat will be available on www.footlocker-inc.com, and a replay will be available on the website for 30 days following the event.
Foot Locker, Inc. leads the celebration of sneaker and youth culture around the globe through a portfolio of brands including Foot Locker, Kids Foot Locker, Champs Sports, Eastbay, atmos, WSS, Footaction, and Sidestep. With approximately 2,900 retail stores in 28 countries across North America, Europe, Asia, Australia, and New Zealand, as well as websites and mobile apps, the Company's purpose is to inspire and empower youth culture around the world, by fueling a shared passion for self-expression and creating unrivaled experiences at the heart of the global sneaker community. Foot Locker, Inc. has its corporate headquarters in New York. For additional information please visit www.footlocker-inc.com.
Investor Contact:
Robert Higginbotham
Vice President, Investor Relations
Foot Locker, Inc.
robert.higginbotham@footlocker.com
(212) 720-4600
Media Contact:
Matthew Di Taranto
Director, Corporate Communications
Foot Locker, Inc.
matthew.ditaranto@footlocker.com
(718) 970-1260
View original content:
SOURCE Foot Locker IR
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/four-seasons-takes-legendary-service-roadways-europe-with-beyond-by-four-seasons-an-exclusive-driving-journey-through-tuscany/
|
Car enthusiasts are invited to enjoy the splendours of Italy with a customized week-long itinerary unlocking scenic drives, world-class cuisine, and insider access to Tuscany's celebrated sites
TORONTO, April 1, 2022 /PRNewswire/ -- Four Seasons Hotels and Resorts, one of the world's leading luxury hospitality companies, today unveils Beyond by Four Seasons, An Exclusive Driving Journey Through Tuscany, a week-long curated drive experience designed to showcase the best of the Italian countryside by luxury car. From September 24 to 30, 2022, the brand's first-of-its-kind journey from behind the wheel explores captivating landscapes, special access to must-see sites, and remarkable culinary offerings, with Four Seasons Hotel Firenze as a home base.
Working in collaboration with leader in lifestyle driving experiences, Canossa Events, as well as the city of Florence, travellers are invited to meet in the Tuscan capital and enjoy an Italian escape from the comfort of their own vehicle or a vintage classic or luxury sportscar arranged by a dedicated guest services team. Every step of the guest journey – from the accommodations and daily activities to the exclusively curated drives and local recommendations – is thoughtfully managed with the attention to detail and genuine service for which Four Seasons is renowned.
"The guest experience is at the heart of everything we do, inspiring our teams to innovate and elevate each new Four Seasons offering," says Christian Clerc, President – Hotels and Resorts. "We came together with Canossa Events to create something truly spectacular for our guests – an ultra-luxury drive adventure where the journey is to be enjoyed just as much as the destination. Against the backdrop of the Tuscan countryside, punctuated by the region's best wine and culinary offerings, and delivered by our talented and caring craftspeople, Beyond by Four Seasons sets a new standard for luxury road travel."
The inaugural Tuscan driving journey will debut with an al fresco welcome dinner in the Faggio Garden at Four Seasons Hotel Firenze, launching a week's worth of discovery. In the days that follow, guests will explore the vineyards of "Chiantishire" with a private tour and wine tasting at the historic Antinori Cellars; drive the colourful landscapes of Siena, enjoying lunch under the storied arcades of the Montalcino City Hall; and journey through idyllic seaside towns and the famous green cypresses of Bolgheri to the famed vineyards of Ornellaia.
"Creating memorable events and unforgettable celebrations centred around a love for cars is what we do best," says Luigi Orlandini, Chairman and CEO, Canossa Events. "Partnering with Four Seasons, we have designed an incredibly unique offering, allowing guests to enjoy every special moment spent on the road and inspiring them to immerse themselves in the splendours of all that Tuscany can offer."
While exploring locally, guests will be granted private entry to venues normally closed to the public, indulging in a memorable Florentine dining experience as well as an unforgettable evening at the Opera. Programming also features built-in time to rest and recharge, offering guests a chance to explore the grounds of Four Seasons Hotel Firenze, their home away from home, relaxing amid the city's largest private garden, by the pool or with a rejuvenating spa treatment.
"Working with Four Seasons and Canossa Events, it is an honour to shine a spotlight on our beautiful capital city and the scenic roads of Tuscany," says Dario Nardella, Mayor, Florence, Italy. "Our unique collaboration gives travellers a rare view of the region's must-see sites, hidden routes, and best-kept secrets – the makings of an incredibly memorable Italian holiday."
Whether guests are on property or en route, a dedicated guest services team ensures seamless delivery and exceptional service at every touchpoint, allowing travellers to focus on the true charm and romance of road travel.
"Beyond by Four Seasons is a testament to our continued focus on gaining deeper insights that inspire and enhance the guest experience," says Marc Speichert, Chief Commercial Officer, Four Seasons Hotels and Resorts. "By designing programs influenced by the passions and preferences of Four Seasons travellers, our guests become the authors of how they connect with our brand. Championing a guest-centric approach in all that we do remains our priority as we look to the future and the myriad of opportunities ahead."
With a luxury lifestyle offering that spans a bespoke Private Jet; a growing collection of luxury villa and vacation home rentals; a line of curated home and travel goods; and a global portfolio of Private Residences, Four Seasons now brings its expertise to the road, tapping into its extensive network of local artisans and experts to elevate every mile.
Booking Information
As space is limited, travellers interested in finding out more about Beyond by Four Seasons, An Exclusive Driving Journey Through Tuscany are invited to click here for additional booking details or email beyond@fourseasons.com. Reservations can also be made by phone at +39 0522 421096 (Italy) or +1 831 521 5190 (U.S.).
Health and Safety
Guests can take comfort in the peace of mind that comes with travelling with Four Seasons. In partnership with Canossa Events, a leader in lifestyle driving experiences, and in adherence with Four Seasons global health and safety program Lead With Care, Four Seasons works closely with leading medical experts to enhance the health, wellbeing and safety of every guest and employee. Throughout their stay, guests are invited to use the Four Seasons App for contactless communication with Four Seasons people at any time, 24 hours a day.
About Four Seasons Hotels and Resorts
Four Seasons Hotels and Resorts opened its first hotel in 1961, and since that time has been dedicated to perfecting the travel experience through continual innovation and the highest standards of hospitality. Currently operating 123 hotels and resorts, and 50 residential properties in major city centres and resort destinations in 47 countries, and with more than 50 projects under planning or development, Four Seasons consistently ranks among the world's best hotels and most prestigious brands in reader polls, traveller reviews and industry awards. For more information and reservations, visit fourseasons.com. For the latest news, visit press.fourseasons.com and follow @FourSeasonsPR on Twitter.
About Canossa Events
Canossa Events was formed in 2010 and is synonymous with excellence in road touring events. The company organizes almost 300 events a year, including the legendary Modena Cento Ore that cuts a swath across the stunning scenery of Italy also featuring races in some of the most famous circuits. Canossa is best known for its classic car rallies and its supercar motor touring events that blend exotic collectable cars, world-class hospitality and road adventures set in some of the world's most picturesque landscapes across Europe, the US and the Middle East. The Canossa family also includes Cavallino, publisher of the famous eponymous magazine since 1978 and organizer of the world's most important Concorso d'Eleganza devoted entirely to Ferrari. Since 2019 Canossa is part of Motorsport Network. For more information about Canossa Events, visit https://canossa.com/category/news/.
Media Contact:
Emily Borgeest
fourseasons@kwtglobal.com
View original content to download multimedia:
SOURCE Four Seasons Hotels and Resorts
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/fulbright-prize-honors-bono-lead-singer-u2-activist-co-founder-one-red/
|
WASHINGTON, April 1, 2022 /PRNewswire/ -- Today, the Fulbright Association presented Bono, U2 lead singer and co-founder of ONE and (RED), with the 2021 J. William Fulbright Prize for International Understanding for his commitment to seek justice by fighting to end extreme poverty, tackle global health crises, and spur economic development in the poorest parts of the planet.
Watch the program here.
Speaking at this evening's event about growing up in Ireland, Bono said, "We looked to America. We saw a country with its own long-running arguments, its own injustices. We knew this promised land wasn't always keeping to that promise. We knew America wasn't living up to all its ideals, but the fact is America had ideals.
"We knew that because you wrote them down, you cited them, you held yourself to account on them. They shaped the struggle for civil rights and women's rights and gay rights. I don't know how, but I seemed to know that America wasn't just a country. I felt it was an idea, if not yet a fact.
"Even when it got messy. Even when it got wild. America isn't classical music, America is punk rock, America is hip-hop. I had a sense of America's wrestling with itself, caught in the act of becoming… becoming itself… becoming its better self.
"William Fulbright talked about 'the magnetism of freedom', though he was selective about it. Even if he missed the full expression of it, in Ireland we felt its pull. And I have ever since.
"I love this song called America. And I ask you tonight as both fanboy and critic: Can you still hold that tune?"
"The causes Bono has devoted himself to remain all too relevant today. While affordable treatments have brought HIV/AIDS under control, a new pandemic left Africans at the back of the queue for vaccines," said Dr. Ngozi Okonjo-Iweala, Director-General of the World Trade Organization, who introduced Bono. "So, we will still need Bono to keep up his advocacy work in the months and years ahead. And though he won't have time to rest on his laurels, there's no one who deserves this award more than he does."
The Prize focuses on and rewards outstanding contributors to bringing cultures, nations and peoples together. Past Prize Laureates include Nelson Mandela, Bill and Melinda Gates, Desmond Tutu, President Bill Clinton, and Chancellor Angela Merkel amongst many others. The Prize also directly benefits the charitable priority of the Laureate. This year, Bono will be donating his $50,000 award to ONE and (RED).
"We're honored to recognize and celebrate Bono's commitment to fighting injustice, extreme poverty, the global AIDS crisis, and more recently, the disparities in the global COVID-19 response," said Justice Cynthia A. Baldwin, Fulbright Association Board Chair and Former Pennsylvania Supreme Court Justice. "The purpose of the Fulbright Prize is to recognize those who promote peace through greater understanding among peoples, cultures, and nations, and there's no doubt that Bono embodies the best of leadership in times of unrelenting global crises and challenges."
"Bono joins a distinguished history of laureates, and the recognition is well deserved," said John Bader, Fulbright Association Executive Director. "We all have a responsibility to advance peace and understanding, and I hope that Bono's leadership serves as an example to people around the world that we can all use our time, unique talent, and platform for a greater purpose."
The 2021 J. William Fulbright Prize for International Understanding Award Ceremony was made possible by generous contributions from sponsors, including the Bill & Melinda Gates Foundation, Dr. H. Andréa Neves, BroadReach Group, Egon Zehnder, Namecoach, and Georgia-Pacific.
Additional photos and video available upon request.
About the J. William Fulbright Prize for International Understanding
The Fulbright Prize honors one of the world's most prestigious international exchange programs, as well as the vision of its sponsor, the late Senator J. William Fulbright. Awarded by the Fulbright Association since 1993, the Prize recognizes outstanding contributions to promoting peace through greater understanding among peoples, cultures, and nations. The Prize has a distinguished history of laureates, among them Nelson Mandela, Jimmy Carter, Desmond Tutu, Bill Clinton, Vaclav Havel, Corazon Aquino, Mary Robinson, Doctors without Borders, Bill and Melinda Gates, and Angela Merkel. More on the Prize, with a complete list of laureates, at fulbright.org/prize
About the Fulbright Program
The Fulbright Program celebrates its 75th Anniversary this year, marking its creation in 1946 through Congressional legislation proposed by Senator J. William Fulbright. The Program embodies the visionary concept of promoting mutual understanding between countries through academic and bicultural exchange. The Program provides exchanges between the United States and more than 160 countries worldwide, funded by the U.S. Government with bipartisan support and contributions from 52 foreign countries whose permanent commissions execute the Fulbright Program on a binational level. Annually, about 8,000 grantees, American and foreign, participate in the Fulbright exchange as students, scholars, researchers, English teachers, and professional specialists. Since its inception, the Program has sponsored approximately 390,000 grantees. Read more at eca.state.gov/fulbright
About the Fulbright Association
The Fulbright Association is the alumni organization of the Fulbright Program in the United States, representing over 140,000 American grantees. Founded in 1977, it is an independent non-profit organization based in Washington, DC, with 55 chapters in 38 states. Its mission is to continue and extend the Fulbright tradition of education, advocacy, and service through local, national and international programs. The Fulbright Association works with partners in more than 160 countries and 70 sister alumni associations around the world. Read more at fulbright.org
View original content to download multimedia:
SOURCE Fulbright Association
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/future-fintech-participate-bitcoin-2022-conference/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ: FTFT) ("hereinafter referred to as "Future FinTech", "FTFT" or "the Company"), a leading blockchain-based e-commerce business and a fintech service provider, announced that it will participate at the Bitcoin 2022 conference to be held in Miami, Florida, from April 6 - 9, 2022. The Company's subsidiaries, FTFT Capital Investment LLC ("FTFT Capital") and Future Fintech Digital Capital Management LLC will also be participating in the event.
Bitcoin 2022, organized by BTC Media based in Nashville, is the most prominent Bitcoin conference event globally and will provide a diverse spectrum of programs. It is expected that more than 15,000 attendees from around the world will attend the conference. The event will bring together the entire Bitcoin ecosystem of companies and projects for collaboration, networking and learning.
Mr. Ola J. Lind, Chief Strategy Officer of Future FinTech, commented, "We are looking forward to participating in Bitcoin 2022 Conference as it will afford us an opportunity to interact with a variety of participants in the cryptocurrency space. We are engaged in several projects that we believe will capitalize upon this next generation asset class and our attendance at the conference will further the Company's projects' implementation and growth. FTFT's conference booth number is 1051, the contact person would be me, Ola J. Lind, and I can be reached at + 971543733406 or by email at ola@ftftcapital.com. We welcome all guests to our booth to discuss our business and potential cooperative ventures."
About Future FinTech Group Inc.
Future FinTech Group Inc. is a leading blockchain e-commerce company and a service provider for financial technology incorporated in Florida. The Company's operations include a blockchain-based online shopping mall platform, Chain Cloud Mall ("CCM"), supply chain financing services, and cryptocurrency market data services. The Company is also engaged in the development of blockchain based e-Commerce technology and cryptocurrency mining, cryptocurrency investment management as well as financial service technology businesses. For more information, please visit http://www.ftft.com/.
Safe Harbor Statement
Certain of the statements made in this press release are "forward-looking statements" within the meaning and protections of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause the actual results, performance, capital, ownership or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as "may," "will," "anticipate," "assume," "should," "indicate," "would," "believe," "contemplate," "expect," "estimate," "continue," "plan," "point to," "project," "could," "intend," "target" and other similar words and expressions of the future.
All written or oral forward-looking statements attributable to us are expressly qualified in their entirety by this cautionary notice, including, without limitation, those risks and uncertainties described in our annual report on Form 10-K for the year ended December 31, 2020 and our other reports and filings with SEC. Such reports are available upon request from the Company, or from the Securities and Exchange Commission, including through the SEC's Internet website at http://www.sec.gov. We have no obligation and do not undertake to update, revise or correct any of the forward-looking statements after the date hereof, or after the respective dates on which any such statements otherwise are made.
View original content to download multimedia:
SOURCE Future FinTech Group Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/gaming-innovation-group-completes-acquisition-sportnco/
|
OSLO, Norway, April 1, 2022 /PRNewswire/ -- Gaming Innovation Group Inc. ("GiG" or the "Company") signed a Share Purchase Agreement ("SPA") to acquire the iGaming company Sportnco Gaming SAS ("Sportnco") on 22 December 2021. GiG has received the necessary approvals from relevant authorities, and GiG's Board of Directors has resolved to complete the acquisition, hereunder to issue new shares to the shareholders of Sportnco and to SkyCity Entertainment Group Limited ("SkyCity").
GiG acquires 100% of the shares in Sportnco Gaming SAS for a consideration of €51.37 million, whereof €27.87 million has been paid in cash and €23.50 million in 12,623,400 new shares in GiG at a share price of NOK 18.08, equal to the VWAP of the GiG share for the past ten days of trading. In addition, Sportnco will retain €18.63 million of its existing long-term loans.
GiG also entered into an agreement with SkyCity in December 2021, whereby SkyCity invests €25 million in GiG through a directed share issue at NOK 18.00 per share, equal to 13,487,500 new GiG shares, financing the main part of the cash consideration to the shareholders of Sportnco.
GiG issues 26,110,900 new shares to the shareholders of Sportnco and SkyCity, increasing the number of outstanding shares from 96,675,626 to 122,786,526. The shares issued to the shareholders of Sportnco are subject to a 6-month lock-up period.
Sportnco has 84 shareholders whereof the largest being its CEO and founder Hervé Schlosser (15.6%), Olivier Marchal, President at Bain&Co France (9.1%) and BNP Paribas Développment (6.6%), and these will hold 1.60%, 0.93% and 0.67% respectively in GiG. SkyCity will hold 10.98% in GiG.
In addition, the shareholders of Sportnco are entitled to a two year earn-out based on the performance in 2022 and 2023 with up to €11.5 million per year. The earn-out will be paid 50% in cash and 50% in new shares in GiG, where the number of shares to be issued shall be based on a 10-day VWAP of the GiG share at the time of payment, expected in April 2023 and April 2024. Further, to keep key employees in Sportnco, a 3-year option program will be entered into, whereby the option holders, pending continued employment, will receive shares in GiG at future VWAP valuation up to a total aggregate value of €4 million.
The combined company
Sportnco is one of the leading platform providers of turnkey betting and gaming solutions for operators in regulated markets through its inhouse developed sportsbook and PAM. The combined company will enhance and strengthen GiG's position as one of the industry leading platforms and media providers with innovative and proprietary products and creating one of the largest and fastest growing providers in regulated iGaming with an unparalleled regulated geographical footprint.
Sportnco has international presence and operates as a leading B2B supplier in France and Spain and is active in other European jurisdictions such as Belgium, Portugal, and Greece, as well as in several high growth Latin American markets and is well positioned to enter the US sportsbook lead states. Sportnco's geographical presence is highly complementary to GiG's current offering and combined, GiG and Sportnco will be licensed in 25 markets, currently with around 55 clients. Through the acquisition, GiG has increased both short- and long-term addressable markets meaningfully. Sportnco's tier 1 sportsbook product is strong, and the acquisition is expected to create attractive commercial, operational, and technological synergies, as well as enable cost savings and accelerated growth.
The combined company will have increased profitability, value proposition with ever increasing growth prospects and further diversification of revenue and geographical reach.
Outlook
With the acquisition of Sportnco, GiG strengthens its position in the platform and sports segments of the iGaming industry and will have multiple possibilities going forward by increasing its product portfolio driving toward a profitable and cash generating business segment. GiG's Media Services has seen a strong performance over the last two years, delivering high growth levels, increasing diversity of earnings and healthy cash-flow. For the full year 2022, the combined operations should generate revenues of €87-93 million with an EBITDA of €30-35 million. The Board of Directors will have a strong focus on overall operations, including the post-merger integration of Sportnco, and will continue to look at possible strategic options to increase shareholder value going forward.
Richard Brown, CEO of GiG said: "It is with tremendous excitement that we now step forward into the next chapter in GiG's history. The team at Sportnco have built a tremendous business, one that is highly complementary to GIG's offering both in product but also addressable market increase, and now the work begins to realise the truly existing growth opportunities that the business combination can pursue. We welcome both the owners of Sportnco & SkyCity as shareholders and the staff of Sportnco into GiG organisation and now move forward with full focus on the execution of the post-merger integration plan."
Hervé Schlosser, CEO and founder of Sportnco, said "Together with all the teams and shareholders who have built the success of Sportnco and Tecnalis, we are extremely proud of the journey we have accomplished since 2008, and of our integration today into the GIG group. I look forward to opening this new chapter as I am confident that, together, we will offer stronger technology solutions for our customers in the fast-growing regulated markets."
For further information, please contact:
Richard Brown, CEO GiG, richard.brown@gig.com, +34 661599025
Herve Schlosser, CEO Sportnco, herve.schlosser@sportnco.fr
About Gaming Innovation Group (GiG)
Gaming Innovation Group is a leading iGaming technology company, providing solutions, products and services to iGaming Operators. Founded in 2012, Gaming Innovation Group's vision is 'To be the industry-leading platform, sportsbook and media provider delivering world-class solutions to our iGaming partners and their customers. GiG's mission is to drive sustainable growth and profitability of our partners through product innovation, scalable technology and quality of service. Gaming Innovation Group operates out of Malta and is dual-listed on the Oslo Stock Exchange under the ticker symbol GIG and on Nasdaq Stockholm under the ticker symbol GIGSEK. www.gig.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Gaming Innovation Group
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/glen-donovan-appointed-vice-president-investor-relations-sempra/
|
SAN DIEGO, April 1, 2022 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced that Glen Donovan, currently vice president of development for Sempra Infrastructure's LNG and net-zero solutions business, has been appointed vice president of investor relations for Sempra. Manuela "Nelly" Molina, Sempra's current vice president of investor relations, has been named vice president of audit services effective April 2, 2022.
"Glen's leadership experience across the Sempra family of companies and contributions to sustainable development at our infrastructure business make him a key asset as he returns to take on a critical leadership role at Sempra," said Trevor Mihalik, executive vice president and chief financial officer of Sempra. "In his new role as vice president of investor relations, Glen will help shape how we highlight Sempra's growth and business story to our shareholders to further demonstrate our commitment to a sustainable future."
As vice president of development at Sempra Infrastructure, Donovan oversaw the development of LNG and net-zero opportunities, including exploring existing infrastructure for clean hydrogen production. Donovan previously served as vice president of finance and vice president of project development and structuring for Sempra LNG and held various positions of increasing responsibility at Sempra Renewables, including vice president of business development. In these roles, he was responsible for renewable project finance, mergers and acquisitions, asset management and renewable contract origination.
At Sempra, Donovan has held several corporate finance roles, including director of investor relations, and oversaw the company's planning and analysis functions.
Sempra's mission is to be North America's premier energy infrastructure company. The Sempra family of companies have 20,000 talented employees who deliver energy with purpose to nearly 40 million consumers. With more than $72 billion in total assets at the end of 2021, the San Diego-based company is the owner of one of the largest energy networks in North America helping some of the world's leading economies move to cleaner sources of energy. The company is helping to advance the global energy transition through electrification and decarbonization in the markets it serves, including California, Texas, Mexico and the LNG export market. Sempra is consistently recognized as a leader in sustainable business practices and for its long-standing commitment to building a high-performing culture focused on safety, workforce development and training, and diversity and inclusion. Sempra is the only North American utility sector company included on the Dow Jones Sustainability World Index and was also named one of the "World's Most Admired Companies" for 2022 by Fortune Magazine. For additional information about Sempra, please visit Sempra's website at www.sempra.com and on Twitter @Sempra.
View original content to download multimedia:
SOURCE Sempra
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/global-net-lease-inc-announces-common-stock-dividend-second-quarter-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Global Net Lease, Inc. ("GNL") (NYSE: GNL/ GNL PRA / GNL PRB) announced today that it intends to continue to pay dividends on its shares of common stock at an annualized rate of $1.60 per share or $0.40 per share on a quarterly basis. GNL anticipates paying dividends authorized by its board of directors on its shares of common stock on a quarterly basis in arrears on the 15th day of the first month following the end of each fiscal quarter (unless otherwise specified) to common stock holders of record on the record date for such payment.
Accordingly, GNL declared a dividend of $0.40 per share of common stock payable on April 18, 2022 to common stock holders of record at the close of business on April 11, 2022.
Global Net Lease, Inc. (NYSE: GNL) is a publicly traded real estate investment trust listed on the NYSE focused on acquiring a diversified global portfolio of commercial properties, with an emphasis on sale-leaseback transactions involving single tenant, mission critical income producing net-leased assets across the United States, Western and Northern Europe. Additional information about GNL can be found on its website at www.globalnetlease.com.
The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. In addition, words such as "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of GNL's control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of the ongoing global COVID-19 pandemic, including actions taken to contain or treat COVID-19, on GNL, GNL's tenants and the global economy and financial markets and that the information about rent collections may not be indicative of any future period, as well as those set forth in the Risk Factors section of GNL's most recent Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 24, 2022, and all other filings with the SEC after that date, as such risks, uncertainties and other important factors may be updated from time to time in GNL's subsequent reports. Further, forward-looking statements speak only as of the date they are made, and GNL undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required by law.
Investors and Media:
Email: investorrelations@globalnetlease.com
Phone: (212) 415-6510
View original content to download multimedia:
SOURCE Global Net Lease, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/grab-shareholder-alert-jakubowitz-law-reminds-grab-holdings-shareholders-lead-plaintiff-deadline-may-16-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Grab Holdings Limited (NASDAQ: GRAB).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/grab-holdings-limited-loss-submission-form/?id=25401&from=4
The lawsuit seeks to recover losses for shareholders who purchased Grab Holdings between November 12, 2021 and March 2, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until May 16, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Grab Holdings Limited issued materially false and/or misleading statements and/or failed to disclose that: (1) Grab's driver supply declined during the third quarter; (2) as a result, Grab continued to invest heavily in driver and consumer incentives to "preemptively recalibrate driver supply"; (3) as a result, the Company's financial results would be adversely impacted, including, among other things, a significant decline in revenue; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/graphite-one-comments-white-house-defense-directive-designating-graphite-essential-national-defense/
|
Graphite elevated into select group of "super-critical minerals" after receiving DPA Title III designation
VANCOUVER, BC, April 1, 2022 /PRNewswire/ - Graphite One Inc. (TSXV: GPH) (OTCQX: GPHOF) ("Graphite One" or the "Company") offers the following comments on President Joe Biden's announcement today that graphite and other critical battery materials are designated as "essential to national defense" under the Defense Production Act (DPA) of 1950.
Graphite and other battery minerals – lithium, manganese, cobalt and nickel – join rare earth materials the only U.S. Government-listed Critical Minerals eligible for the comprehensive support provided by the DPA. Unlike Presidential Executive Orders, designations under the DPA, first passed during the Korean War, carry the full force of U.S. federal law.
"With this new defense designation under U.S. law, graphite joins a select group of 'super-critical minerals' that are essential to commercial technology and national security applications," said Anthony Huston, CEO of Graphite One. "This action by President Biden validates Graphite One's strategy of creating a full supply chain for advanced graphite materials located in the United States."
According to the Department of Defense, the (DPA) "provides the President a broad set of authorities to ensure the timely availability of essential domestic industrial resources to support national defense and homeland security requirements."
According to the White House statement, President Biden
"…issue[d] a directive, authorizing the use of the Defense Production Act to secure American production of critical materials to bolster our clean energy economy by reducing our reliance on China and other countries for the minerals and materials that will power our clean energy future. Specifically, the DPA will be authorized to support the production and processing of minerals and materials used for large capacity batteries–such as lithium, nickel, cobalt, graphite, and manganese—and the Department of Defense will implement this authority using strong environmental, labor, community, and tribal consultation standards. The sectors supported by these large capacity batteries—transportation and the power sector—account for more than half of our nation's carbon emissions. The President is also reviewing potential further uses of DPA – in addition to minerals and materials – to secure safer, cleaner, and more resilient energy for America."
Earlier this month, U.S. Senators Lisa Murkowski (R-AK) and Joe Manchin (D-WV), former and current Chairs of the Senate Energy and Natural Resource Committee, sent a letter to President Biden urging him to make a DPA Title III designation to "invoke the Defense Production Act to accelerate domestic production of lithium-ion battery materials, in particular graphite, manganese, cobalt, nickel, and lithium." Mr. Huston commented: "All of us at Graphite One want to thank Senator Murkowski, the Senate's undisputed expert on critical minerals, and Chairman of the Senate ENR Committee, Joe Manchin who made such a compelling case for President Biden to take this step. Giving graphite and the battery materials the DPA Title III designation – as 'essential to national defense' – is a strong signal that the full force of the U.S. federal government will now be behind domestic development of these 'super-critical minerals'. With the USGS recognizing Graphite One's Alaska deposit just last month as being America's largest known graphite deposit, and adding to that our plan to produce battery-ready anode material, Graphite One is ready to answer the call, and create a complete advanced graphite supply chain solution for the U.S."
Dean of the House, the Honorable Don Young
"I also want to single out a real leader, a great patriot and friend who we mourn and miss: Congressman Don Young, Dean of the House," continued Mr. Huston. "Congressman Young was a supporter of Graphite One from the first moment I had a chance to meet him, and he was an advocate of DPA Title III being used to drive domestic production of graphite and other critical minerals. We talked about the issue the last time we met. On a personal level, all of us at Graphite One want to express our deepest condolences to Mrs. Young and the Young family. When you were talking to him, it didn't matter what huge issues of government were in play on Capitol Hill, Don Young had a way of making you feel like the conversation you were having with him was the most important thing he could be doing. He was a happy warrior – and Alaska and all of America were lucky to have him."
With the United States currently 100 per cent import dependent for natural graphite, Graphite One is developing a complete U.S.-based, advanced graphite supply chain solution anchored by the Graphite Creek resource near Nome, Alaska. The Graphite One project plan includes an advanced graphite material and battery anode manufacturing plant expected to be sited in Washington State1 with the development of the Graphite Creek resource.
As announced on March 7th2, Graphite One Inc.'s Graphite Creek resource in Alaska has been cited as the largest known graphite deposit in the United States by the U.S. Geological Survey (USGS) in its updated U.S. Mineral Deposit Database (USMIN).
The USGS report confirms Alaska Governor Mike Dunleavy's statement in support of Graphite One's designation as a U.S. government high-priority infrastructure project, stating, "Graphite Creek is the largest deposit of graphite in the nation and would be a superior domestic supply of this critical mineral.
GRAPHITE ONE INC. (GPH: TSXV) (GPHOF: OTCQB) continues to develop its Graphite One Project (the "Project"), whereby the Company could potentially become an American producer of high-grade anode materials that is integrated with a domestic graphite resource. The Project is proposed as a vertically integrated enterprise to mine, process and manufacture high grade anode materials primarily for the lithium‐ion electric vehicle battery market. As set forth in the Company's Preliminary Economic Assessment, potential graphite mineralization mined from the Company's Graphite Creek Property, is expected to be processed into concentrate at a graphite processing plant. The proposed processing plant would be located on the Graphite Creek Property situated on the Seward Peninsula about 60 kilometers north of Nome, Alaska. Graphite anodes and other value‐added graphite products would be manufactured from the concentrate and other materials at the Company's proposed advanced graphite materials manufacturing facility expected to be located in Washington State. The Company intends to make a production decision on the Project once a feasibility study is completed.
On Behalf of the Board of Directors
"Anthony Huston" (signed)
For more information on Graphite One Inc., please visit the Company's website, www.GraphiteOneInc.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All statements in this release, other than statements of historical facts, including those related to future production, establishment of a processing plant and a graphite manufacturing plant, and events or developments that the Company intends, expects, plans, or proposes are forward-looking statements Generally, forward‐looking information can be identified by the use of forward‐looking terminology such as "proposes", "expects", or "is expected", "scheduled", "estimates", "projects", "intends", "assumes", "believes", "indicates" or variations of such words and phrases that state that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved". The Company cautions that there is no certainty that tests of the Company's material will be successful or that such tests will result in the development of successful products. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continuity of mineralization, uncertainties related to the ability to obtain necessary permits, licenses and title and delays due to third party opposition, changes in government policies regarding mining and natural resource exploration and exploitation, and continued availability of capital and financing, and general economic, market or business conditions. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date it is expressed in this press release, and the Company undertakes no obligation to update publicly or revise any forward-looking information, except as required by applicable securities laws. For more information on the Company, investors should review the Company's continuous disclosure filings that are available at www.sedar.com.
View original content to download multimedia:
SOURCE Graphite One Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/healthlynked-reports-annual-revenue-growth-50-92-million/
|
Company remains well positioned to drive continued top-line growth in 2022
NAPLES, Fla., April 1, 2022 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), a global healthcare network focused on care management of its members and a provider of healthcare technologies that connects doctors, patients, and medical data, reported its financial results for the fourth quarter and full year ended December 31, 2021.
2021 Financial Highlights
- Revenue of $9.2 million, up 50% compared to $6.1 million in 2020
- ACO/MSO revenue grew 125% to $2.7 million compared to $1.2 million for the prior year
- Health Services revenue grew 22% to $5.8 million compared to $4.7 million for the prior year
- Net equity of $7.2 million, up 434% from $1.2 million in 2020
Fourth Quarter 2021 Financial Highlights
- Revenue of $1.7 million increased by 4% compared to $1.5 million in the fourth quarter of 2020
- Net loss of ($1.7) million decreased by 11% compared to ($1.9) million in the fourth quarter of 2020
Business Highlights
- Released AI-enabled healthcare directory CareLynk to connect HealthLynked users to any doctor across the U.S.
- Launched telemedicine platform DocLynk for all HealthLynked patients and providers for primary care and women's healthcare virtual appointments in a simple and easy-to-use interface
- QwikCheck V2.0 launched to streamline the patient check-in process while maintaining social distancing
- Announced the addition of Dr. Paul Hobaica and Dr. Sam Diasti to its medical advisory board
- Appointed Jeffrey Cohen as Vice President of Sales to increase revenue by introducing HealthLynked products and services to health systems, third party payers, hospitals, universities, and group purchasing organizations
Dr. Michael Dent, HealthLynked's Chairman and Chief Executive Officer, commented, "HealthLynked finished 2021 with a record 50% revenue growth, capping off another milestone year for the company. We are proud of our accomplishments throughout 2021 as we completed several key product announcements and continued to make investments in our existing digital product portfolio. These accomplishments, combined with our strong financial performance, provides us confidence in our ability to continue to reduce healthcare costs and improve patient outcomes."
George O'Leary, HealthLynked's Chief Financial Officer, added, "We are very proud of our proven historical revenue growth, including 60% CAGR from 2018-21. We closed the year with a strong net equity of $7.2 million, a significant improvement to our balance sheet from the previous year. We continue to remain excited about the growth we are experiencing, and we look forward to continuing to provide value to our patients and shareholders in 2022 as the company executes on its business strategy."
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries, and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent-pending patient access hub "PAH" for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last-minute cancelations using the Company's "real-time appointment scheduling" all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, Instagram, and LinkedIn.
Forward-Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
Investor Relations Contacts:
Lisa Fortuna or Josh Carroll
HLYK@alpha-ir.com
HLYK Contact:
George O'Leary
Chief Financial Officer
goleary@healthlynked.com (800)-928-7144, ext. 103
View original content:
SOURCE HealthLynked Corp.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/high-tide-acquire-boreal-cannabis-company-adding-two-established-retail-cannabis-stores-northern-alberta/
|
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated December 3, 2021, to its short form base shelf prospectus dated April 22, 2021.
CALGARY, AB, April 1, 2022 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets, is pleased to announce that it is taking yet another step to expand its bricks-and-mortar retail cannabis operations, by entering into a definitive agreement (the "Acquisition Agreement") pursuant to which High Tide will acquire 100% of the equity interest of 2080791 Alberta Ltd. operating as Boreal Cannabis Company ("Boreal") which operates two retail cannabis stores in Alberta (the "Stores") for CAD$2.2 Million, plus the wholesale value of inventory and cash on hand at closing (the "Transaction"). The Stores are located at 1104 Main Street SW in Slave Lake, Alberta, and 4225 50 Avenue in St. Paul, Alberta. The Slave Lake store was the first to open in the municipality and is located in a commercial plaza that is a short walk or drive away from the main campus of Northern Lakes College, and the Slave Lake Inn and Conference Centre. The St. Paul store is situated on the main east-west corridor in the town, as part of a commercial district that features several national big box chains and restaurants. For the three months ended January 31, 2022, Boreal generated annualized revenue of CAD$3.9 Million and annualized Adjusted EBITDA1 of CAD$0.6 Million. The purchase price represents 3.5x annualized Adjusted EBITDA for the three months ended January 31, 2022.
"Boreal was one of the earliest players in the northeastern Alberta cannabis market, having opened the first store in the community of Slave Lake. This announcement is yet another example of how we continue to strategically advance our retail store footprint across Canada through organic growth and accretive acquisitions with a focus on regions where we are currently lighter on exposure, such as northern Alberta which has a dynamic economy that supports working families, a key consumer demographic for Canna Cabana," said Raj Grover, President and Chief Executive Officer of High Tide. "We continue to execute on opportunities to acquire established stores with good fundamentals at attractive multiples. Once these acquisitions have closed, we will have surpassed the 120-store threshold, and will be well on our way to achieving the 150-store milestone by the end of this calendar year," added Mr. Grover.
"Through its online consumption accessories sales, value-added CBD activities, and retail spaces, High Tide has managed to diversify itself within the cannabis value chain. We strongly believe Boreal Cannabis is in capable hands, and will continue to unlock value for not only shareholders, but our customers through competitive pricing and a customer-centric approach," said Glenn Boisvert, Chief Executive Officer of Boreal.
TRANSACTION DETAILS
The Transaction, which is an arm's length transaction, is subject to, among other things, receipt of required TSX Venture Exchange ("TSXV") approval, Alberta Gaming, Liquor and Cannabis Commission approval, and other customary conditions of closing, is expected to close in the coming weeks. The consideration (the "Consideration") for the Stores being acquired will be CAD$2.2 Million plus the wholesale value of the inventory, paid in common shares of High Tide ("High Tide Shares") on the closing of the Transaction (the "Closing") on the basis of a deemed price per High Tide Share equal to the volume weighted average price per High Tide Share on TSXV for the 10 consecutive trading days preceding Closing, plus the cash on hand on Closing, paid in cash. The purchase price represents 3.5x annualized Adjusted EBITDA for the three months ended January 31, 2022. Upon the closing of Boreal, as well as the Crossroads and Bud Heaven transactions announced last month, High Tide will have at least 121 stores nationwide and 63 stores in Alberta.
ABOUT HIGH TIDE
High Tide is a leading retail-focused cannabis company with bricks-and-mortar as well as global e-commerce assets. The Company is the largest non-franchised Canadian retailer of recreational cannabis as measured by revenue, with 113 current locations spanning Ontario, Alberta, Manitoba, and Saskatchewan. High Tide was featured in the third annual Report on Business Magazine's ranking of Canada's Top Growing Companies in 2021 and was named as one of the top 10 performing diversified industries stocks in the 2022 TSX Venture 50™. The Company is also North America's first and only cannabis discount club retailer, featuring Canna Cabana, Meta Cannabis Co., and Meta Cannabis Supply Co. banners, with additional locations under development across the country. High Tide's portfolio also includes retail kiosk and smart locker technology – Fastendr™. High Tide has been serving consumers for over a decade through its established e-commerce platforms including Grasscity.com, Smokecartel.com, Dailyhighclub.com, and Dankstop.com and more recently in the hemp-derived CBD space through Nuleafnaturals.com, FABCBD.com, BlessedCBD.co.uk, and BlessedCBD.de, as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide's strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information about High Tide Inc., please visit www.hightideinc.com, its profile page on SEDAR at www.sedar.com, and its profile page on EDGAR at www.sec.gov.
ABOUT BOREAL
Founded in 2019, Boreal Cannabis is built on a foundation of love, passion, and a strong belief in how cannabis can help in the lives of everyday Canadians. With equal commitments to quality and fairness in price, Boreal's mission is to ensure that cannabis culture is accessible and welcoming for all. Whether it is providing insight and education or friendly service, Boreal strongly believes in treating everyone as people, not just customers.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include statements relating to: High Tide completing the Transaction on the terms and within the timelines set out in this news release; High Tide receiving requisite approvals for the Transaction; the anticipated effects of the Transaction on the business and operations of High Tide; Mr. Grover's expectation to announce more retail acquisitions in the future; Mr. Grover's statement with respect to High Tide's goal of reaching 150 stores by the end of calendar 2022; and High Tide's plans to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: that High Tide will have the ability to successfully complete the Transaction (and will have the ability to obtain all requisite approvals) on the terms and within the timelines anticipated by High Tide; High Tide's financial condition and development plans do not change as a result of unforeseen events; there will continue to be a demand, and market opportunity, for High Tide's product offerings; current and future economic conditions will neither affect the business and operations of High Tide nor High Tide's ability to capitalize on anticipated business opportunities), although considered reasonable by management of High Tide at the time of preparation, may prove to be imprecise and result in actual results differing materially from those anticipated, and as such, undue reliance should not be placed on forward-looking statements.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the risks associated with the cannabis and CBD industries in general; the inability of High Tide to close the Transaction; the inability of High Tide to obtain requisite approvals, the inability of High Tide to pursue more retail acquisitions in the future, the inability of High Tide to acquire more stores and to reach 150 stores by the end of calendar 2022, the inability of High Tide to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value.
Forward-looking statements, forward-looking financial information and other metrics presented herein are not intended as guidance or projections for the periods referenced herein or any future periods, and in particular, past performance is not an indicator of future results and the results of High Tide in this press release may not be indicative of, and are not an estimate, forecast or projection of High Tide future results. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect our expectations as of the date hereof, and thus are subject to change thereafter. High Tide disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Factors that could cause anticipated opportunities and actual results to differ materially include, but are not limited to, matters referred to above and elsewhere in High Tide's public filings and material change reports, which are and will be available on SEDAR.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States of America. The securities have not been and will not be registered under the United States Securities Act of 1933 (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons (as defined in the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration is available.
View original content to download multimedia:
SOURCE High Tide Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/hoth-therapeutics-announces-pipeline-presentation-2022-bio-international-convention/
|
Dr. Stefanie Johns, Chief Scientific Officer, will present updates on the Hoth Therapeutics Pipeline, including new proof-of-concept data for HT-ALZ, a novel Alzheimer's Disease Therapeutic
NEW YORK, April 1, 2022 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the company will be presenting at the BIO International Convention taking place June 13 - 16, 2022 in San Diego, California.
Dr. Stefanie Johns, Chief Scientific Officer, will be presenting an overview of the Hoth Therapeutics pipeline, including new proof-of-concept data for HT-ALZ, a novel Alzheimer's disease therapeutic under development.
To learn more about the BIO International Convention or register to attend, visit the conference website. To attend Dr. Johns' session, please check our website for the presentation time closer to the conference date.
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's pipeline development is focused to improve the quality of life for patients suffering from skin toxicities associated with cancer therapy, mast-cell derived cancers and anaphylaxis, Alzheimer's Disease, atopic dermatitis, and other indications. To learn more, please visit https://ir.hoththerapeutics.com/.
Forward-Looking Statement
This press release includes forward-looking statements based upon Hoth's current expectations which may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995 and other federal securities laws, and are subject to substantial risks, uncertainties and assumptions. These statements concern Hoth's business strategies; the timing of regulatory submissions; the ability to obtain and maintain regulatory approval of existing product candidates and any other product candidates Hoth may develop, and the labeling under any approval Hoth may obtain; the timing and costs of clinical trials, the timing and costs of other expenses; market acceptance of Hoth's products; the ultimate impact of the current Coronavirus pandemic, or any other health epidemic, on Hoth's business, its clinical trials, its research programs, healthcare systems or the global economy as a whole; Hoth's intellectual property; Hoth's reliance on third party organizations; Hoth's competitive position; Hoth's industry environment; Hoth's anticipated financial and operating results, including anticipated sources of revenues; Hoth's assumptions regarding the size of the available market, benefits of Hoth's products, product pricing, timing of product launches; management's expectation with respect to future acquisitions; statements regarding Hoth's goals, intentions, plans and expectations, including the introduction of new products and markets; and Hoth's cash needs and financing plans. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. You should not place undue reliance on these forward-looking statements, which include words such as "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" or similar terms, variations of such terms or the negative of those terms. Although Hoth believes that the expectations reflected in the forward-looking statements are reasonable, Hoth cannot guarantee such outcomes. Hoth may not realize its expectations, and its beliefs may not prove correct. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including, without limitation, market conditions and the factors described in the section entitled "Risk Factors" in Hoth's most recent Annual Report on Form 10-K and Hoth's other filings made with the U.S. Securities and Exchange Commission. All such statements speak only as of the date of this press release. Consequently, forward-looking statements should be regarded solely as Hoth's current plans, estimates, and beliefs. Hoth cannot guarantee future results, events, levels of activity, performance or achievements. Hoth does not undertake and specifically declines any obligation to update or revise any forward-looking statements to reflect new information, future events or circumstances or to reflect the occurrences of unanticipated events, except as may be required by applicable law.
Investor Contact:
LR Advisors LLC
Email: investorrelations@hoththerapeutics.com
www.hoththerapeutics.com
Phone: (678) 570-6791
View original content to download multimedia:
SOURCE Hoth Therapeutics, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/hublot-launches-two-nfts-with-takashi-murakami/
|
NYON, Switzerland, April 1, 2022 /PRNewswire/ -- Hublot and Takashi Murakami are pushing back the boundaries of artistic expression by presenting two NFT digital works. These are inspired by the Hublot Classic Fusion Takashi Murakami All Black and the Classic Fusion Takashi Murakami Sapphire Rainbow, the first two watches launched jointly by the Swiss watchmaker and the great Japanese artist in 2021. These two limited editions of 200 and 100 pieces respectively were sold out in just a few days.
"Our collaboration with Takashi Murakami has led us to digital art, a field of expression in which Hublot has become a pioneer on the watchmaking planet. From now on, NFTs will be an integral part of our 'Hublot loves art' artistic world."
RICARDO GUADALUPE
HUBLOT CEO
"Continuing my artistic collaboration with Hublot by using new forms of artistic expression such as NFTs seems to be the natural way to develop our relationship. By looking forward."
TAKASHI MURAKAMI
This new phase in the artistic collaboration developed with Takashi Murakami is in the form of two static NFTs featuring the smiling flower with its mischievous smile, the iconic theme of Murakami's work and his Superflat artistic movement. The first NFT based on the All Black version, is a limited edition of 216, while the second, which will recreate the colours of the highly exclusive Sapphire Rainbow version, will be a limited edition of 108. These NFT digital works are mainly intended for the current owners of these two limited-edition watches, to whom they will be offered under certain conditions explained under (Hublot.com). The current owners of these watches shall actively claim the NFT as from 1st April 2022 and no later than 25th April 2022. If they claim and wish, these watch owners may then receive their free NFT in their eWallet. In May, Hublot will then open a page on a decentralised non-fungible token marketplace, where owners may exchange their NFTs.
The launch of the Hublot Classic Fusion Takashi Murakami NFTs will be supported by a very arty promotional campaign, based on the principles of guerrilla marketing. After being presented at Watches & Wonders, the watchmaking fair in Geneva, posters will go up secretively in London and New York and giant light projections will illuminate iconic buildings.
A limited number of these NFT's will be available to the public in May 2022. Stay tuned!
HUBLOT
Founded in Switzerland in 1980, Hublot is defined by its innovation, which began with the highly original combination of gold and rubber. This "Art of Fusion" stems from the imagination of its visionary Honorary Chairman, Jean-Claude Biver, and has been driven forward by CEO Ricardo Guadalupe since 2012.
The release of the iconic, multi-award-winning Big Bang in 2005 paved the way for new flagship collections (Classic Fusion, Spirit of Big Bang), with complications ranging from the simple to the highly sophisticated, establishing the extraordinary DNA of the Swiss watchmaking house and ensuring its impressive growth.
Keen to preserve its traditional and cutting-edge expertise, and guided by its philosophy to "Be First, Different and Unique", the Swiss watchmaker is consistently ahead of the curve, through its innovations in materials (scratch-resistant Magic Gold, ceramics in vibrant colours, sapphire), and the creation of Manufacture movements (Unico, Meca-10, Tourbillon).
Hublot is fully committed to creating a Haute Horlogerie brand with a visionary future: a future which is fused with the key events of our times (FIFA World Cup™, UEFA Champions League, UEFA EURO™) and the finest ambassadors our era has to offer (Chiara Ferragni, Pelé, Kylian Mbappé, Usain Bolt, Novak Djokovic).
Discover the Hublot universe at our network of boutiques located in key cities across the globe: Geneva, Paris, London, New York, Hong Kong, Dubai, Tokyo, Singapore, Zurich and at HUBLOT.com
Photo - https://mma.prnewswire.com/media/1778657/Hublot_NFT_1.jpg
Photo - https://mma.prnewswire.com/media/1778658/Hublot_NFT_2.jpg
Logo - https://mma.prnewswire.com/media/1765293/Hublot_Logo.jpg
View original content to download multimedia:
SOURCE Hublot SA
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/invitation-autolivs-q1-2022-earnings-call/
|
STOCKHOLM, April 1, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the first quarter 2022 on Friday, April 22, 2022 at 12:00 Central European Time (CEST).
The report will be available at www.autoliv.com
In addition, a teleconference will take place the same day.
Audio replay will be available on www.autoliv.com/investors/reports-presentations-transcripts after the conference until May 27, 2022.
Transcript will be available on www.autoliv.com/investors/reports-presentations-transcripts.
For more information about Autoliv, please visit www.autoliv.com.
Best regards,
Anders Trapp
V.P. Investor Relations
Email contact: anders.trapp@autoliv.com
Phone number: +46 (0)8 587 206 71
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Autoliv
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/john-williams-amp-yo-yo-ma-reunite-upcoming-album-gathering-friends-with-new-york-philharmonic-available-may-20-2022/
|
OUT NOW: THEME FROM SCHINDLER'S LIST
New Album Features Premiere Recording of a Revised Version of Williams' Cello Concerto, Plus New Arrangements of Selections from Schindler's List, Lincoln, and Munich
NEW YORK, April 1, 2022 /PRNewswire/ -- John Williams and Yo-Yo Ma renew their celebrated, decades-long collaboration and friendship with A Gathering of Friends, an all-new recording from Sony Classical set for release on May 20, 2022 and available now for preorder. The album is comprised of two acclaimed concert works the composer wrote for the cellist, plus selections from his film scores for Schindler's List, Lincoln, and Munich. Featuring Williams himself conducting the New York Philharmonic, A Gathering of Friends also includes special appearances by the Spanish guitarist Pablo Sáinz-Villegas and harpist Jessica Zhou. Accompanying today's album announcement is the first track release, Theme from Schindler's List – LISTEN HERE – along with a visualizer featuring John Williams and Yo-Yo Ma discussing the poignant theme – WATCH HERE.
THEME FROM SCHINDLER'S LIST - STREAM / PURCHASE HERE
JOHN WILLIAMS & YO-YO MA ON SCHINDLER'S LIST – WATCH HERE
John Williams and Yo-Yo Ma first met some four decades ago, when the Oscar-winning composer became conductor of the Boston Pops Orchestra and Ma was just beginning his remarkable solo career. Their creative collaboration has extended from the concert hall to the scoring stage to the 2008 inauguration of President Barack Obama, all anchored by an abiding personal connection and mutual regard. From their first encounters, each recognized in the other an understanding that, as Williams simply puts it, "music is our oxygen."
The centerpiece of A Gathering of Friends is the first recording of Williams' newly revised version of his Cello Concerto, a work composed for Ma in 1994 and originally recorded for Sony Classical in 2001. As the four-movement concerto was performed over the last three decades, Williams made significant revisions to the score. Ma noted that the new version incorporates even "bigger changes, structural changes," with a final movement that turns into "one glorious song, spinning and spinning, spinning to the very end."
Also heard on A Gathering of Friends are new arrangements Williams created for Ma of three selections from his Oscar-winning score for Schindler's List and a new arrangement for cello and strings of "With Malice Toward None" from his score for the 2012 film Lincoln. The album concludes with a duo arrangement for Ma and guitarist Pablo Sáinz-Villegas of "Prayer for Peace" from the 2005 film Munich. All three film scores are part of Williams' enduring partnership with director Steven Spielberg.
The other concert work on A Gathering of Friends – Highwood's Ghost – reaffirms the Williams-Ma friendship in the context of the Tanglewood Music Festival and in the spirit of the legendary composer/conductor Leonard Bernstein. Williams composed the work to celebrate the Bernstein centennial at Tanglewood in the summer of 2018, evoking the legend of a ghost said to haunt the Highwood Manor House on the Tanglewood grounds – a ghost that Bernstein memorably encountered. Williams wrote haunting solo roles for Ma and the Boston Symphony Orchestra's principal harp, Jessica Zhou, who reunite for this recording with the New York Philharmonic.
ALBUM ARTWORK (FOR MEDIA USE): DOWNLOAD
YO-YO MA & JOHN WILLIAMS (CREDIT: LAWRENCE SUMULONG) - PUBLICITY PHOTO - DOWNLOAD
JOHN WILLIAMS, YO-YO MA, NEW YORK PHILHARMONIC
A GATHERING OF FRIENDS
Cello Concerto (2021 Revision)
1 I. Theme & Cadenza
2 II. Blues
3 III. Scherzo
4 IV. Song
Three Pieces from Schindler's List
5 I. Theme
6 II. Kraków Ghetto - Winter '41
7 III. Remembrances
8 Highwood's Ghost
9 With Malice Toward None from Lincoln
10 A Prayer for Peace from Munich
Sony Music Masterworks comprises Masterworks, Sony Classical, Milan Records, XXIM Records, and Masterworks Broadway imprints. For email updates and information please visit www.sonymusicmasterworks.com/.
MEDIA CONTACTS:
Larissa Slezak | Jamie Bertel – Sony Music Masterworks
View original content to download multimedia:
SOURCE Sony Music Masterworks
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/lifesaving-lung-cancer-screening-now-recommended-14-million-americans/
|
American Lung Association works to increase access to lifesaving screening for those at high risk for lung cancer
CHICAGO , April 1, 2022 /PRNewswire/ -- Today, the American Lung Association announced a new campaign to raise awareness of lung cancer screening and work to ensure that insurance programs cover the new guidelines expanding screening eligibility across the nation.
In March 2021, the U.S. Preventative Services Task Force (USPSTF) expanded the guidelines for lung cancer screening to include individuals ages 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. Now more than double the number of Black and Brown Americans are eligible for screening. In addition, close to twice as many women are also eligible for screening under the new guidelines.
"More than 14 million people are now eligible for lung cancer screening, so it is critical for these people to have access to this lifesaving screening through Medicare or their private insurance programs," said Harold Wimmer, National President and CEO of the American Lung Association. "The updated lung cancer screening guidelines are also an important step forward in addressing racial disparities associated with lung cancer. Black Americans with lung cancer are less likely to be diagnosed at an early stage, less likely to receive surgical treatment, and less likely to receive any treatment at all compared to white Americans. Many Black and Brown Americans who previously were not eligible for lung cancer screening now meet the updated criteria and it's especially important for them to talk with their healthcare providers about whether they should be screened."
On February 10, the Centers for Medicare and Medicaid Services (CMS) announced that it updated its lung cancer screening eligibility guidelines for people covered by Medicare to be similar to the USPSTF guidelines (CMS guidelines are for ages 50-77 instead of the USPSTF guidelines of ages 50-80). As a result of the Affordable Care Act, most private insurance plans are required to cover lung cancer screening for those now at high risk under the USPSTF criteria for plan years beginning after March 31, 2022.
Lung cancer is the leading cancer killer in America, but there is hope. Lung cancer screening is used to detect lung cancer early when it is more likely to be curable. If lung cancer is caught before it spreads, the likelihood of surviving five years or more improves to 60%. Unfortunately, lung cancer screening is underutilized. Nationally, only 5.7% of people who are eligible have been screened.
Through an unrestricted grant from AstraZeneca, the American Lung Association is working to raise awareness for lung cancer screening, especially for Black and Brown Americans and women. A helpful Q&A document is available at Lung.org/screening.
Media interested in speaking with an expert about lung cancer should contact Jill Dale at the American Lung Association at Media@Lung.org or 312-940-7001.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, a holder of the coveted 4-star rating from Charity Navigator and a Gold-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.
American Lung Association • 55 W. Wacker Drive, Suite 1150 • Chicago, IL 60601
1331 Pennsylvania Ave. NW, Ste. 1425 North • Washington, D.C. 20004
1-800-LUNGUSA (1-800-586-4872) Lung.org
View original content to download multimedia:
SOURCE American Lung Association
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/lilly-presents-updated-data-retevmo-selpercatinib-advanced-ret-fusion-positive-non-small-cell-lung-cancer-nsclc-2022-european-lung-cancer-congress/
|
INDIANAPOLIS, April 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 LIBRETTO-001 trial of Retevmo® (selpercatinib 40 mg & 80 mg capsules) in patients with RET fusion-positive non-small cell lung cancer (NSCLC). Retevmo (marketed as Retsevmo® outside of the U.S.) is a selective and potent RET kinase inhibitor that is approved in multiple countries including the United States for treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive NSCLC, and the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy, or advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate). These data were presented at the European Lung Cancer (ELCC) 2022 (poster 27p).
"The LIBRETTO trial provides the largest set of clinical data for a RET inhibitor and these results continue to demonstrate evidence of meaningful clinical outcomes for patients with metastatic RET fusion-positive NSCLC treated with Retevmo, including those with difficult-to-treat brain metastases," said David Hyman, M.D. chief medical officer, oncology at Lilly. "We are continuing to build on the robust body of evidence supporting Retevmo, including through an ongoing randomized Phase 3 confirmatory study, with a planned readout in 2023."
The updated analysis utilized a June 15, 2021, data cut-off and included 355 patients who were eligible for efficacy analysis, 247 of which were previously treated with at least one line of platinum chemotherapy and 69 of which were treatment-naïve. Patients who were previously treated with at least one line of platinum chemotherapy received a median of two prior treatment regimens (range: 1-15), with 58% having received anti-PD-1 or anti-PD-L1 therapy. Responses are based on independent review committee (IRC) assessment.
Among 247 patients previously treated with platinum chemotherapy, the confirmed objective response rate (ORR) was 61.1% (95% CI: 54.7-67.2%) and among 69 treatment-naïve patients, the confirmed ORR was 84.1% (95% CI: 73.3-91.8%). Twenty-six patients had measurable central nervous system (CNS) metastases at baseline and treatment with Retevmo resulted in a CNS ORR of 84.6%, with 22 patients having a confirmed best response of complete response or partial response.
At a median follow-up of approximately two years in both the treatment-naïve and platinum-chemotherapy pretreated populations, median duration of response (DoR) is estimated at 20.2 (55.2% censoring rate; 20.3 months median duration of follow-up) and 28.6 (60.9% censoring rate; 21.2 months median duration of follow-up) months, respectively and median progression free survival (PFS) is estimated at 22.0 (53.6% censoring rate; 21.9 months median duration of follow-up) and 24.9 (55.9% censoring rate; 24.7 months median duration of follow-up) months, respectively. Of the 26 patients with measurable CNS disease, Retevmo treatment resulted in a median intracranial PFS of 19.4 months. These median estimates remain immature.
Safety among patients in this cohort was consistent with the known safety profile of Retevmo. In the safety population (all NSCLC patients that received at least one dose of Retevmo, N=356), the most common adverse events (AEs in ≥25% of patients) were dry mouth, diarrhea, hypertension, increased ALT/AST, peripheral edema, constipation, rash, headache, and fatigue. Thirty-four patients discontinued due to an adverse event (10%), eleven (3%) of which were deemed related to Retevmo.
A global, randomized, Phase 3 trial is currently recruiting and will compare treatment with Retevmo to the current standard of care in the first-line treatment of advanced or metastatic RET fusion-positive NSCLC.
Retevmo was the first RET inhibitor to receive Accelerated Approval from the U.S. Food and Drug Administration (FDA) in May 2020 and was the first approved by the European Commission in February 2021. Retevmo was approved under the FDA's Accelerated Approval regulations based on the LIBRETTO-001 Phase 1/2 trial's endpoints of objective response rate and duration of response. Continued approval for these indications may be contingent upon verification and description of clinical benefit in confirmatory trials.
The Phase 1/2 LIBRETTO-001 trial is the largest clinical trial of patients with RET-driven cancers treated with a RET inhibitor. The trial, which spans 16 countries and 89 sites, included a dose escalation phase (Phase 1) and a dose expansion phase (Phase 2). The primary objective was to determine ORR by independent review committee (IRC) and key secondary objectives included DoR, CNS ORR & DOR, safety and PFS.
LIBRETTO-001 continues to enroll patients with RET-altered tumors beyond lung cancer.
Retevmo (selpercatinib, formerly known as LOXO-292) (pronounced ret- tév-mo) is a selective and potent RET kinase inhibitor. Retevmo may affect both tumor cells and healthy cells, which can result in side effects. RET-driver alterations are predominantly mutually exclusive from other oncogenic drivers. Retevmo is an U.S. FDA-approved oral prescription medicine, 120 mg or 160 mg dependent on weight (<50 kg or ≥50 kg, respectively), taken twice daily until disease progression or unacceptable toxicity. Continued approval may be contingent upon verification and description of clinical benefit in confirmatory trials.
IMPORTANT SAFETY INFORMATION FOR RETEVMO® (selpercatinib)
Hepatotoxicity: Serious hepatic adverse reactions occurred in 2.6% of patients treated with Retevmo. Increased aspartate aminotransferase (AST) occurred in 51% of patients, including Grade 3 or 4 events in 8% and increased alanine aminotransferase (ALT) occurred in 45% of patients, including Grade 3 or 4 events in 9%. The median time to first onset for increased AST was 4.1 weeks (range: 5 days to 2 years) and increased ALT was 4.1 weeks (range: 6 days to 1.5 years). Monitor ALT and AST prior to initiating Retevmo, every 2 weeks during the first 3 months, then monthly thereafter and as clinically indicated. Withhold, reduce dose or permanently discontinue Retevmo based on the severity.
Hypertension occurred in 35% of patients, including Grade 3 hypertension in 17% and Grade 4 in one (0.1%) patient. Overall, 4.6% had their dose interrupted and 1.3% had their dose reduced for hypertension. Treatment-emergent hypertension was most commonly managed with anti-hypertension medications. Do not initiate Retevmo in patients with uncontrolled hypertension. Optimize blood pressure prior to initiating Retevmo. Monitor blood pressure after 1 week, at least monthly thereafter, and as clinically indicated. Initiate or adjust anti-hypertensive therapy as appropriate. Withhold, reduce dose, or permanently discontinue Retevmo based on the severity.
Retevmo can cause concentration-dependent QT interval prolongation. An increase in QTcF interval to >500 ms was measured in 6% of patients and an increase in the QTcF interval of at least 60 ms over baseline was measured in 15% of patients. Retevmo has not been studied in patients with clinically significant active cardiovascular disease or recent myocardial infarction. Monitor patients who are at significant risk of developing QTc prolongation, including patients with known long QT syndromes, clinically significant bradyarrhythmias, and severe or uncontrolled heart failure. Assess QT interval, electrolytes and TSH at baseline and periodically during treatment, adjusting frequency based upon risk factors including diarrhea. Correct hypokalemia, hypomagnesemia and hypocalcemia prior to initiating Retevmo and during treatment. Monitor the QT interval more frequently when Retevmo is concomitantly administered with strong and moderate CYP3A inhibitors or drugs known to prolong QTc interval. Withhold and dose reduce or permanently discontinue Retevmo based on the severity.
Serious, including fatal, hemorrhagic events can occur with Retevmo. Grade ≥3 hemorrhagic events occurred in 2.3% of patients treated with Retevmo including 3 (0.4%) patients with fatal hemorrhagic events, including one case each of cerebral hemorrhage, tracheostomy site hemorrhage, and hemoptysis. Permanently discontinue Retevmo in patients with severe or life-threatening hemorrhage.
Hypersensitivity occurred in 4.3% of patients receiving Retevmo, including Grade 3 hypersensitivity in 1.6%. The median time to onset was 1.7 weeks (range 6 days to 1.5 years). Signs and symptoms of hypersensitivity included fever, rash and arthralgias or myalgias with concurrent decreased platelets or transaminitis. If hypersensitivity occurs, withhold Retevmo and begin corticosteroids at a dose of 1 mg/kg prednisone (or equivalent). Upon resolution of the event, resume Retevmo at a reduced dose and increase the dose of Retevmo by 1 dose level each week as tolerated until reaching the dose taken prior to onset of hypersensitivity. Continue steroids until patient reaches target dose and then taper. Permanently discontinue Retevmo for recurrent hypersensitivity.
Tumor lysis syndrome (TLS) occurred in 1% of patients with medullary thyroid carcinoma receiving Retevmo. Patients may be at risk of TLS if they have rapidly growing tumors, a high tumor burden, renal dysfunction, or dehydration. Closely monitor patients at risk, consider appropriate prophylaxis including hydration, and treat as clinically indicated.
Impaired wound healing can occur in patients who receive drugs that inhibit the vascular endothelial growth factor (VEGF) signaling pathway. Therefore, Retevmo has the potential to adversely affect wound healing. Withhold Retevmo for at least 7 days prior to elective surgery. Do not administer for at least 2 weeks following major surgery and until adequate wound healing. The safety of resumption of Retevmo after resolution of wound healing complications has not been established.
Based on data from animal reproduction studies and its mechanism of action, Retevmo can cause fetal harm when administered to a pregnant woman. Administration of selpercatinib to pregnant rats during organogenesis at maternal exposures that were approximately equal to those observed at the recommended human dose of 160 mg twice daily resulted in embryolethality and malformations. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential and males with female partners of reproductive potential to use effective contraception during treatment with Retevmo and for at least 1 week after the final dose. There are no data on the presence of selpercatinib or its metabolites in human milk or on their effects on the breastfed child or on milk production. Because of the potential for serious adverse reactions in breastfed children, advise women not to breastfeed during treatment with Retevmo and for 1 week after the final dose.
Severe adverse reactions (Grade 3-4) occurring in ≥15% of patients who received Retevmo in LIBRETTO-001, were hypertension (18%), prolonged QT interval (4%), diarrhea (3.4%), dyspnea (2.3%), fatigue (2%), abdominal pain (1.9%), hemorrhage (1.9%), headache (1.4%), rash (0.7%), constipation (0.6%), nausea (0.6%), vomiting (0.3%), and edema (0.3%).
Serious adverse reactions occurred in 33% of patients who received Retevmo. The most frequently reported serious adverse reaction (in ≥ 2% of patients) was pneumonia.
Fatal adverse reactions occurred in 3% of patients; fatal adverse reactions which occurred in >1 patient included sepsis (n=3), cardiac arrest (n=3) and respiratory failure (n=3).
Common adverse reactions (all grades) occurring in ≥15% of patients who received Retevmo in LIBRETTO-001, were dry mouth (39%), diarrhea (37%), hypertension (35%), fatigue (35%), edema (35%), rash (27%), constipation (25%), nausea (23%), abdominal pain (23%), headache (23%), cough (18%), prolonged QT interval (17%), dyspnea (16%), vomiting (15%), and hemorrhage (15%).
Laboratory abnormalities (all grades; Grade 3-4) ≥20% worsening from baseline in patients who received Retevmo in LIBRETTO-001, were AST increased (51%; 8%), ALT increased (45%; 9%), increased glucose (44%; 2.2%), decreased leukocytes (43%; 1.6%), decreased albumin (42%; 0.7%), decreased calcium (41%; 3.8%), increased creatinine (37%; 1.0%), increased alkaline phosphatase (36%; 2.3%), decreased platelets (33%; 2.7%), increased total cholesterol (31%; 0.1%), decreased sodium (27%; 7%), decreased magnesium (24%; 0.6%), increased potassium (24%; 1.2%), increased bilirubin (23%; 2.0%), and decreased glucose (22%; 0.7%).
Concomitant use of acid-reducing agents decreases selpercatinib plasma concentrations which may reduce Retevmo anti-tumor activity. Avoid concomitant use of proton-pump inhibitors (PPIs), histamine-2 (H2) receptor antagonists, and locally-acting antacids with Retevmo. If coadministration cannot be avoided, take Retevmo with food (with a PPI) or modify its administration time (with a H2 receptor antagonist or a locally-acting antacid).
Concomitant use of strong and moderate CYP3A inhibitors increases selpercatinib plasma concentrations which may increase the risk of Retevmo adverse reactions including QTc interval prolongation. Avoid concomitant use of strong and moderate CYP3A inhibitors with Retevmo. If concomitant use of a strong or moderate CYP3A inhibitor cannot be avoided, reduce the Retevmo dosage as recommended and monitor the QT interval with ECGs more frequently.
Concomitant use of strong and moderate CYP3A inducers decreases selpercatinib plasma concentrations which may reduce Retevmo anti-tumor activity. Avoid coadministration of Retevmo with strong and moderate CYP3A inducers.
Concomitant use of Retevmo with CYP2C8 and CYP3A substrates increases their plasma concentrations which may increase the risk of adverse reactions related to these substrates. Avoid coadministration of Retevmo with CYP2C8 and CYP3A substrates where minimal concentration changes may lead to increased adverse reactions. If coadministration cannot be avoided, follow recommendations for CYP2C8 and CYP3A substrates provided in their approved product labeling.
The safety and effectiveness of Retevmo have not been established in pediatric patients less than 12 years of age. The safety and effectiveness of Retevmo have been established in pediatric patients aged 12 years and older for medullary thyroid cancer (MTC) who require systemic therapy and for advanced RET fusion-positive thyroid cancer who require systemic therapy and are radioactive iodine-refractory (if radioactive iodine is appropriate). Use of Retevmo for these indications is supported by evidence from adequate and well-controlled studies in adults with additional pharmacokinetic and safety data in pediatric patients aged 12 years and older. Monitor open growth plates in adolescent patients. Consider interrupting or discontinuing Retevmo if abnormalities occur.
No dosage modification is recommended for patients with mild to severe renal impairment (estimated Glomerular Filtration Rate [eGFR] ≥15 to 89 mL/min, estimated by Modification of Diet in Renal Disease [MDRD] equation). A recommended dosage has not been established for patients with end-stage renal disease.
Reduce the dose when administering Retevmo to patients with severe hepatic impairment (total bilirubin greater than 3 to 10 times upper limit of normal [ULN] and any AST). No dosage modification is recommended for patients with mild or moderate hepatic impairment. Monitor for Retevmo-related adverse reactions in patients with hepatic impairment.
Please see full Prescribing Information for Retevmo.
SE HCP ISI All_25MAR2021
Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram, Twitter and LinkedIn. P-LLY
© Lilly USA, LLC 2022. ALL RIGHTS RESERVED.
Retevmo® and Retsevmo® are trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates.
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about Retevmo® (selpercatinib) for the treatment of metastatic RET fusion-positive NSCLC, advanced or metastatic RET mutation-positive MTC, and advanced or metastatic RET fusion-positive thyroid cancer, and as a potential treatment for other indications, and reflects Lilly's current beliefs and expectations. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization. Among other things, there is no guarantee that future study results will be consistent with study findings to date or that Retevmo will receive additional regulatory approvals. For further discussion of these and other risks and uncertainties, see Lilly's Form 10-K and Form 10-Q filings with the United States Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this release.
View original content to download multimedia:
SOURCE Eli Lilly and Company
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/malwarebytes-announces-results-fourth-round-mitre-engenuity-attampck-enterprise-evaluations/
|
ATT&CK Evaluations Emulate Wizard Spider and Sandworm Threat Groups
SANTA CLARA, Calif., April 1, 2022 /PRNewswire/ -- MalwarebytesTM, a global leader in real-time cyberprotection, today announced the results of its completed MITRE Engenuity ATT&CK® Evaluation for Endpoint Detection and Response. This round of independent ATT&CK Evaluations for enterprise cybersecurity solutions emulated the Wizard Spider and Sandworm threat groups, highlighting results across 30 vendors.
MITRE ATT&CK Evaluations prioritize threats that present unique impacts to businesses and governments worldwide. Through the lens of the ATT&CK knowledge base, Evals focused on two threat actors, Wizard Spider and Sandworm. Wizard Spider is a financially motivated criminal group that has been conducting ransomware campaigns since August 2018 against a variety of organizations, ranging from major corporations to hospitals. Sandworm is a destructive Russian threat group that is known for carrying out notable attacks such as the 2015 and 2016 targeting of Ukrainian electrical companies and 2017's NotPetya attacks. These two threat actors were chosen based on their complexity, relevancy to the market, and how well MITRE Engenuity's staff can fittingly emulate the adversary.
"As cybersecurity threats increase in both number and sophistication, it is essential for organizations to strengthen their prevention and response capabilities," said Barry Mainz, Malwarebytes' Chief Operating Officer. "Malwarebytes' Endpoint Detection and Response platform includes the powerful tools that individuals and enterprises alike need in order to ensure an effective proactive security posture. The results of our ATT&CK evaluations are a testament to our leadership and continued growth in this space."
"This latest round indicates significant product growth from our vendor participants. We are seeing greater emphasis in threat informed defense capabilities, which in turn has developed the infosec community's emphasis on prioritizing the ATT&CK Framework," said Ashwin Radhakrishnan, acting General Manager of ATT&CK Evaluations at MITRE Engenuity.
The Evals team chose to emulate two threat groups that abuse the Data Encrypted For Impact (T1486) technique. In Wizard Spider's case, they have leveraged data encryption for ransomware, including the widely known Ryuk malware (S0446). Sandworm, on the other hand, leveraged encryption for the destruction of data, perhaps most notably with their NotPetya malware (S0368) that disguised itself as ransomware. While the common thread to this year's evaluations is "Data Encrypted for Impact," both groups have substantial reporting on a broad range of post-exploitation tradecraft.
With a lightweight agent that can be set up in less than an hour, Malwarebytes' Endpoint Detection and Response (EDR) solution simplifies prevention, detection, isolation, investigation, and remediation of threats in a matter of minutes. The cloud-based platform includes a comprehensive suite of tools that modern enterprises need to protect their organizations, including brute force protection, policies to block USB devices and enforce data encryption remotely, continuous monitoring, and visibility into Windows and macOS devices. Malwarebytes' EDR platform also offers automated functions that accelerate threat detection and response, enabling customers to quickly isolate and investigate suspicious activity, remediate, and implement 72-hour ransomware rollback without disrupting end-user productivity.
For full results and more information about the evaluations, please visit: https://attackevals.mitre-engenuity.org/enterprise/wizard-spider-and-sandworm/.
About MITRE Engenuity
MITRE Engenuity, a subsidiary of MITRE, is a tech foundation for the public good. MITRE's mission-driven teams are dedicated to solving problems for a safer world. Through our public-private partnerships and federally funded R&D centers, we work across government and in partnership with industry to tackle challenges to the safety, stability, and well-being of our nation.
MITRE Engenuity brings MITRE's deep technical know-how and systems thinking to the private sector to solve complex challenges that government alone cannot solve. MITRE Engenuity catalyzes the collective R&D strength of the broader U.S. federal government, academia, and private sector to tackle national and global challenges, such as protecting critical infrastructure, creating a resilient semiconductor ecosystem, building a genomics center for public good, accelerating use case innovation in 5G, and democratizing threat-informed cyber defense.
To read more about the latest threats and cyberprotection strategies, visit our newsroom, or follow us on Facebook, Instagram, LinkedIn, TikTok, and Twitter.
About Malwarebytes
Malwarebytes believes that when people and organizations are free from threats, they are free to thrive. Founded in 2008, Malwarebytes CEO Marcin Kleczynski had one mission: to rid the world of malware. Today, that mission has expanded to provide cyberprotection for every one. Malwarebytes provides consumers and organizations with device protection, privacy, and prevention through effective, intuitive, and inclusive solutions in the home, on-the-go, at work, or on campus. A world-class team of threat researchers and security experts enable Malwarebytes to protect millions of customers and combat existing and never-before-seen threats using artificial intelligence and machine learning to catch new threats rapidly. With threat hunters and innovators across the world, the company is headquartered in California with offices in Europe and Asia. For more information, visit https://www.malwarebytes.com/.
MEDIA RELATIONS CONTACTS:
Lisette Rauwendaal
Director, Corporate Communications & Social Impact
Malwarebytes
press@malwarebytes.com
View original content to download multimedia:
SOURCE Malwarebytes
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/medscape-american-college-cardiology-launch-latin-america-center-cardiovascular-health-promotion/
|
New collaboration to deliver information and resources targeted to the needs of physicians throughout Latin America
NEW YORK, April 1, 2022 /PRNewswire/ -- Medscape and the American College of Cardiology (ACC) today announced the launch of the Latin America Center for Cardiovascular Health Promotion (Spanish and Portuguese), a new collaboration that will deliver trusted scientific information and resources on cardiovascular disease, specifically targeted to the patient care needs of physicians throughout Latin America.
Leveraging the ACC's global leadership in cardiovascular care with that of Medscape, the leading global news and information platform for physicians, the new initiative will provide updates and insights, in both Spanish and Portuguese, on the latest research and emerging clinical trends in heart failure, atrial fibrillation, anticoagulation, thromboembolism, and lipid management -- all from the perspective of regional experts and thought-leaders.
The Center will also feature conference coverage and commentary, expert interviews, quizzes, case studies, and other point-of-care tools.
"The ACC is mission-driven, aiming to transform cardiovascular care and improve heart health on a global scale," Cesar J. Herrera, MD, FACC, Latin America Representative, ACC Assembly of International Governors Steering Committee said. "Through this collaboration, we're able to reach clinicians in Latin America with the latest cardiovascular research, news, and resources they need in order to provide the highest quality care to patients and save lives."
"Medscape shares ACC's commitment to giving physicians the resources and tools they need to improve patient care, and we are excited to be leveraging our reach in Latin America through this collaboration," said Bernardo Schubsky, MD, MPH, Vice President of Content, Medscape Global. "Together with the leadership of the ACC and its Latin American chapters, we can deepen our contribution to the region's medical community and support them in navigating the challenges of cardiovascular medicine."
Medscape and its affiliate network of platforms currently reach 5 million physicians worldwide, with 750,000 in Latin America.
The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes. As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health. The ACC bestows credentials upon cardiovascular professionals who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. The College also provides professional medical education, disseminates cardiovascular research through its world-renowned JACC Journals, operates national registries to measure and improve care, and offers cardiovascular accreditation to hospitals and institutions. For more, visit acc.org.
Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care doctors, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programs for doctors, nurses, and other healthcare professionals
View original content to download multimedia:
SOURCE Medscape
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/morrell-group-obtains-new-midwest-territories/
|
Published: Apr. 1, 2022 at 6:01 AM CDT|Updated: 1 hour ago
Bosch Rexroth Appoints Company as an Exclusive Partner of Midwest Areas
AUBURN HILLS, Mich., April 1, 2022/PRNewswire/ -- The latest threshold has been surpassed in the partnership between Morrell Group and Bosch Rexroth. Effective today, Morrell will welcome new companies across the Midwest after Bosch Rexroth appointed them as their exclusive partner in the states of Minnesota, Iowa, and the Dakotas.
Morrell Group serves as an Engineering Partner, Systems Integrator, and Value-Added Distributor (ESV) to all companies with which they work. Within the new territories, their ESV strategy will be implemented in the area of mobile hydraulics and controls, where the focus will be on the off-highway sector. Morrell will provide industry-leading prowess and resources to supply integrated solutions for propulsion, actuation, optimization, and electrification technologies.
The appointment is just the latest development in the 45-year history between the two companies. This may come as no surprise when looking at the steady stream of innovations and cutting-edge solutions Morrell continues to bring to the industry. However, much of the partnership's longevity stems from the exceptional level of service and support Morrell provides.
On Wednesday, March 23, Morrell was recognized by Bosch Rexroth and awarded the "Certified Excellence Sales Partner" Status, which Morrell received certifications in four separate categories, one of which being Mobile Hydraulics. Morrell Group became one of the first U.S.-based companies to receive the distinction.
"Being awarded the status was an honor, especially from such an admirable industry leader and partner," said Mark Garrett, President, and Co-Owner of Morrell Group. "With the new territories, we've been provided an opportunity to showcase exactly why we received such a distinguishment. It's time to execute."
Morrell Group has doubled its midwestern presence as the new territories join Michigan, Ohio, Indiana, and Illinois, with Ontario neighboring the region.
"When you look at some of the companies we get to work with, their engineering is truly amazing and inspiring," shared Mark Majewski, Co-Owner and Executive Vice President. "Connecting with these companies is what it's all about. Providing them with a dedicated and talented team that understands their industry and needs is how we're best able to offer solutions."
Several years ago, Morrell Group made a massive shift, dividing the company into two silos aligned with the Industrial and Mobile Industries. Majewski added, "Companies want partners who understand what they do and add value to their present and future endeavors. In our position, confining ourselves to acting only as a distributor simply wasn't enough. Collaboration is the way of the future."
About Morrell Group
For more than 40 years, Morrell Group has been a leading Engineering Partner, Systems Integrator, and Value-Added Distributor of advanced motion control solutions for industrial and mobile applications.
Using industry-leading components, our application specialists leverage product and industry knowledge to provide custom-engineered solutions for automation, controls, tightening, conveyors, pneumatic, electrical, hydraulic, and lubrication applications. Morrell offers real-time managed inventory, quick ship programs, 24/7 customer support, engineering, prototyping, sizing, print review, and turnkey solutions. The company has eight locations servicing eight states throughout the Midwest — Michigan, Ohio, Indiana, Illinois, Iowa, Minnesota, and the Dakotas — as well as Ontario, Canada.
The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/motion-intelligence-speaks-out-during-distracted-driving-awareness-month/
|
COLORADO SPRINGS, Colo., April 1, 2022 /PRNewswire/ -- Motion Intelligence, in recognition of Distracted Driving Awareness Month starting today, is strengthening its mission to raise awareness of distracted driving. We are proud of the work being done by several organizations, including EndDD, the National Highway Safety Council, Together for Safer Roads, the National Safety Council, and others working to raise awareness of the severity of this issue and the ways it can be prevented.
The rate of traffic accidents, injuries, and even fatalities attributed to smartphone distractions continues to rise. As shared by EndDD, "A pedestrian is killed every two hours and injured every 7 minutes somewhere in the U.S. due to distracted driving."
At Motion Intelligence, we recognize the root cause of distracted driving caused by mobile devices is technology addiction. The dopamine rush we feel when we hear a "ping" on our devices prevents us from willfully putting our phones down while behind the wheel. That's why our company is committed to developing technology that supports fleet drivers — those on the road day-in and day-out — in adopting safer driving behaviors with our Evvy App distraction-prevention software.
"The responsibility for distracted driving is a burden we all share to improve the safety of our roads for everyone," says Sue Spradley, Motion Intelligence CEO. "We believe we can use technology to make technology distractions preventable, solving the problem before it occurs."
Motion Intelligence is bringing the message about the importance of investing in technology to help drivers have safer relationships with their smartphones and other mobile devices to events throughout Distracted Driving Awareness Month. You can learn more about fleet safety and our unique solution at the upcoming Idelic Fleet Safety & Operations Conference on April 4-6, where James Curnel will be presenting on ways to effectively manage and reduce distracted driving incidents, and the National Private Truck Council Conference April 9-11.
About Motion Intelligence
Motion Intelligence, Inc., provides software solutions for distracted driving prevention. Motion Intelligence's flagship products, the Evvy App and the MotionIQ Evvy Manager Dashboard, were designed to be affordable, effective solutions for fleets of all sizes. Learn more: www.motionintelligence.com.
Contact:
Laura Johnston
ljohnston@motionintelligence.com
View original content to download multimedia:
SOURCE Motion Intelligence
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/mp-shareholder-alert-jakubowitz-law-reminds-mp-materials-shareholders-lead-plaintiff-deadline-april-25-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of MP Materials Corp. f/k/a Fortress Value Acquisition Corp. (NYSE: MP).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/mp-materials-corp-f-k-a-fortress-value-acquisition-corp-loss-submission-form/?id=25390&from=4
The lawsuit seeks to recover losses for shareholders who purchased MP Materials between May 1, 2020 and February 2, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until April 25, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, MP Materials Corp. f/k/a Fortress Value Acquisition Corp. issued materially false and/or misleading statements and/or failed to disclose that: (i) Fortress Value Acquisition Corp. ("FVAC") had overstated its due diligence efforts and expertise with respect to identifying target companies to acquire; (ii) FVAC performed inadequate due diligence into Legacy MP Materials prior to the business combination, or else ignored significant red flags regarding, inter alia, Legacy MP Materials' management, compliance policies, and Mountain Pass's profitability; (iii) as a result, the Company's future business and financial prospects post-business combination were overstated; (iv) MP Materials engaged in an abusive transfer price manipulation scheme with a related party in the People's Republic of China to artificially inflate the Company's profits; (v) MP Materials' ore at the Mountain Pass Rare Earth Mine and Processing Facility was not economically viable to harvest for rare earth metals; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/natera-announces-publication-highlighting-importance-testing-total-cfdna-when-monitoring-kidney-transplant-patients-with-covid-19-infection/
|
AUSTIN, Texas, April 1, 2022 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, announced the results of a study1 to examine both total and donor-derived cell-free DNA (dd-cfDNA) in kidney transplant recipients hospitalized with COVID-19 using its Prospera™ test to assess disease severity and risk of rejection.
The study, published in Transplantation Proceedings, used the Prospera test to examine the relationship between total cfDNA and dd-cfDNA fraction when monitoring for rejection. The results indicate that high levels of total cfDNA, as can occur due to COVID-19 infection, result in a lower dd-cfDNA donor fraction and could inadvertently mask rejection when using donor fraction alone. The Prospera test identified two patients in the cohort with elevated total cfDNA and biopsy-proven rejection that would have otherwise gone undetected by dd-cfDNA donor fraction alone.
"COVID-19 has presented unique challenges in monitoring and treating kidney transplant recipients and it's clear that infection is one of the many factors that can impact cfDNA levels - and therefore a dd-cfDNA fraction," said José Otto Reusing Jr., principal investigator and lead author of the study, at the University of São Paulo School of Medicine in Brazil. "The ability to test total cfDNA with Prospera is critical to establishing a more complete and thorough understanding of graft health with these patients."
Natera incorporated total cfDNA into the Prospera test in 2021, based on previous studies2-4 that showed combining analysis of dd-cfDNA and total cfDNA improved performance when evaluating transplant rejection.
The Prospera test leverages Natera's core single-nucleotide (SNP)-based massively multiplexed PCR (mmPCR) technology to identify allograft rejection non-invasively and with high precision and accuracy, without the need for prior donor or recipient genotyping. The test works by measuring the fraction of donor-derived cell-free DNA (dd-cfDNA,) and the total cfDNA in the recipient's blood. It may be used by physicians considering the diagnosis of active rejection, helping to rule in or out this condition when evaluating the need for diagnostic testing or the results of an invasive biopsy. The Prospera test has been clinically and analytically validated for performance regardless of donor relatedness, rejection type, and clinical presentation. It has been developed and its performance characteristics determined by Natera, the CLIA-certified laboratory performing the test. The test has not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified.
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier, more targeted interventions that help lead to longer, healthier lives. Natera's tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.
All statements other than statements of historical facts contained in this press release are forward-looking statements and are not a representation that Natera's plans, estimates, or expectations will be achieved. These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including with respect to our efforts to develop and commercialize new product offerings, our ability to successfully increase demand for and grow revenues for our product offerings, whether the results of clinical or other studies will support the use of our product offerings, our expectations of the reliability, accuracy and performance of our screening tests, or of the benefits of our screening tests and product offerings to patients, providers and payers. Additional risks and uncertainties are discussed in greater detail in "Risk Factors" in Natera's recent filings on Forms 10-K and 10-Q and in other filings Natera makes with the SEC from time to time. These documents are available at www.natera.com/investors and www.sec.gov.
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., 720-318-4080 pr@natera.com
- Reusing Jr JO, Yoo J, Desai A, et al. Association between total cell free DNA and SARS-CoV-2 in Kidney Transplant Patients: A Preliminary Study. Transplant. Proc. 2022. ISSN 0041-1345.
- Halloran, et al. Manuscript in preparation, anticipated publication in 2022.
- Bunnapradist S, Homkrailas P, Ahmed E, Fehringer G, Billings PR, Tabriziani H. Using both Fraction and Quantity of Donor-Derived Cell-Free DNA to Detect Kidney Allograft Rejection. J Am Soc Nephrol. 2021;32(10):2439-2441.
- Bunnapradist S, Datta N, Schaenman J, et al. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection. Transplant Direct. 2021;7(5):e691.
View original content to download multimedia:
SOURCE Natera, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/necessity-retail-reit-announces-common-stock-dividend-second-quarter-2022/
|
NEW YORK, April 1, 2022 /PRNewswire/ -- The Necessity Retail REIT, Inc. (Nasdaq: RTL/ RTLPP / RTLPO) ("RTL") announced today that it intends to continue to pay dividends on its shares of Class A common stock at an annualized rate of $0.85 per share or $0.2125 per share on a quarterly basis. RTL anticipates paying dividends authorized by its board of directors on its shares of Class A common stock on a quarterly basis in arrears on the 15th day of the first month following the end of each fiscal quarter (unless otherwise specified) to Class A common stock holders of record on the record date for such payment.
Accordingly, RTL declared a dividend of $0.2125 per share of Class A common stock payable on April 18, 2022 to Class A common stock holders of record at the close of business on April 11, 2022.
The Necessity Retail REIT, Inc. (Nasdaq: RTL) is a publicly traded real estate investment trust listed on the Nasdaq focused on acquiring and managing a diversified portfolio of primarily service-oriented and traditional retail and distribution related commercial real estate properties in the U.S. Additional information about RTL can be found on its website at www.necessityretailreit.com.
The statements in this press release that are not historical facts may be forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause the outcome to be materially different. In addition, words such as "anticipates," "believes," "expects," "estimates," "projects," "plans," "intends," "may," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of RTL's control, which could cause actual results to differ materially from the results contemplated by the forward-looking statements. These risks and uncertainties include the potential adverse effects of the ongoing global COVID-19 pandemic, including actions taken to contain or treat COVID-19, on RTL, RTL's tenants and the global economy and financial markets and that the information about rent collections may not be indicative of any future period, as well as those set forth in the Risk Factors section of RTL's most recent Annual Report on Form 10-K for the year ended December 31, 2021 filed on February 24, 2022, and all other filings with the SEC after that date, as such risks, uncertainties and other important factors may be updated from time to time in RTL's subsequent reports. Further, forward-looking statements speak only as of the date they are made, and RTL undertakes no obligation to update or revise any forward-looking statement to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, unless required by law.
Contacts:
Investor Relations
ir@rtlreit.com
(866) 902-0063
View original content to download multimedia:
SOURCE The Necessity Retail REIT, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/neurobo-pharmaceuticals-reports-full-year-2021-financial-results/
|
BOSTON, April 1, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year ended December 31, 2021.
Management Commentary
"Since I joined NeuroBo in November of 2021, we have had the opportunity to significantly strengthen our team including the addition of highly accomplished executive, D. Gordon Strickland, to our Board of Directors in January and, most recently, with the appointment of Danamarie Belpulsi, M.D. to our Scientific Advisory Board. Their collective experience will be invaluable as we continue to move programs through the clinic," stated Gil Price, M.D. President and Chief Executive Officer of NeuroBo.
"Also of note, following a positive recommendation from the independent data safety monitoring board, in the fourth quarter of last year, we continue to advance our Phase 2/3 clinical trial of lead drug candidate, ANA001, a proprietary oral niclosamide formulation, in development as a treatment for patients with moderate to severe COVID-19 and expect to complete the phase 2 portion of the trial in the third quarter of this year. We look forward to providing further updates on our clinical progress in the near future."
Management also noted that, subsequent to the October 2021 registered direct offering, the company expects that its cash will be adequate to fund operations into the fourth quarter of 2022.
Full Year 2021 Financial and Operating Results
- Research and Development (R&D) Expenses were $6.5 million for the year ended December 31, 2021 as compared to $4.5 million for the year ended December 31, 2020. The $2.0 million increase during the year ended December 31, 2021 was primarily attributed to increased clinical trial and drug manufacturing of $1.9 million and $0.4 million, respectively, for the development of ANA001, offset by a reduction of preclinical costs of $0.3 million.
- General and Administrative Expenses were $8.8 million for the year ended December 31, 2021 compared to $7.8 million for the year ended December 31, 2020. The increase of $1.0 million was primarily due to increased personnel costs of $0.6 million, increased costs associated with operating as a public company of $0.3 million, and increased insurance costs of $0.4 million, offset by reductions of facilities and professional fees costs of $0.3 million and $0.1 million, respectively, when compared to the comparable prior year.
- Net Loss for the year ended December 31, 2021 was $15.3 million, or $0.66 per basic and diluted share, based on 23,143,792 weighted average common shares outstanding, compared with a net loss of $29.7 million, or $1.83 per basic and diluted share, based on 16,217,339 weighted average common shares outstanding for the year ended December 31, 2020.
- Cash and Cash Equivalents were $16.4 million as of December 31, 2021, compared with $10.1 million as of December 31, 2020. Operating at its current level of clinical activity, NeuroBo expects its cash position will be adequate to fund operations into the fourth quarter of 2022.
About NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies.
For more information visit: https://www.neurobopharma.com.
Forward Looking Statements
Any statements in this press release that are not statements of historical fact constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding NeuroBo's obtaining financing for development of its products and conducting clinical trials and the nature of such financing, the development of NeuroBo's product candidates, the ability to obtain regulatory and other approvals for and commence new clinical trials and the therapeutic potential, timing and nature of clinical trials and potential regulatory approval of NeuroBo's clinical programs and pipeline. Forward-looking statements are usually identified by the use of words, such as "believes," "anticipates," "expects," "intends," "plans," "may," "potential," "will," "could" and similar expressions. Actual results may differ materially from those indicated by forward-looking statements as a result of various important factors and risks. These factors, risks and uncertainties include, but are not limited to: recent changes in NeuroBo's management; the ability to obtain approval and initiate new clinical trials, including the Phase 2/3 trial as a post-exposure prophylaxis for the prevention of COVID-19; the clinical utility, potential benefits and market acceptance of NeuroBo's product candidates, including ANA001 and Gemcabene; the effect of future milestone payments and royalties on the results of operations and financial position of NeuroBo; the occurrence of health epidemics or contagious diseases, such as COVID-19, and potential effects on NeuroBo's business, clinical trial sites, supply chain and manufacturing facilities; the effects of the ongoing war in Ukraine, particularly as it relates to NeuroBo's clinical trials; NeuroBo's ability to continue as a going concern; the timing of completion of NeuroBo's clinical trials, including with respect to ANA001; the timing of the availability of data from NeuroBo's clinical trials, including with respect to ANA001; NeuroBo's ability to successfully collaborate with existing collaborators or enter into new collaborations and to fulfill its obligations under any such collaboration agreements; the impact of government laws and regulations; NeuroBo's ability to protect its intellectual property position; and NeuroBo's need for additional financing and the nature of such financing to fulfill its stated goals. Please refer to NeuroBo's most recent annual report on Form 10-K, as well as NeuroBo's subsequent filings on Form 10-Q and Form 8-K, which are available on the SEC's website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this press release. In addition, the forward-looking statements included in this press release represent NeuroBo's views as of the date hereof. NeuroBo anticipates that subsequent events and developments will cause its views to change. However, while NeuroBo may elect to update these forward-looking statements at some point in the future, NeuroBo specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing NeuroBo's views as of any date subsequent to the date hereof.
Contact:
Rx Communications Group
Michael Miller
+1-917-633-6086
mmiller@rxir.com
- Tables to Follow -
View original content:
SOURCE NeuroBo Pharmaceuticals, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/northstar-announces-project-economics-its-calgary-scale-up-facility-based-front-end-engineering-design/
|
Highlights
- $7.6 Million in Potential Annual Revenue Per Facility (1)
- $4.9 Million in Potential Annual Gross Profit Per Facility (65% Gross Margin) (1)
- $4.0 Million in Potential Annual EBITDA (2) Per Facility (52% EBITDA(2) Margin) (1)
- Excludes Any Potential Carbon Credit Revenue or Sustainability "Green" Premium
- Numerous Potential Upside Opportunities Have Been Identified
VANCOUVER, BC, April 1, 2022 /PRNewswire/ - Northstar Clean Technologies Inc. (TSXV: ROOF) (OTCQB: ROOOF) ("Northstar" or the "Company") is pleased to announce the results from its internal management-prepared economic analysis for its planned expanded-capacity asphalt shingle reprocessing scale up facility in Calgary, Alberta ("Calgary Empower Facility"). As part of the recently released independent front-end engineering design ("FEED") study prepared by BBA Engineering Ltd. which provided a pre-feasibility level capital estimate for the planned Calgary Empower Facility, the Company completed a detailed internal financial analysis of the planned Calgary Empower Facility. The Company sensitized a broad range of both operational and financial assumptions to ultimately arrive on a conservative base case, which is provided here, as well as identify certain variables to provide potential upside. The results and major assumptions are provided below. All currencies quoted within this press release are in Canadian dollars.
Mr. Aidan Mills, President & CEO and Director of Northstar stated, "For a sustainable, environmental, social and governance-focused business to succeed, we believe it needs the following: Step 1) a technology that works; Step 2) the ability to scale up that technology; and Step 3) a clear and profitable commercialization strategy. Our steady state production of specification products at our Empower Pilot Facility in Delta, B.C. demonstrates Step 1 and we believe our announcement of the successful completion of our FEED study means we are on a clear pathway to Step 2. Our detailed analysis of the potential financial returns for our facilities, described below, hopes to convey to stakeholders that Step 3 is achievable."
Mr. Mills continued, "While these results are exciting for our Company, we believe a clear pathway to further upside may be available. Our internal financial analysis underpins the triple bottom-line potential of our technology, creating potential profit while benefiting our stakeholders, including shareholders, employees and the communities where we operate, and creating a positive impact on the environment. In the City of Calgary, we have the ability to not only divert approximately 30,000 to 50,000 tonnes of asphalt shingles per facility from the municipal landfill, but also potentially deliver an approximate annual EBITDA(2) of $4 Million. Not only can we help provide major municipalities across Canada and the United States with a unique circular economy and modular solution for reprocessing single-use asphalt shingles, but we hope that we can increase shareholder value and provide additional benefits to our various stakeholders."
Key Operational Assumptions:
- Total Hourly Processing Tonnage: 15 tonnes per hour
- Total Daily Processing Tonnage: 150 tonnes per day
- Total Annual Processing Tonnage: 34,200 tonnes per year
- Operational Assumptions:
- Asphalt Shingle Product Composition:
Key Financial Metrics:
Key Additional Financial Considerations
- Initial Capex: $11.7 million (based on FEED study)
- Carbon Credit Revenue: Nil
Management's View on Potential Upside of Project Economics:
- Conservative Liquid Asphalt Price: As of February 2022, the average market price of the Edmonton "Rack Rate" over the last four years since January 2018 is $715 per tonne. The Company therefore believes that its pricing assumptions are conservative relative to market prices. In addition, the current Company pricing assumptions do not include a potential impact of either locational or quality differential for Northstar's liquid asphalt.
- Potential 'Green Premium' Excluded From Pricing: The Company's liquid asphalt price does not factor in any potential green premium. The Company believes its liquid asphalt product has the potential to be North America's lowest carbon footprint asphalt and therefore could potentially command a premium to market prices.
- Operational Upside: The planned scale up facility is assumed to run 10 hours per day and 5 days a week. As a first step, the Company believes an extension of working days will allow facility operation of 24-28 days per month. In addition, on steady state operation of the first scale up facility, the Company will determine the operational potential to extend working hours each day beyond 10 hours of production. Both these elements, in turn, would potentially increase processing tonnage and further enhance project economics.
- Carbon Credit Revenue Excluded from Revenue Model: Carbon credits are not factored into the Company's revenue model. The Company assumes 0% of carbon credits are sold throughout the life of the project. Given the previously released results of the Company's independent life cycle assessment for the Empower Pilot Facility, the Company believes that it has the lowest carbon footprint of any asphalt in North America. The Company is currently undertaking a review of the range of potential carbon monetization options for the Company's facilities.
- Conservative Municipal Landfill Tipping Fee Revenue: The Company's revenue model assumes that the Company receives only 85% of its feedstock from landfill diversion, with the remaining 15% generating no tipping fee revenue. The model also assumes that the tipping fee pricing it receives will be at a discount to municipal landfill tipping fees and that tipping fees remain flat through term of the economics. Ultimately, the Company believes in time that it may be able to obtain revenue on all feedstock, decrease the discount on tipping fees and that overall tipping fees will be under pressure to increase, especially when diversion alternatives are available for hydrocarbon-based products.
- Conservative Operating Assumptions: The Company's revenue model factors a facility capacity of 95%, includes a 2-week shutdown period (excluded from the capacity figures) and a 95% yield per product. The performance objectives for each facility will be to improve on availability (capacity) and product yield, with measurement systems included in the recent FEED study design to ensure transparency of that performance.
For more information of the FEED study, please see the Company's news release dated March 31, 2022 filed under its profile on SEDAR.
Notes:
About Northstar
Northstar Clean Technologies Inc. is a Vancouver-based clean technology company focused on the sustainable recovery and reprocessing of asphalt shingles. Northstar has developed a proprietary design process for taking discarded asphalt shingles, otherwise destined for already over-crowded landfills, and extracting the liquid asphalt, aggregate and fiber for usage in new hot mix asphalt, construction products and other industrial applications. Focused on the circular economy, Northstar plans to reprocess used or defective asphalt shingle waste back into its three primary components for reuse/resale in the circular economy. As an emerging innovator in sustainable processing, Northstar's mission is to be the leader in the recovery and reprocessing of asphalt shingles in North America, extracting the recovered components from asphalt shingles that would otherwise be sent to landfill.
For further information about Northstar, please visit www.northstarcleantech.com.
On Behalf of the Board of Directors,
Aidan Mills
President & CEO, Director
Cautionary Statement on Forward-Looking Information
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. The TSXV has neither approved nor disapproved the contents of this press release.
This press release contains forward–looking information within the meaning of applicable securities legislation, which forward–looking information reflects the Company's current expectations regarding future events. Forward-looking statements are often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions. Forward-looking statements in this press release include, but are not limited to, statements regarding: the steps necessary for an environmental, social and governance-focused business to succeed; any anticipated upside from the Company's management-prepared economic analysis and, in connection therewith, the Company's ability increase shareholder value and provide additional benefits to our various stakeholders; the Company's various pricing assumptions, processing tonnage quotes, operation hours, tax incentives or carbon credits, and other operation assumptions noted under the heading "Management's View on Potential Upside of Project Economics", as well as any other general statements regarding the perceived benefits of the Calgary Empower Facility and Northstar's technology. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including risks related to factors beyond the control of the Company as well as those risks and uncertainties which are more fully described under the heading "Risk Factors" in the final prospectus of the Company dated June 18, 2021 and in the Company's annual and quarterly management's discussion and analysis and other filings with the Canadian securities regulatory authorities under the Company's profile on SEDAR. The novel strain of coronavirus, COVID-19, also poses new risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. The Company does not undertake any obligation to update such forward–looking information whether because of new information, future events or otherwise, except as expressly required by applicable law.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. The Company does not intend, and does not assume any obligation, to update the forward-looking statements except as otherwise required by applicable law.
This news release also contains future-oriented financial information and financial outlook information (collectively, "FOFI") about the Company's expected revenues, cash flow, gross margins, and EBITDA(2) following the start of operations at its Calgary Empower Facility, all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraphs. The actual financial results of the Company accordingly may vary from the amounts set out herein and such variation may be material. Northstar and its management believe that the FOFI quotes herein has been prepared on a reasonable basis, reflecting management's best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, the Company undertakes no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about Northstar's anticipated future business operations following the start of operations at its Calgary Empower Facility. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.
View original content to download multimedia:
SOURCE Northstar Clean Technologies Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/notice-2022-annual-general-meeting-2021-annual-report-accounts/
|
LONDON, April 1, 2022 /PRNewswire/ -- International Game Technology PLC ("IGT") (NYSE: IGT) today announced the posting of its Notice of the 2022 Annual General Meeting ("AGM"), accompanying proxy for the meeting, and the 2021 Annual Report and Accounts for the year ended December 31, 2021 to shareholders. The AGM will be held at IGT's registered office, Marble Arch House, 66 Seymour Street, Second Floor, London W1H 5BT, on May 10, 2022, at 3:00 p.m. British Summer Time (BST).
The Notice of the 2022 AGM and the 2021 Annual Report and Accounts are available in the Investor Relations section of the Company's website at www.IGT.com, along with IGT's 2021 Annual Report on Form 20-F for the year ended December 31, 2021. These materials can be viewed online and are also available for download in PDF format.
The Company's current plan is to hold a physical AGM in accordance with Government guidelines that may be in effect at the time of the AGM. In order to minimize public health risks, the Company is implementing health and safety arrangements for the AGM, details of which are set out in the Notice of the 2022 AGM. Shareholders are also encouraged to monitor the 2022 AGM page of the Company's website at www.IGT.com for any updates or changes to the AGM arrangements.
IGT (NYSE:IGT) is a global leader in gaming. We deliver entertaining and responsible gaming experiences for players across all channels and regulated segments, from Lotteries and Gaming Machines to Sports Betting and Digital. Leveraging a wealth of compelling content, substantial investment in innovation, player insights, operational expertise, and leading-edge technology, our solutions deliver unrivaled gaming experiences that engage players and drive growth. We have a well-established local presence and relationships with governments and regulators in more than 100 countries around the world, and create value by adhering to the highest standards of service, integrity, and responsibility. IGT has approximately 10,500 employees. For more information, please visit www.IGT.com.
This news release may contain forward-looking statements (including within the meaning of the Private Securities Litigation Reform Act of 1995) concerning International Game Technology PLC and its consolidated subsidiaries (the "Company") and other matters. These statements may discuss goals, intentions, and expectations as to future plans, trends, events, dividends, results of operations, or financial condition, or otherwise, based on current beliefs of the management of the Company as well as assumptions made by, and information currently available to, such management. Forward-looking statements may be accompanied by words such as "aim," "anticipate," "believe," "plan," "could," "would," "should," "shall," "continue," "estimate," "expect," "forecast," "future," "guidance," "intend," "may," "will," "possible," "potential," "predict," "project," or the negative or other variations of them. These forward-looking statements speak only as of the date on which such statements are made and are subject to various risks and uncertainties, many of which are outside the Company's control. Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may differ materially from those predicted in the forward-looking statements and from past results, performance, or achievements. Therefore, you should not place undue reliance on such statements. Factors that could cause actual results to differ materially from those in the forward-looking statements include (but are not limited to) the factors and risks described in the Company's annual report on Form 20-F for the financial year ended December 31, 2021 and other documents filed from time to time with the SEC, which are available on the SEC's website at www.sec.gov and on the investor relations section of the Company's website at www.IGT.com. Except as required under applicable law, the Company does not assume any obligation to update these forward-looking statements. You should carefully consider these factors and other risks and uncertainties that affect the Company's business. All forward-looking statements contained in this news release are qualified in their entirety by this cautionary statement. All subsequent written or oral forward-looking statements attributable to International Game Technology PLC, or persons acting on its behalf, are expressly qualified in their entirety by this cautionary statement.
Contact:
Phil O'Shaughnessy, Global Communications, toll free in U.S./Canada +1 (844) IGT-7452; outside U.S./Canada +1 (401) 392-7452
Francesco Luti, +39 06 5189 9184; for Italian media inquiries
James Hurley, Investor Relations, +1 (401) 392-7190
© 2022 IGT
The trademarks and/or service marks used herein are either trademarks or registered trademarks of IGT, its affiliates or its licensors.
View original content to download multimedia:
SOURCE International Game Technology PLC
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/numinus-host-q2-2022-results-conference-call-april-14-2022/
|
VANCOUVER, BC, April 1, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, will release its financial results for the quarter ended February 28, 2022, after market close on Thursday, April 14, 2022.
Interested parties are invited to participate in the Company's Q2 2022 results conference call and webcast occurring on the same day, at 5:30 p.m. Eastern time / 2:30 p.m. Pacific time. During the call, Numinus executives will review the Company's performance and recent initiatives, and answer questions from analysts.
To listen to the live webcast, please register at: https://event.on24.com/wcc/r/3723657/8A7C51BC48923FC18A54C2754EF10DBA
The webcast will also be archived on the Events and Presentations page of Numinus' Investor Relations website: https://www.investors.numinus.com/events-and-presentations
To participate in the live conference call, please use the following dial-in information:
- 1 (888) 330-3632 (Toll-free North America)
- 1 (646) 960-0837 (International)
- Please ask to participate in Numinus' Q2 2022 Results Call. To avoid any delays in joining the call, please dial in at least five minutes prior to the call start time. If prompted, please provide conference passcode 3547386.
A replay of the conference call can also be accessed after 8:30 p.m. Eastern time / 5:30 p.m. Pacific time on April 14, 2022, at 1-800-770-2030 or 1-647-362-9199 (using passcode 3547386). The replay will be available until April 28, 2022.
About Numinus
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Forward-Looking Statements
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:
SOURCE Numinus Wellness Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/nurtec-rimegepant-lactation-clinical-study-published-breastfeeding-medicine-journal/
|
NEW HAVEN, Conn., April 1, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), today announced that data from a Phase 1, single-center, open-label study evaluating the excretion of a single dose of rimegepant 75 mg in the human milk of healthy lactating women was published in the peer-reviewed journal, Breastfeeding Medicine, the official journal of the Academy of Breastfeeding Medicine.
This study is particularly important as migraine affects more than 30 million women in America and is the most common cause of disability among women of reproductive age (15 – 49 years).1,2 Often for women with migraine, attacks may subside during pregnancy but resume within 4 weeks of childbirth.3 Given a lack of science-based information about migraine medication for nursing mothers, women are often apprehensive about taking their migraine medications while breastfeeding.
The results of the study showed that excretion of rimegepant into human milk is very low and rimegepant was safe and well tolerated by lactating women. It was estimated that on a weight-adjusted basis, a nursing infant would receive <1% of the maternal dose of rimegepant which is much below the commonly cited safety threshold of <10% of the maternal dose. Further, there were no serious adverse events and no participants discontinued the study due to treatment related adverse events.
Robert Croop, M.D., Chief Development Officer - Neurology at Biohaven commented, "This is important data for women of reproductive age with migraine as it provides helpful new information for those who are lactating and wish to breastfeed their infants. Recognizing the lack of available data on migraine medications for breastfeeding women, Biohaven is proud to take a science-based approach by conducting a clinical study in this population."
The study evaluated 12 healthy lactating women who were administered a single-dose of rimegepant 75 mg with a 36-hour follow-up. The primary objective of this study was to investigate whether rimegepant is excreted in human milk after a single 75 mg dose and to determine the concentration–time profiles of rimegepant in the human milk and plasma of healthy lactating women.
Thomas W. Hale, Ph.D., Professor of Pediatrics and Associate Dean for Research at Texas Tech University Health Sciences Center School of Medicine, noted, "I'm very pleased with the results of this clinical trial. Lactating mothers often end up having to choose between taking a migraine medication or breastfeeding their infant. Many of the questions we receive at the InfantRisk Center are about using migraine medications when breastfeeding. Now, with this research, we can share with lactating mothers that there is clinical data supporting a treatment option during breastfeeding."
Dr. Hale and Teresa Baker, M.D., Associate Professor and Chair of the Department of Obstetrics and Gynecology at Texas Tech University Health Sciences Center School of Medicine, are coauthors of the publication.
About NURTEC ODT
NURTEC® ODT (rimegepant) is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist available in a quick-dissolve ODT formulation that is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine with or without aura and the preventive treatment of episodic migraine in adults. The activity of the neuropeptide CGRP is thought to play a causal role in migraine pathophysiology. NURTEC ODT is a CGRP receptor antagonist that works by reversibly blocking CGRP receptors, thereby inhibiting the biologic activity of the CGRP neuropeptide. For more information about NURTEC ODT, visit www.nurtec.com.
Rimegepant is available as Nurtec® ODT in the United States for the acute and preventive treatment of migraine in adults. Biohaven and Pfizer Inc. recently announced a positive opinion by the Committee for Medicinal Products for Human Use of the European Medicines Agency recommending the marketing authorization for rimegepant 75 mg for the acute and preventive treatment of migraine. If approved, the trade name will be Vydura™ in the European Union.
Indication
NURTEC ODT orally disintegrating tablets is a prescription medicine that is used to treat migraine in adults. It is for the acute treatment of migraine attacks with or without aura and the preventive treatment of episodic migraine. It is not known if NURTEC ODT is safe and effective in children.
Important Safety Information
Do not take NURTEC ODT if you are allergic to NURTEC ODT (rimegepant) or any of its ingredients. Before you take NURTEC ODT, tell your healthcare provider (HCP) about all your medical conditions, including if you:
- have liver problems,
- have kidney problems,
- are pregnant or plan to become pregnant,
- breastfeeding or plan to breastfeed.
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
NURTEC ODT may cause serious side effects including allergic reactions, trouble breathing and rash. This can happen days after you take NURTEC ODT. Call your HCP or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing. This occurred in less than 1% of patients treated with NURTEC ODT.
The most common side effects of NURTEC ODT were nausea (2.7%) and stomach pain/indigestion (2.4%). These are not the only possible side effects of NURTEC ODT. Tell your HCP if you have any side effects.
You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1–800–FDA–1088 or report side effects to Biohaven at 1–833–4NURTEC.
See full Prescribing Information and Patient Information.
About Biohaven
Biohaven is a commercial-stage biopharmaceutical company with a portfolio of innovative, best-in-class therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. Biohaven's Neuroinnovation™ portfolio includes FDA-approved NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a broad pipeline of late-stage product candidates across three distinct mechanistic platforms: CGRP receptor antagonism for the acute and preventive treatment of migraine; glutamate modulation for obsessive-compulsive disorder, and spinocerebellar ataxia; and MPO inhibition for amyotrophic lateral sclerosis; Kv7 Ion Channel Activators (Kv7), and Myostatin. More information about Biohaven is available at www.biohavenpharma.com.
Forward-looking Statement
This news release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including "believe", "continue", "may", "will", "anticipate", "expect" and similar expressions, are intended to identify forward-looking statements. These forward-looking statements involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of Biohaven's management about NURTEC ODT as an acute treatment for patients with migraine and preventive treatment for migraine. Factors that could affect these forward-looking statements include those related to: Biohaven's ability to effectively commercialize NURTEC ODT, delays or problems in the supply or manufacture of NURTEC ODT, complying with applicable U.S. regulatory requirements, the expected timing, commencement and outcomes of Biohaven's planned and ongoing clinical trials, the timing of planned interactions and filings with the FDA, the timing and outcome of expected regulatory filings, the potential commercialization of Biohaven's product candidates, the potential for Biohaven's product candidates to be first in class or best in class therapies and the effectiveness and safety of Biohaven's product candidates. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by forward-looking statements. Additional important factors to be considered in connection with forward-looking statements are described in the "Risk Factors" section of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 25, 2022, and in Biohaven's subsequent filings with the Securities and Exchange Commission. The forward-looking statements are made as of the date of this new release, and Biohaven does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
NURTEC and NURTEC ODT are registered trademarks of Biohaven Pharmaceutical Ireland DAC. Neuroinnovation is a trademark of Biohaven Pharmaceutical Holding Company Ltd.
Biohaven Contact
Jennifer Porcelli
Vice-President, Investor Relations
jennifer.porcelli@biohavenpharma.com
201-248-0741
Media Contact
Mike Beyer
Sam Brown Inc.
mikebeyer@sambrown.com
312-961-2502
REFERENCES FOR REVIEW:
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020;396:1204–1222.
- GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17:954–976.
- Sances G, Granella F, Nappi RE, et al. Course of migraine during pregnancy and postpartum: A prospective study. Cephalalgia 2003;23:197–205.
View original content to download multimedia:
SOURCE Biohaven Pharmaceutical Holding Company Ltd.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/opti9-technologies-llc-announces-launch-hybrid-it-management-tool-optixdashboard/
|
GARDEN CITY, N.Y., April 1, 2022 /PRNewswire/ -- Opti9 Technologies LLC (Opti9) of Garden City, NY and Omaha, NE, announces the launch of its hybrid cloud management tool, OptiXdashboard. This single pane of glass platform provides unparalleled insights and orchestration tools for public, private, and hybrid infrastructure including the integration of Opti9's enhanced CloudOps Managed Services offering for Amazon Web Services (AWS).
"We've enhanced our dashboard to address the unique needs of managing complex workloads across multiple clouds, services, and platforms. It provides a single interface to define and manage resources, alerts, reporting, service-level-agreements (SLAs), security, and networking across the hybrid cloud landscape. This ensures all systems are delivered and secured in the same manner, all backed by Opti9's managed service offerings. This is the true realization of the hybrid vision behind the formation of Opti9 earlier this year," said Sagi Brody, CTO of Opti9.
The most notable addition to the dashboard is the inclusion of CloudOps, Opti9's fully managed AWS service. The dashboard now provides full integration for CloudOp's managed security, compliance, networking, FinOps, best practices, asset management, and customizable alarms as they relate to AWS. Additionally, customers can utilize the dashboard's existing management, orchestration, and resilience capabilities. CloudOps is also integrated into the existing granular role-based-access-control, authentication, service help desk, and notification routing for the entire hybrid ecosystem. This includes AWS, private clouds, networking, backups, and disaster recovery services, allowing network and security standards to remain consistent across the entire hybrid cloud domain.
The OptiXdashboard allows organizations to customize and control the value they receive from a managed service offering. This includes the ability to dictate which alarms and events are impactful to their business and should be immediately routed to Opti9's Network Operations Center (NOC), as opposed to those which should be sent to their own business units for further investigation. Additionally, businesses can define per-service and per-cloud recovery point objective (RPO) SLAs, technical contacts, and escalations. The dashboard also provides real-time and historical aggregated hybrid cloud usage data, along with service-specific details.
About Opti9
Opti9 is a hybrid cloud solutions provider with offices in Garden City, NY, Omaha, NE, Overland Park, KS, and St. Louis, MO, and data centers in North America, Europe and the APAC region. The company is an AWS Advanced Consulting Partner and Veeam Platinum VCSP, along with several other key partnerships and certifications. Opti9 specializes in managed cloud services, application development and modernization, backup and disaster recovery, security, and compliance. With its business-first focus, Opti9 blends experience with innovation and new solutions to deliver on its "Right Workload, Right Cloud, Right Time" approach.
To learn more about Opti9, visit opti9tech.com, and connect on LinkedIn and Twitter.
View original content:
SOURCE Opti9
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/penske-automotive-group-expands-presence-united-kingdom/
|
Acquires Three BMW MINI Dealerships and a Collison Center
Adds $250 Million in Annualized Revenues; Builds Further Scale in U.K. Market
BLOOMFIELD HILLS, Mich., April 1, 2022 /PRNewswire/ -- Penske Automotive Group, Inc. (NYSE: PAG), a diversified international transportation services company and one of the world's premier automotive and commercial truck retailers, today announced that its U.K. subsidiary ("Sytner Group") has acquired three BMW MINI dealerships and a collision center in the U.K. The acquired dealerships are located in South East England, north of London, complementing the existing presence of 32 BMW MINI franchises operated by the company in the U.K. market.
Commenting on the acquisition, Darren Edwards, CEO of the Sytner Group, said, "I am pleased to announce that we have expanded our relationship with the BMW and MINI brands in the U.K. The acquisition of these dealerships enhances our position as the largest retail partner for the BMW and MINI brands in the U.K. and provides an opportunity for our business to build additional scale in this important market. We welcome these new businesses to our team."
This acquisition is expected generate $250 million in annualized revenues for Penske Automotive Group and was funded using existing capacity under the company's U.K.-based credit agreement. Year-to-date 2022, Penske Automotive Group has added approximately $550 million in annualized revenue through acquisitions and open points.
Penske Automotive Group, Inc., (NYSE: PAG) headquartered in Bloomfield Hills, Michigan, is a diversified international transportation services company and one of the world's premier automotive and commercial truck retailers. PAG operates dealerships principally in the United States, the United Kingdom, Germany, Italy, and Japan and is the largest retailer of commercial trucks in North America for Freightliner. PAG also distributes and retails commercial vehicles, diesel and gas engines, power systems and related parts and services principally in Australia and New Zealand. Additionally, PAG owns 28.9% of Penske Transportation Solutions, a business that manages a fleet of over 360,000 vehicles providing innovative transportation, supply chain and technology solutions to North American fleets. PAG is a member of the Fortune 500, Russell 1000, and Russell 3000 indexes, and is ranked among the World's Most Admired Companies by Fortune Magazine. For additional information, visit the company's website at www.penskeautomotive.com.
Statements in this press release may involve forward-looking statements, including forward-looking statements regarding Penske Automotive Group, Inc.'s financial performance, and growth plans. Actual results may vary materially because of risks and uncertainties that are difficult to predict. These risks and uncertainties include, among others, the duration, severity, and resolution of the COVID-19 pandemic, government mandated restrictions on our business in light of COVID-19 or otherwise, economic and geo-political conditions generally, conditions in the credit markets, changes in interest rates and foreign currency exchange rates, changes in tariff rates, changes in the distribution model in our international operations via agency or other means, adverse conditions affecting a particular manufacturer, including the adverse impact to the vehicle and parts supply chain due to limited vehicle availability due to the COVID-19 pandemic, the shortage of automotive semiconductor chips or other components, natural disasters, recall or other disruptions that interrupt the supply of vehicles or parts to us, changes in consumer credit availability, the outcome of legal and administrative matters, and other factors over which management has limited control. These forward-looking statements should be evaluated together with additional information about Penske Automotive Group's business, markets, conditions, and other uncertainties, which could affect Penske Automotive Group's future performance. These risks and uncertainties are addressed in Penske Automotive Group's Form 10-K for the year ended December 31, 2021, and its other filings with the Securities and Exchange Commission ("SEC"). This press release speaks only as of its date, and Penske Automotive Group disclaims any duty to update the information herein.
Inquiries should contact:
View original content to download multimedia:
SOURCE Penske Automotive Group, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/points-light-kicks-off-third-annual-global-volunteer-month/
|
Organization calls on citizens, nonprofits and corporations to recognize volunteers in their communities and learn best ways to engage as the need for volunteers rises.
ATLANTA, April 1, 2022 /PRNewswire/ -- Points of Light, the world's largest nonprofit dedicated to accelerating people-powered change, today launched its third annual Global Volunteer Month. Occurring each April, Global Volunteer Month was established to inspire and activate volunteers in support of the most vulnerable populations and to tackle society's greatest challenges. This year, Points of Light is leading a joint effort with leading sponsor Phillips 66 and supporting sponsor The UPS Foundation to encourage individuals, nonprofits and corporate partners to recognize individual action and inspire more people to volunteer in their communities.
"Throughout the pandemic and most recently surrounding the war in Ukraine, we have seen powerful and inspiring stories of people rising to the occasion to support their neighbors and people around the world," said Natalye Paquin, president and CEO of Points of Light. "During times of uncertainty like these, one thing we can be certain of is that the most powerful force of change in our world is the individual – one person making a positive difference – and Global Volunteer Month is our opportunity to recognize them and inspire others in the process."
Research shows that 87% of people will make time for a worthwhile volunteer opportunity, yet 44% are unsure how to get involved or where to find opportunities to volunteer. Individuals, nonprofits, companies, and government officials seeking to get involved can download resources from Points of Light, including creative ideas to make the most of Global Volunteer Month. They can also visit Points of Light Engage, the world's largest digital hub of virtual and in-person volunteer opportunities with resources from over 170 local Points of Light affiliates, to learn what individual communities need.
"Companies, nonprofits and governments alike have a unique and critical role to play as partners in fostering a thriving society," said Claudia Kreisle, manager of social impact at Phillips 66. "At Phillips 66, we believe actions speak louder than words. That's why we're proud to partner once again with Points of Light to inspire action and support our communities' most pressing needs during Global Volunteer Month."
Points of Light's Global Volunteer Month is a cross-industry collaboration with partners spanning the corporate and nonprofit sectors. Some of the brands recognizing and activating during April include: Lowe's, AARP, Thrive Global, Deloitte, Chicago White Sox, Gas South, AmeriCorps, America's Service Commissions, Heart of America and Voices for National Service.
State governments across the country have joined in to recognize volunteers during Global Volunteer Month. Georgia, Michigan and a growing list of other states have issued formal proclamations honoring the millions of individuals who volunteer throughout the year.
Those who wish to participate in Global Volunteer Month are encouraged to use #GlobalVolunteerMonth for social media posts related to Global Volunteer Month.
About Points of Light
Points of Light is a nonpartisan, global nonprofit organization that inspires, equips and mobilizes millions of people to take action that changes the world. We envision a world in which every individual discovers the power to make a difference, creating healthy communities in vibrant, participatory societies. Through 177 affiliates across 38 countries, and in partnership with thousands of nonprofits and corporations, Points of Light engages 5 million volunteers in 16 million hours of service each year. We bring the power of people to bear where it's needed most. For more information, visit www.pointsoflight.org.
About Phillips 66
Phillips 66 is a diversified energy manufacturing and logistics company. With a portfolio of Midstream, Chemicals, Refining, and Marketing and Specialties businesses, the company processes, transports, stores and markets fuels and products globally. Phillips 66 Partners, the company's master limited partnership, is integral to the portfolio. Headquartered in Houston, the company has 14,000 employees committed to safety and operating excellence. Phillips 66 had $56 billion of assets as of Dec. 31, 2021. For more information, visit www.phillips66.com or follow us on Twitter @Phillips66Co.
View original content to download multimedia:
SOURCE Points of Light
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/points-light-releases-global-research-trends-civic-engagement/
|
Report Provides Best Practices and Solutions for Businesses, Nonprofits and Individuals
ATLANTA, April 1, 2022 /PRNewswire/ -- Points of Light, the world's largest nonprofit dedicated to accelerating people-powered change, today released its first global report, revealing key trends in civic engagement and providing actionable takeaways for businesses, non-profits and individuals. The research is released as Points of Light kicks off Global Volunteer Month, a time to recognize the impact of volunteering on society's greatest challenges. Points of Light's Civic Life Today: The State of Global Civic Engagement surveyed respondents in the U.S., the U.K., Brazil and India, to provide insight on issues driving people to civic engagement and expectations around volunteering.
"This research is crucial for businesses and nonprofits to understand the challenges society is facing and the motivations of employees and consumers looking to enact change," said Natalye Paquin, president and CEO of Points of Light. "There is a new expectation that businesses and nonprofits must support people by making it easier for them to act effectively."
Among its findings, the global study revealed:
- Volunteering is ranked among the most important activities since the pandemic, but by varying degrees among countries. 54% of global respondents said, "I plan to volunteer more than I did before the pandemic." India and Brazil showed substantially more commitment to increasing volunteerism with the U.S. and the U.K. showing less commitment to increasing how much they volunteer.
- Globally, individuals share most interest in supporting education, environment and healthcare. Across the countries responding, healthcare, education and environment/climate uniformly demand attention. India (59%) and Brazil (70%) were most focused on education, the U.K. (52%) on environment/climate and the U.S. (48%) on healthcare.
- Finances remain one of the largest barriers to engagement. Two of the top three reasons people cited for a lack of social issue involvement were financial in nature. This reflects the public's continued perception that being involved with a cause, nonprofit or NGO means giving money. Organizations have much work to do in educating current and potential audiences about the many ways they can influence change.
- Corporations have an obligation to act. Nearly every respondent in India (95%) and Brazil (90%) and two-thirds of those in the U.S. and U.K. said they expect companies to address social challenges. However, while people have high expectations for corporate involvement in social issues, consumers have low desire for a company to involve them directly. Respondents will measure a company's sincerity in its social actions by the way it treats its employees.
- Nontraditional forms of engagement are the new normal. The most common actions taken to support issues were using one's voice (posted or shared content on social media), listen and learn (took time to learn about a cause or social issue) and volunteerism (intentionally helped someone else).
The report also supports Points of Light's Civic Circle. The Civic Circle is a framework to help companies around the world create a variety of workforce service commitments by giving them tools to institute and streamline their volunteer processes – a critical resource now more than ever. "The most powerful force in the world is the individual who has realized their power to make change happen," said Paquin.
You can view the full civic engagement report here. On Tuesday, May 10 at 1 pm ET, Points of Light will host a special webinar with INFLUENCE|SG to discuss the research findings in more detail. You can click here to register.
About Points of Light
Points of Light is a nonpartisan, global nonprofit organization that inspires, equips and mobilizes millions of people to take action that changes the world. We envision a world in which every individual discovers the power to make a difference, creating healthy communities in vibrant, participatory societies. Through 177 affiliates across 38 countries, and in partnership with thousands of nonprofits and corporations, Points of Light engages 5 million volunteers in 16 million hours of service each year. We bring the power of people to bear where it's needed most. For more information, visit www.pointsoflight.org.
About INFLUENCE|SG
INFLUENCE|SG is a global research and advisory firm focused on helping companies and causes bolster their social change initiatives by informing through new insights and guiding through strategy. We create and drive public involvement in our clients' social change work. Influencesg.com.
Contact:
Meghann Gibbons
mgibbons@pointsoflight.org
View original content to download multimedia:
SOURCE Points of Light
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/ponsses-solutions-processing-operations/
|
HELSINKI, April 1, 2022 /PRNewswire/ -- Productivity and reliability are key properties in Ponsse's harvester heads. Harvester heads must withstand constant stress in varying conditions and operate accurately without damaging stems. Continuous research and development together with customers and decades of experience have made our wood processing solutions productive and reliable. Ponsse provides highly advanced harvesting solutions, and we are one of the leading manufacturers in the markets.
Sign up to the PONSSE Studio online event to hear our customers' experiences and Ponsse employees' thoughts of harvester heads that are ideal for base machines used for processing wood.
Date and time: 6 April at 7 pm EEST
The event will be held in English, and it will be subtitled in Spanish, Portuguese, French and Finnish.
FURTHER INFORMATION:
Janne Loponen, product manager, harvester heads,
janne.loponen@ponsse.com,
tel. +358 40 502 8018
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE Ponsse Oyj
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/pop-mart-introduces-latest-400-space-molly-blind-box-its-high-end-collection/
|
BEIJING, April 1, 2022 /PRNewswire/ -- China's leading pop culture and entertainment company POP MART announces the launch of the MEGA COLLECTION 400% SPACE MOLLY SOFT DRINKS series. MOLLY fans can enjoy refreshing new colorful designs of the classic SPACE MOLLY figure with the limited blind box collection from April 8th.
Inspired by iconic alcohol-free soft drinks, the latest 400% SPACE MOLLY blind box collection comes in six styles and one secret edition. The figurine stands at 29.5 cm, and the six designs include Pink Lady, Blue Hawaii, Maui Moscow Mule, Angel's Kiss, Manhattan, and Mojito, and a hidden design named Rainbow Paradise. Fans can savor a taste of life as the styles showcase the vibrant hues of each respective soft drink flavor. Toy ice cubes also feature in the body for the first time to add extra flavor and wonderment. With MOLLY's signature accessories styled to reflect each fizzy drink, fans are bound to get a pop of excitement every time they play with the colorful new series.
As a high-end product line of POP MART, the MEGA COLLECTION is created to satisfy the interests of art toy collectors, specifically those who enjoy high-end art toys. The iconic design of SPACE MOLLY has attracted world-renowned luxury brands, e-sports teams, and pop culture artists to collaborate and launch crossover products, including MONCLER, EDG and Keith Haring. So far, POP MART has invested in expanding the MEGA COLLECTION into more characters, including the company's top IP figures, such as Molly, SKULLPANDA, Dimoo, Flabjacks, and Crybaby.
MEGA COLLECTION 400% SPACE MOLLY soft drinks series blind box will be available on April 8th on all POP MART global online and offline channels outside mainland China. Each buyer is limited to buying two sets of the MEGA COLLECTION. For more information on the MEGA COLLECTION and to keep up to date with upcoming products, visit the brand's social platforms @popmartglobal on Instagram, Twitter and Facebook.
View original content to download multimedia:
SOURCE POP MART
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/quantix-receives-multiple-responsible-care-awards-american-chemistry-council/
|
Awards Recognize Chemical Industry Leaders for Excellence in Environmental, Health, Safety & Security Initiatives
HOUSTON, April 1, 2022 /PRNewswire/ -- Quantix, North America's leading supply chain services company to the chemical industry, announced today it received multiple Responsible Care® awards from the American Chemistry Council (ACC) during the 2022 Responsible Care & Sustainability Conference. The annual event was held in late-March.
Through its awards program, the ACC recognizes chemical industry leaders for their environmental, health, safety and security (EHS&S) performance, commitment to sustainability and sound chemicals management practices. Recipients of the awards qualify based on exemplary performance and leadership in Responsible Care.
The following awards were presented to the company:
- 2022 Partner Company Employee of the Year awarded to Tanya Rogers, Corporate Compliance Manager at Quantix. Tanya is actively engaged in numerous committees and work groups focused on updating Responsible Care's Codes of Management Practices across the industry, enhancing the initiative's third-party auditing program, and developing tools for ACC companies to use to assess the EHS&S performance of their commercial partners.
- Responsible Care New Company of the Year awarded to Quantix In-Plant Services. This award recognizes a company that has joined Responsible Care during the most recent certification cycle and fulfilled their obligations ahead of schedule.
- 2022 Facility Safety Award awarded to 25 sites across Quantix's Dry Bulk Transportation, In-Plant Services and Liquid Transportation divisions that met requirements for a Certificate of Achievement or Excellence.
"It's an honor to be recognized by the ACC for our support of, and participation in, the Responsible Care program," said Dionne Quiachon, Chief Environmental Health Safety Security & Quality Officer at Quantix. "Tanya works tirelessly across our divisions to ensure Responsible Care compliance and she has played a vital role in educating our newly acquired companies about the Responsible Care certification process. Receiving these awards shows our continued commitment to prioritizing safety and sustainability across our operations."
In January of this year, Quantix was the first company to achieve Responsible Care certification for its own operations within a customer's plant. While the ACC has certified companies as Responsible Care within a company's facilities for nearly 35 years, Quantix was the first company ever to achieve this certification. Additionally, the company received its first ever Responsible Care certification for its liquid chemical trucking operations division bringing it to a total of four certifications received through the ACC.
Quantix joined the Responsible Care program 15 years ago with its bulk plastics division, under the legacy name of A&R Transport. By participating in this program, Quantix has made CEO-level commitments to the program, including tracking and transparently reporting company performance on EH&S and security metrics, undergoing third-party audit and certification to Responsible Care Management System (RCMS®) and implementing the Product Safety, Process Safety and Security Codes.
Learn more at www.quantixscs.com.
About Quantix
Quantix is the leading supply chain services company to the chemical industry. It provides the world's largest chemical providers with end-to-end support through a nationwide network and comprehensive suite of services including transportation, 3PL solutions, distribution centers, export/import and Eco-Recovery. Headquartered in The Woodlands, TX with over 50 locations across the U.S., Quantix is committed to providing the highest level of safety, quality, compliance and integrity across its entire operation. Learn more at www.quantixscs.com.
View original content to download multimedia:
SOURCE Quantix
| true
| true
|
both
|
www.kbtx
|
20220401
|
https://www.kbtx.com/prnewswire/2022/04/01/reduce-lap-hf-ii-analyses-show-50-study-patients-demonstrated-significant-clinical-benefit-corvia-atrial-shunt/
|
Landmark trial advances understanding of which HFpEF patients may benefit from atrial shunt therapy
TEWKSBURY, Mass., April 1, 2022 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), announced publication of analyses from its global, phase III REDUCE LAP-HF II randomized trial of heart failure patients with preserved (HFpEF) or mildly reduced (HFmrEF) ejection fraction. In a large responder population, representing 50% of study patients, treatment with the Corvia® Atrial Shunt resulted in a 45% reduction in HF events and a 55% greater improvement in quality of life compared to sham control. Additionally, these data offer essential new insights into the role of exercise in accurately predicting patients who may or may not benefit from this novel therapy. The analyses were published online in Circulation1
"We are extremely encouraged by these analyses from the REDUCE LAP-HF II trial. Not only have we identified a large responder group comprising two-thirds of people with HFpEF, or approximately 2 million people in the US alone, but we have also learned how to identify potential patients who are most likely to derive significant benefit," said Sanjiv Shah, MD, Professor of Medicine, Director of Research for the Bluhm Cardiovascular Institute, Director of the HFpEF Program at Northwestern University Feinberg School of Medicine and co-principal investigator of the REDUCE LAP-HF II trial.
More than 26 million people worldwide have HF,2 and over half those have HFpEF,3 which has been described as the largest unmet clinical need in cardiovascular medicine. The Corvia Atrial Shunt is designed to reduce elevated left atrial pressure (LAP), the primary contributor of HF symptoms in HFpEF patients. The shunt is placed via catheter between the left and right atria, forming a passage that allows blood to flow from the high pressure left atrium to the lower pressure right atrium, with the aim of reducing HF symptoms and events and improving quality of life.
Barry Borlaug, MD, Professor of Medicine, Director of Circulatory Failure Research at Mayo Clinic and lead author of the publication commented, "Exercise hemodynamic evaluation appears to be a key factor in predicting which patients will do well with atrial shunt therapy. Patients whose pulmonary blood vessels, or vessels in the lungs, can accommodate an increase in blood flow during exercise appear to derive significant benefit from the shunt, compared to those whose blood vessels can't accommodate the additional flow. While I have long been an advocate for hemodynamic testing in heart failure, the data from this study reinforces the importance of exercise phenotyping and will change how we evaluate heart failure patients and personalize their care."
The REDUCE LAP-HF II trial randomized 626 patients at 89 centers across the US, Canada, Europe, Australia, and Japan. A systematic, independent, statistical analysis identified exercise pulmonary vascular resistance (PVR), a measure indicating the degree of pulmonary vascular disease, and the presence of a pacemaker as the most significant variables affecting how patients responded to atrial shunting. The results showed that patients without a pacemaker and with normal exercise PVR comprised 50% of the total study population and derived significant clinical benefit:
- 45% reduction in HF events compared to sham control (12 vs. 22 events per 100 patient-years, p=0.007)
- 55% greater improvement (+5.5 points) in health status as measured by Kansas City Cardiomyopathy Questionnaire (KCCQ), with 40% more shunt patients reporting a very large improvement (≥20 points) in quality of life
- 50% greater improvement in New York Heart Association (NYHA) HF class, indicating fewer HF symptoms
"HFpEF has a complex pathophysiology and remains a significant therapeutic challenge. While novel drugs are now available, limitations remain, and additional therapies are required to treat this heterogenous population," commented Prof. David Kaye, MD, PhD, Director of the Department of Cardiology at The Alfred Hospital, Head of Heart Failure Research at the Baker Institute in Melbourne, Australia, and an investigator in the study." We now know the importance of exercise hemodynamic phenotyping prior to determining a therapeutic strategy for HFpEF patients and these learnings should be applied today in both the commercial and clinical trial settings. Assuming additional studies confirm the responder population findings, this therapy has enormous potential to improve the lives of millions of heart failure patients."
REDUCE LAP-HF II represents the largest randomized controlled trial of device-based therapy for HFpEF patients and is the only study of an implantable therapeutic device to show clinical benefit in this population. "The Corvia Atrial Shunt is the most rigorously studied atrial shunt therapy. Exercise hemodynamic evaluation has been a key component of all our studies and its importance in identifying suitable patients for atrial shunting has now been confirmed," commented Jan Komtebedde, Senior Vice President and Chief Medical Officer at Corvia Medical. "We are working with advisors and regulators to design a confirmatory study that builds on the extensive data and progressive learnings from REDUCE LAP-HF II and we look forward to bringing this breakthrough therapy to the US and international markets to help this underserved population."
About Corvia Medical, Inc.
Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, Corvia is dedicated to transforming the standard of care for heart failure treatment, enabling patients to reclaim their lives. The Corvia Atrial Shunt was granted Breakthrough Device designation by the FDA in 2019. Privately held, the company is backed by Third Rock Ventures, General Catalyst Partners, AccelMed, Lumira Ventures, Edwards Lifesciences, and an undisclosed strategic investor. Visit https://corviamedical.com/.
MEDIA CONTACT:
Lisa Ensz
+1 978-654-6120
lensz@corviamedical.com
https://corviamedical.com/newsroom/
- Borlaug BA et al. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure. Circulation. 2022;10.1161.
- Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017;3(1):7-11.
- Owan TE et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.
View original content to download multimedia:
SOURCE Corvia Medical, Inc.
| true
| true
|
both
|
www.kbtx
|
20220401
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.